syndrome	score	normalized_score
PARAMYOTONIA CONGENITA OF VON EULENBURG	4.678294900000001	100.0
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	42.75061839303888
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	1.55725642	33.28683747576493
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	1.31973289	28.20969858056618
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	1.31932692	28.201020846291662
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	1.1749821700000003	25.115607184147372
GLOMUVENOUS MALFORMATION	1.142857	24.428921742406615
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	1.11676445	23.871185418430972
MYOTONIA CONGENITA, AUTOSOMAL DOMINANT	1.083334	23.15659921310219
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	1.06368982	22.736698791690106
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	1.02516359	21.91318871326388
CHIARI MALFORMATION TYPE II	1.0192308	21.786373492615866
SPINOCEREBELLAR ATAXIA, X-LINKED 3	1.01777445	21.755243561067513
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.01151131	21.62136700702642
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	1.00617284	21.50725556014008
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	1.00605815	21.504804025928333
ATRESIA OF SMALL INTESTINE	1.00401606	21.461153720771215
ADRENOCORTICAL CARCINOMA	1.00294985	21.438363152352792
DEHYDRATED HEREDITARY STOMATOCYTOSIS	1.0	21.37530919651944
DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR	1.0	21.37530919651944
ANAPLASTIC THYROID CARCINOMA	1.0	21.37530919651944
JERVELL AND LANGE-NIELSEN SYNDROME	1.0	21.37530919651944
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0	21.37530919651944
HORNER SYNDROME, CONGENITAL	1.0	21.37530919651944
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	1.0	21.37530919651944
DEXTROCARDIA	1.0	21.37530919651944
PEUTZ-JEGHERS SYNDROME	1.0	21.37530919651944
PLUMMER-VINSON SYNDROME	1.0	21.37530919651944
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	1.0	21.37530919651944
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.0	21.37530919651944
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	1.0	21.37530919651944
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	1.0	21.37530919651944
PIGMENTED VILLONODULAR SYNOVITIS	1.0	21.37530919651944
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.0	21.37530919651944
TYPICAL NEMALINE MYOPATHY	0.99306875	21.22715158465106
GNE MYOPATHY	0.97272545	20.79230725707351
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.91961685	19.657094511079237
PURE MITOCHONDRIAL MYOPATHY	0.8876474100000001	18.973737846239665
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.8777029000000001	18.761170870181783
MYOPATHY AND DIABETES MELLITUS	0.8616059	18.417092518045408
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.8232661	17.59756743851269
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.81932692	17.513366248031943
CONGENITAL MYASTHENIC SYNDROME	0.79407962	16.97369740415466
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.79407962	16.97369740415466
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.7695421	16.44920032723888
RICHIERI COSTA-DA SILVA SYNDROME	0.73442799	15.698625368828287
RIGID SPINE MUSCULAR DYSTROPHY 1	0.72279045	15.44986935304142
HEREDITARY ACROKERATOTIC POIKILODERMA	0.7081871	15.13771823148643
HYPOKALEMIC PERIODIC PARALYSIS	0.6882391999999999	14.71132570116518
ARNOLD-CHIARI MALFORMATION TYPE I	0.6625	14.161142342694127
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.6530591	13.959340186100707
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.64902984	13.873213507767538
MIYOSHI MYOPATHY	0.6428359	13.740816125122848
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.6412884000000001	13.707737834141238
MYOPATHY, SCAPULOHUMEROPERONEAL	0.6189391399999999	13.23001549132783
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.6180286	13.210552417292035
OCULOPHARYNGODISTAL MYOPATHY	0.59552757	12.729585943801872
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.59280268	12.67134057752537
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.58531968	12.511389138807813
GANGLIONEUROMA	0.5833333	12.468929652126032
DESMINOPATHY	0.5777846000000001	12.350324473987307
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.5665849	12.110927423579044
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.56215541	12.016245705246154
LAING EARLY-ONSET DISTAL MYOPATHY	0.5490065900000001	11.735185612176778
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.54515757	11.652911619573187
AMYLOIDOSIS	0.54467025	11.64249500389554
THYROTOXIC PERIODIC PARALYSIS	0.53628652	11.463290182925405
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.5314464	11.359831121377146
AURICULOCONDYLAR SYNDROME	0.5285714	11.298377107437155
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.52430598	11.207202436084135
MYHRE SYNDROME	0.52082013	11.13269131452145
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.5126755000000001	10.958597329980202
RIPPLING MUSCLE DISEASE 1; RMD1	0.5120482	10.945188598521224
RIPPLING MUSCLE DISEASE; RMD	0.5120482	10.945188598521224
HYDROLETHALUS	0.50549451	10.805101448393087
PEUTZ-JEGHERS SYNDROME	0.50401606	10.773499122511492
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.50316456	10.755298046730656
OBESITY DUE TO SIM1 DEFICIENCY	0.5	10.68765459825972
ANEURYSM OF SINUS OF VALSALVA	0.5	10.68765459825972
CLUSTER HEADACHE, FAMILIAL	0.5	10.68765459825972
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	10.68765459825972
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.5	10.68765459825972
FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA	0.5	10.68765459825972
FOCAL EPITHELIAL HYPERPLASIA, ORAL	0.5	10.68765459825972
TRIGEMINAL NEURALGIA	0.5	10.68765459825972
HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN-BETA-THALASSEMIA SYNDROME	0.5	10.68765459825972
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.5	10.68765459825972
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.49483608000000007	10.577274211593629
NEMALINE MYOPATHY 2; NEM2	0.48801948	10.431567278924634
NEMALINE MYOPATHY 3; NEM3	0.47876022	10.23364773349367
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.47483770000000003	10.149802655664137
MULTIPLE SYSTEM ATROPHY	0.47483770000000003	10.149802655664137
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.47483770000000003	10.149802655664137
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.4683315	10.010730618969744
CLASSIC MULTIMINICORE MYOPATHY	0.4539895	9.704165934473261
AMYOTROPHIC LATERAL SCLEROSIS	0.43933507000000005	9.390922962124511
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.4361472	9.322781255196203
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.43148848	9.223199674736193
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.4221956	9.024561491410042
SYRINGOMYELIA, ISOLATED	0.4120878	8.808504141113463
TIBIAL MUSCULAR DYSTROPHY	0.4054035	8.665625161851167
PERIODONTITIS, AGGRESSIVE, 1	0.40396809999999994	8.634943043030482
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.39698694	8.48571858948011
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.39469470000000006	8.436721250727482
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.3932286000000001	8.405382909914465
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.38931325	8.321691093051871
INCLUSION BODY MYOSITIS	0.3861462	8.253994420061034
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.3859646	8.250112663910945
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.37596693999999997	8.03640959016927
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.37037	7.916773267114903
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.3697941	7.9044632265486285
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.36912197	7.890096239978373
ZEBRA BODY MYOPATHY	0.36774676000000006	7.860700701018228
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.36348955000000005	7.7697015209537135
AMYOTROPHY, MONOMELIC	0.3627448	7.753782259429603
O'SULLIVAN-MCLEOD SYNDROME	0.3627448	7.753782259429603
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.3618908	7.7355277453757765
SHEEHAN SYNDROME	0.36064095	7.708811815176507
YOUNG-ONSET PARKINSON DISEASE	0.3541663	7.570414169487262
CONGENITAL TRACHEAL STENOSIS	0.3505744	7.493636196384284
DISTAL MYOPATHY, TATEYAMA TYPE	0.34957119999999997	7.4721924861983355
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.3449609	7.373645898209623
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.3449609	7.373645898209623
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.34304174	7.33262325981203
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.34270872999999996	7.325505068096495
SALT-AND-PEPPER SYNDROME	0.33976266	7.262531910931906
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.33870933999999997	7.240016870249027
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.33747541000000003	7.213641234972168
CAP MYOPATHY	0.3371275500000001	7.206205619915068
176620 PRIAPISM, FAMILIAL IDIOPATHIC	0.333333	7.125095940403413
PIERPONT SYNDROME	0.333333	7.125095940403413
HEMOGLOBIN--BETA LOCUS	0.333333	7.125095940403413
SICKLE CELL ANEMIA	0.333333	7.125095940403413
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	7.125095940403413
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.333333	7.125095940403413
KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL	0.333333	7.125095940403413
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.33308826	7.119864547230657
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.33158636	7.0877609703484055
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.32744121	6.999157107432453
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.3269231	6.988082345984645
NEMALINE MYOPATHY 7; NEM7	0.3184354	6.806655134117346
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.31040321000000004	6.634964589342155
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.30968257	6.6195606865227745
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.30808665	6.585447403069865
OROFACIODIGITAL SYNDROME TYPE 4	0.30549451000000005	6.5300396090892
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.30211239	6.457745748349467
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.30167487	6.448393623069805
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.29660496000000003	6.34002272922128
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.29619402	6.331238759660063
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.29442302000000004	6.293383087073027
MULTIMINICORE MYOPATHY	0.29232481	6.248533199563797
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.28975131000000004	6.193523841346555
DERMATOMYOSITIS	0.28871368	6.171344179264969
NEUTRAL LIPID STORAGE MYOPATHY	0.28741340000000004	6.143550292222921
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.28571430000000003	6.107231504367114
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.2844828	6.080907811091599
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.28374688	6.065177293547697
PITUITARY APOPLEXY	0.28349057	6.059698588047537
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.28300387	6.0492952250615915
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.28250234	6.038574866240261
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.28221604000000006	6.0324551152172985
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.2806759	5.999534146511369
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.27777465	5.9375190307049674
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.27683198000000003	5.917369167984686
AORTIC ANEURYSM, FAMILIAL THORACIC 6	0.2763158	5.9063356608836255
CHIARI MALFORMATION TYPE I	0.27460713999999997	5.8698125250719
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.27278698	5.830906042284764
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.2705631	5.783369919668808
SCLERODERMA	0.26951694	5.7610079261997775
INCLUSION BODY MYOSITIS	0.26662210999999997	5.699130039878416
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.265641	5.6781585102726195
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.265174	5.6681762408778456
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.2614676	5.588950794871866
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.261236	5.584000273261952
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.26079248	5.574519896127112
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.2607184	5.572936413221834
BARTH SYNDROME; BTHS	0.25699438	5.493334334267811
FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	0.25581395	5.468102278032964
DISTAL MYOPATHY WITH ANTERIOR TIBIAL ONSET	0.252381	5.394721910326773
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.25	5.34382729912986
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS; DCWHKTA	0.25	5.34382729912986
DYSTONIA 6, TORSION	0.25	5.34382729912986
HYPERPARATHYROIDISM 2	0.25	5.34382729912986
YUNIS-VARON SYNDROME	0.25	5.34382729912986
HYPERTRICHOSIS CUBITI	0.25	5.34382729912986
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.25	5.34382729912986
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25	5.34382729912986
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	5.34382729912986
WEST SYNDROME	0.25	5.34382729912986
CONGENITAL ENTEROVIRUS INFECTION	0.25	5.34382729912986
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.24936660000000002	5.330288178284785
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.24792665	5.299508801807256
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.24746847	5.289715062639595
CARDIOFACIOCUTANEOUS SYNDROME	0.24737900000000002	5.287802613725782
ACATALASEMIA	0.2460315	5.258999384583472
WHIM SYNDROME	0.242857	5.19114346553912
PFAPA SYNDROME	0.24254292	5.184429908426678
SARCOSINEMIA	0.23950448000000002	5.119482313951606
LIGNEOUS CONJUNCTIVITIS	0.23915314	5.111972312818501
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.23711466000000006	5.068399172527581
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.23606828	5.0460324764905256
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.23588023	5.042012849596119
MYOTILINOPATHY	0.23432314999999998	5.008729783152403
STUVE-WIEDEMANN SYNDROME	0.23316704000000002	4.984017574437216
HYPERKALEMIC PERIODIC PARALYSIS	0.23261691	4.972258375588934
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.23219755000000003	4.963294425924283
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.23108779	4.939572962790352
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.23108306	4.939471857577853
CLASSICAL EHLERS-DANLOS SYNDROME	0.22512337	4.812081641112448
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.2223946	4.753753338636262
LEUKOCYTE ADHESION DEFICIENCY	0.2196686	4.695484245766549
NASU-HAKOLA DISEASE	0.2185185	4.670900502659633
MYOPATHY, DISTAL 3	0.21791721	4.658047742992857
STÜVE-WIEDEMANN SYNDROME	0.21703794	4.639253074875635
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.21700306	4.638507504090859
MULTIPLE MYELOMA	0.2165331	4.628461963780863
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.21626700000000001	4.622773994003669
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.215873	4.614352122180241
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.214286	4.580429506485364
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.2142856	4.580420956361685
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.21351350000000002	4.563917080131053
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.212987	4.552662979839085
GLYCOGEN STORAGE DISEASE WITH SEVERE CARDIOMYOPATHY DUE TO GLYCOGENIN DEFICIENCY	0.21242060000000001	4.540556004710177
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.21228052	4.537561751397928
FIBULAR HEMIMELIA	0.2119048	4.529530620226612
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.211236	4.51523481343598
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.20970874	4.4825891587125035
CRI-DU-CHAT SYNDROME	0.20934066	4.474721334903449
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.20854095	4.4576272863858994
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.20826446	4.451717227146155
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.20727593	4.430587092746119
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.20649595	4.413914779079018
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.20502577	4.382489227004479
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.20424821999999998	4.365868855338725
19P13.13 MICRODELETION SYNDROME	0.20401606	4.360906363555661
POST-TRAUMATIC PITUITARY DEFICIENCY	0.2035461	4.3508608232456645
AREGENERATIVE ANEMIA	0.2035461	4.3508608232456645
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.2035461	4.3508608232456645
PANHYPOPITUITARISM	0.2035461	4.3508608232456645
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.2035461	4.3508608232456645
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.20308642000000002	4.341035021114209
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.20238130000000001	4.32596286309356
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.2022267	4.322658240291777
YELLOW NAIL SYNDROME	0.20168049999999998	4.310983046408638
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.2	4.275061839303888
MUNGAN SYNDROME	0.2	4.275061839303888
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.2	4.275061839303888
OSTEOGLOSPHONIC DYSPLASIA	0.2	4.275061839303888
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.2	4.275061839303888
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.2	4.275061839303888
MOMO SYNDROME	0.2	4.275061839303888
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.2	4.275061839303888
CONGENITAL AORTIC VALVE STENOSIS	0.2	4.275061839303888
TRANSALDOLASE DEFICIENCY	0.2	4.275061839303888
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.2	4.275061839303888
CATEL-MANZKE SYNDROME	0.2	4.275061839303888
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.2	4.275061839303888
AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8	0.2	4.275061839303888
46,XX GONADAL DYSGENESIS	0.2	4.275061839303888
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.2	4.275061839303888
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.2	4.275061839303888
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.19916522	4.257218158692817
HYPERKALEMIC PERIODIC PARALYSIS; HYPP	0.19892510000000002	4.252085519448549
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.19846036	4.242151558252559
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.19846036	4.242151558252559
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.19846036	4.242151558252559
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.19846036	4.242151558252559
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.19846036	4.242151558252559
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.19846036	4.242151558252559
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.19846036	4.242151558252559
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.1984125	4.241128535954412
MUCOLIPIDOSIS TYPE II	0.197917	4.230537070247538
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.19692785000000002	4.209393683155801
MULTIFOCAL MOTOR NEUROPATHY	0.1961695	4.19318371742662
VASCULAR EHLERS-DANLOS SYNDROME	0.19519906	4.17244026236995
TAKAYASU ARTERITIS	0.19328407	4.131506759011707
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.1929823	4.125056331955473
RELAPSING POLYCHONDRITIS	0.19268470000000001	4.118695039938589
CHARGE SYNDROME	0.19245569999999998	4.113800094132585
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.19170232	4.097696363690112
NORRIE DISEASE	0.18993464999999998	4.0599118708827
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18944160000000002	4.0493727746833565
GRANULOMATOSIS WITH POLYANGIITIS	0.18488897	3.9520589007760067
DISTAL NEBULIN MYOPATHY	0.18300889999999997	3.9118718232149052
AL AMYLOIDOSIS	0.18150880000000003	3.879806721889208
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.1807829	3.8642903849434536
DERMATOLEUKODYSTROPHY	0.179654	3.840159798391503
BOTULISM	0.17961557	3.839338345259081
PHACE ASSOCIATION	0.17897671999999998	3.825682728978884
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.1782949	3.8111086156625134
TUBULAR AGGREGATE MYOPATHY	0.1782949	3.8111086156625134
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.1782949	3.8111086156625134
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.177903	3.8027316319883973
TUBEROUS SCLEROSIS COMPLEX	0.17641917999999998	3.7710145206964176
PAPILLON-LEFÈVRE SYNDROME	0.1761903	3.766122139927518
PERRY SYNDROME	0.17391298000000002	3.7174437207881015
HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2	0.17187533000000002	3.673888322003813
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED INTERMEDIATE	0.1711832	3.659093829249626
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.17054297000000002	3.645408715042739
PGM3-CDG	0.17051315	3.6447713033224987
HADDAD SYNDROME	0.17051275	3.6447627531988194
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.17026087	3.6393787403184006
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.1702131	3.6383576417980823
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17011528	3.636266709052479
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.16828316000000001	3.597104577567352
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.16768202999999998	3.584255237950048
PEMPHIGUS VULGARIS	0.166667	3.562558657856305
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.166667	3.562558657856305
CEREBROOCULONASAL SYNDROME	0.166667	3.562558657856305
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	3.562558657856305
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.166667	3.562558657856305
PITYRIASIS RUBRA PILARIS	0.166667	3.562558657856305
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	3.562558657856305
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.16564779999999998	3.5407729427232124
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.16534970000000002	3.53440096305173
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.16446191999999998	3.5154243910532434
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.16419330000000001	3.509682555496875
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.16419330000000001	3.509682555496875
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.16419330000000001	3.509682555496875
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.16364447999999998	3.4979513583036406
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.1624265	3.471916659208464
KAPOSI SARCOMA	0.1623696	3.4707004041151825
WILD TYPE ATTR AMYLOIDOSIS	0.16233770000000003	3.4700185317518137
VARIANT ABETA2M AMYLOIDOSIS	0.16233770000000003	3.4700185317518137
%109500 BASILAR IMPRESSION, PRIMARY	0.16208779999999998	3.4646768419836027
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.15996125	3.4192211782117448
JUVENILE HYALINE FIBROMATOSIS	0.15970874000000002	3.413823698886532
MUCOPOLYSACCHARIDOSIS TYPE 2	0.15970874	3.413823698886531
MENINGIOMA	0.15909756	3.400759537411803
LAMBERT-EATON MYASTHENIC SYNDROME	0.1582251	3.3821104351502074
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.1575658	3.368017693796942
DISTAL ANOCTAMINOPATHY	0.1575124	3.366876252285848
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.15669115000000003	3.3493217796082075
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.15476179999999998	3.3080813268099014
CHOREOACANTHOCYTOSIS	0.15446947	3.3018326826724835
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.15324529	3.2756654566602887
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.1526786	3.2635522826917125
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.15266091999999998	3.2631743672251177
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.1526316	3.262547643159476
ALPHA-MANNOSIDOSIS	0.15256573999999998	3.2611398652957932
JUVENILE XANTHOGRANULOMA	0.15174276	3.2435484133332424
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.15123441999999998	3.2326824886562826
KIKUCHI-FUJIMOTO DISEASE	0.1511651	3.23120075222278
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.15111543	3.230139040614989
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.15080265999999998	3.223453485157594
HYPOPLASMINOGENEMIA	0.15079744	3.2233419060435886
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.15010337999999998	3.2085061589426513
HEREDITARY COPROPORPHYRIA	0.14899196999999997	3.1847494265485476
CREST SYNDROME	0.14899196999999997	3.1847494265485476
KAWASAKI DISEASE	0.14835399	3.1711124067873526
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.14802237000000001	3.1640239267516033
PORPHYRIA, ACUTE HEPATIC	0.14687305999999997	3.1394570701389504
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.14594342	3.1195857276974985
AUTOIMMUNE HYPOPARATHYROIDISM	0.14594342	3.1195857276974985
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.14594342	3.1195857276974985
POEMS SYNDROME	0.14592276999999998	3.1191443275625903
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.14508968	3.1013367712240623
KALLMANN SYNDROME	0.1446867	3.092722949124049
22Q11.2 DELETION SYNDROME	0.14388455	3.075576744852061
DYSKERATOSIS CONGENITA	0.14381798	3.0741537905188485
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.14285699999999998	3.0536125458871766
REYNOLDS SYNDROME	0.14285699999999998	3.0536125458871766
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.14285699999999998	3.0536125458871766
MUSCULAR ATROPHY, MALIGNANT NEUROGENIC	0.14285699999999998	3.0536125458871766
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.14285699999999998	3.0536125458871766
HAIM-MUNK SYNDROME	0.14285699999999998	3.0536125458871766
PAPILLON-LEFEVRE SYNDROME	0.14285699999999998	3.0536125458871766
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	3.0536125458871766
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.14206665000000002	3.0367185702637087
ENCEPHALITIS LETHARGICA	0.14203452	3.036031781579224
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.14138824000000003	3.022217346751698
CARIBBEAN PARKINSONISM	0.14103337999999999	3.0146321045302202
ELLIS VAN CREVELD SYNDROME	0.14077381	3.00908371552208
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.14011197	2.9949366808834554
FANCONI ANEMIA	0.13973866000000001	2.9869570642073033
PRADER-WILLI SYNDROME	0.13936025999999999	2.9788686472073396
DISTAL MYOTILINOPATHY	0.13755386	2.940256288674747
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.13703700000000002	2.9292082463634346
IMMUNODEFICIENCY 9; IMD9	0.13681873	2.9245426576251097
SYSTEMIC SCLEROSIS	0.13676882999999998	2.923476029696203
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.13563855000000002	2.899315945217562
RHEUMATIC FEVER	0.13487980000000002	2.8830974293647027
CUSHING SYNDROME	0.13421104	2.8688024775864385
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.1334587	2.852720977465529
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.1332453	2.8481594864829916
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.13273800000000002	2.8373157921275975
CYCLIC NEUTROPENIA	0.1316804	2.8147092651213583
WHIPPLE DISEASE	0.13102617	2.800724896585719
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.13070708	2.793904249174202
MALIGNANT ATROPHIC PAPULOSIS	0.13059599	2.79152966607556
MARINESCO-SJÖGREN SYNDROME	0.12945456	2.767131246899377
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.12878981	2.752922010110991
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.12829459999999998	2.7423367432437824
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.12810364000000002	2.7382549141996155
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.12691264	2.7127969209465603
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3	0.1263158	2.70003928140571
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.12629097	2.6995085324783603
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.12609224000000002	2.6952606172817366
SCHWARTZ-JAMPEL SYNDROME	0.12557237999999998	2.684148449042833
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.12544027000000002	2.681324556944882
SENIOR-LOKEN SYNDROME	0.12480959999999999	2.667843790693912
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.1246149	2.66368201799335
X-LINKED ADRENOLEUKODYSTROPHY	0.12353158000000002	2.640525718034577
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	0.1230019	2.629203644259364
SARCOIDOSIS	0.12277927	2.624444859172943
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.12143190000000001	2.595644408820829
POLYARTERITIS NODOSA	0.1208333	2.5828491487357925
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.12060193999999999	2.577903757200085
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.11885228	2.540504233711303
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11783925	2.518850404235953
KENNEDY DISEASE	0.11764569999999999	2.5147132131409666
GLUCAGONOMA	0.11759007	2.5135241046903642
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.11728780000000001	2.5070629899795325
MARFAN SYNDROME	0.11719191999999999	2.5050135253337698
APLASIA CUTIS CONGENITA	0.11692494999999999	2.499306959037575
AGEL AMYLOIDOSIS	0.11686541	2.4980342731280145
MONOSOMY 5P	0.11660550999999998	2.492478830267839
ISOLATED SPINA BIFIDA	0.11660550999999998	2.492478830267839
ACHONDROGENESIS	0.11660550999999998	2.492478830267839
SPINOCEREBELLAR ATAXIA TYPE 43	0.11594279000000002	2.478312985357122
PAROXYSMAL HEMICRANIA	0.11593889	2.478229621651255
AA AMYLOIDOSIS	0.11592086	2.477844224826442
PLAGUE	0.11588835	2.4771493135244635
LICHEN PLANUS PEMPHIGOIDES	0.115873	2.476821202528297
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.11512705999999999	2.460876504386245
SCHINZEL-GIEDION SYNDROME	0.11506936	2.4596431490456054
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.11485743000000001	2.455113079767588
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.11455927999999999	2.448740031330645
TREACHER-COLLINS SYNDROME	0.11427555999999998	2.4426754286054084
BEHÇET DISEASE	0.11403057	2.437438691605353
MICROSPORIDIOSIS	0.11228052000000001	2.4000308317459846
LEPTOSPIROSIS	0.11151131	2.38358873015893
PHELAN-MCDERMID SYNDROME	0.11121057000000001	2.3771603196711686
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.11111099999999999	2.375031980134471
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.11111099999999999	2.375031980134471
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.11111099999999999	2.375031980134471
HIP DYSPLASIA, BEUKES TYPE	0.11111099999999999	2.375031980134471
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.11111099999999999	2.375031980134471
ADULT-ONSET NEMALINE MYOPATHY	0.11099702000000002	2.3725956223922524
NEMALINE MYOPATHY 1; NEM1	0.11070368	2.366325389192545
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L	0.11065313	2.365244867312661
GRAFT VERSUS HOST DISEASE	0.11045856000000001	2.361085873402294
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.11030411	2.3577844568968915
RADICULONEUROPATHY, FATAL NEONATAL	0.11016528000000002	2.354816922721139
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.10982167000000001	2.347472152728123
RAT-BITE FEVER	0.1093924	2.338296373749333
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.10937573	2.337940047345027
CRANIOPHARYNGIOMA	0.10926771000000002	2.3356310864456193
FABRY DISEASE	0.10860453	2.321455408892671
PRADER-WILLI SYNDROME; PWS	0.10831598	2.3152875634240155
KINDLER SYNDROME	0.1074073	2.2958642474633217
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.10701399	2.287457124603239
PROTEUS SYNDROME	0.1067821	2.2825004041536583
MENKES DISEASE	0.10659793	2.278563713458935
MONOSOMY 13Q14	0.10549451	2.2549777697853117
NEUROFACIODIGITORENAL SYNDROME	0.10549451	2.2549777697853117
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.10487981000000002	2.2418383672222113
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.10458825999999999	2.235606395825966
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.10416660000000001	2.226593282950162
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.10396362	2.2222545226894526
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.10384615000000001	2.219743565118137
LEISHMANIASIS	0.1035461	2.2133299035937215
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.1035461	2.2133299035937215
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.1035461	2.2133299035937215
NON-FUNCTIONING PARAGANGLIOMA	0.1035461	2.2133299035937215
MANTLE CELL LYMPHOMA	0.1035461	2.2133299035937215
INFANTILE MYOFIBROMATOSIS	0.1030914	2.2036105505020642
NOCARDIOSIS	0.10301199999999999	2.2019133509518602
MUCKLE-WELLS SYNDROME	0.1023018	2.186732606360492
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.1023018	2.186732606360492
MILROY DISEASE	0.10207823	2.1819537284834265
MYXOPAPILLARY EPENDYMOMA	0.10030150000000002	2.1439755753746947
PARANEOPLASTIC PEMPHIGUS	0.1002506	2.1428875721365914
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.1	2.137530919651944
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1	2.137530919651944
LIPOID PROTEINOSIS	0.1	2.137530919651944
PARAGANGLIOMAS 1	0.1	2.137530919651944
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.1	2.137530919651944
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	2.137530919651944
CARNEY COMPLEX	0.1	2.137530919651944
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.1	2.137530919651944
PARAGANGLIOMAS 3	0.1	2.137530919651944
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.1	2.137530919651944
ACUTE MYELOMONOCYTIC LEUKEMIA	0.1	2.137530919651944
PARAGANGLIOMAS 4	0.1	2.137530919651944
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.09965114	2.130073929285646
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0994623	2.1260374158969753
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.09927812999999999	2.122100725202252
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.09923629	2.1212063822654703
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.09883717	2.112675068858955
ILEAL NEUROENDOCRINE TUMOR	0.09808610000000001	2.096620715380725
JEJUNAL NEUROENDOCRINE TUMOR	0.09808610000000001	2.096620715380725
MYOPATHY, SPHEROID BODY	0.09793662	2.093425534162029
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.09727865	2.0793612219699957
ACUTE PROMYELOCYTIC LEUKEMIA	0.09725038999999999	2.078757155732102
NEMALINE MYOPATHY 6	0.09700671	2.0735484203870937
XQ21 MICRODELETION SYNDROME	0.0960785	2.0537076446377927
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.09570195000000001	2.0456587719598436
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.0955556	2.0425304954589327
THYMIC TUMOR	0.09544984000000001	2.0402698427583092
ACROMEGALY	0.09502981999999999	2.031291785389586
SOMATOMAMMOTROPINOMA	0.09502981999999999	2.031291785389586
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09491755	2.028891979426094
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.09491755	2.028891979426094
BETHLEM MYOPATHY 1	0.09490272	2.0285749835907088
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.09483857000000002	2.027203757505753
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.09444440000000001	2.018778251879761
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.09433691	2.0164806198942262
DISTAL MYOPATHY, WELANDER TYPE	0.0942925	2.015531342412809
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.09425965	2.0148291635057034
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.09376962999999999	2.004354834493225
THYMIC EPITHELIAL NEOPLASM	0.0936196	2.0011478968544707
THYMIC CARCINOMA	0.0936196	2.0011478968544707
IATROGENIC BOTULISM	0.0936196	2.0011478968544707
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	1.9944510124832018
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.09326736	1.993618657943089
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.09299033	1.9876970560363774
CRYPTOCOCCOSIS	0.09295073000000001	1.9868505937921954
MELAS	0.09275384	1.9826420091644925
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.09259256000000002	1.9791945992972781
NEMALINE MYOPATHY 4	0.09238772	1.974816080961463
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.09226190000000001	1.9721266395583568
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.09215680000000001	1.9698800945618027
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.09187994000000001	1.9639621264576541
H SYNDROME	0.09181054	1.9624786799994156
SPONTANEOUS PERIODIC HYPOTHERMIA	0.09180433	1.9623459393293055
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.09159776000000001	1.9579304417085805
GIANT CELL ARTERITIS	0.09156525	1.9572355304066016
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0914173	1.9540730534109767
LOEYS-DIETZ SYNDROME 3; LDS3	0.09126378	1.9507915159431268
TETANUS	0.0909091	1.9432101212773052
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.0909091	1.9432101212773052
PERRY SYNDROME	0.09057968000000001	1.936168666921788
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.09052335	1.9349645957547477
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0904606	1.9336232951026662
BILATERAL POLYMICROGYRIA	0.0900735	1.9253489129126937
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.0900735	1.9253489129126937
POSTPOLIOMYELITIS SYNDROME	0.08982925000000001	1.9201279936414442
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.08929225	1.908649452602913
OCCIPITAL HORN SYNDROME	0.08904123	1.9032838224884023
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.08903135000000001	1.903072634433541
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.08891128000000001	1.9005061010583149
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0887993	1.8981124939344884
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.08873033000000002	1.8966382388592051
NELSON SYNDROME	0.088551	1.8928050046609926
LEBER HEREDITARY OPTIC NEUROPATHY	0.08830427	1.8875310746229355
CONE-ROD DYSTROPHY 2	0.0879433	1.8798152292622679
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.08751447000000001	1.8706488554195246
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.08743003	1.8688439243109705
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0873949	1.8680930096988964
611961 STEVENSON-CAREY SYNDROME	0.08717945000000002	1.863487699332507
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.086493	1.8488146183345557
MUCOUS MEMBRANE PEMPHIGOID	0.08596490000000001	1.8375263175478738
ADRENOLEUKODYSTROPHY	0.08564266000000001	1.8306383379123874
WHITE-SUTTON SYNDROME; WHSUS	0.08557299	1.829149120120666
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0853608	1.8246134932622564
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.08489861000000001	1.814734039104717
EBOLA HEMORRHAGIC FEVER	0.08489861000000001	1.814734039104717
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.08477757999999999	1.8121469854326622
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.08464326	1.8092758539013858
ISOTRETINOIN-LIKE SYNDROME	0.08384615	1.7922373811877481
VIPOMA	0.08351827	1.7852288448083935
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.08333330000000001	1.7812750538663134
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.08333330000000001	1.7812750538663134
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.08333330000000001	1.7812750538663134
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.08333330000000001	1.7812750538663134
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	1.7812750538663134
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.08333330000000001	1.7812750538663134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.08333330000000001	1.7812750538663134
OBESITY-HYPOVENTILATION SYNDROME	0.08333330000000001	1.7812750538663134
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08333330000000001	1.7812750538663134
DYSTROPHIA MYOTONICA 2	0.08298278	1.7737825804867495
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.08296096	1.7733161712400813
COFFIN-LOWRY SYNDROME	0.08278703000000001	1.7695983637115307
PYCNODYSOSTOSIS	0.08253970000000001	1.7643116084879555
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.08253949	1.764307119673024
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0825032	1.7635314097022823
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.08193980000000001	1.7514885605009634
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.08183731000000001	1.7492978050614123
GLYCOGEN STORAGE DISEASE II	0.08171054999999999	1.7465882708676612
DOORS SYNDROME	0.08163765000000002	1.7450300108272354
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.08119660000000001	1.7356024307061104
VULVOVAGINAL GINGIVAL SYNDROME	0.0809523	1.7303804426694005
FRIEDREICH ATAXIA	0.08091095000000001	1.7294965736341243
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.08079218	1.726957828160854
MUCOLIPIDOSIS TYPE III	0.08078476000000001	1.7267992233666158
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.08044082999999999	1.7194476132746563
RETINITIS PUNCTATA ALBESCENS	0.0803653	1.7178331361710435
CONE-ROD DYSTROPHY 10	0.0803653	1.7178331361710435
SMITH-MAGENIS SYNDROME; SMS	0.0799173	1.7082569976510027
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.07953173	1.7000153196841006
KID SYNDROME	0.0793172	1.6954296746021718
SEVERE CONGENITAL NEMALINE MYOPATHY	0.078869	1.6858492610202915
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.07867498	1.681702023529983
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.07848348	1.677608651818849
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.07822057	1.6719888692779925
OCULOCEREBRORENAL SYNDROME OF LOWE	0.07809242000000001	1.6692496234044587
LETTERER-SIWE DISEASE	0.0776914	1.66067769691047
MUCOPOLYSACCHARIDOSIS TYPE 1	0.07768816	1.6606084409086737
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.07746487000000002	1.655835548118183
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.077342	1.6532091638772062
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.07723784	1.650982711671297
GIANT AXONAL NEUROPATHY	0.07693921	1.64459940308594
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.07692311	1.6442552606078762
CONE-ROD DYSTROPHY 11; CORD11	0.07692310000000001	1.6442550468547847
OPTIC ATROPHY 5; OPA5	0.07692310000000001	1.6442550468547847
CENTRAL AREOLAR CHOROIDAL DYSTROPHY	0.07692310000000001	1.6442550468547847
NEUROTROPHIC KERATOPATHY	0.07692310000000001	1.6442550468547847
MYOPATHIC EHLERS-DANLOS SYNDROME	0.07674095	1.6403615342846383
FOODBORNE BOTULISM	0.07672317000000001	1.6399814812871245
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.07648641000000002	1.6349206630817565
AGNATHIA-OTOCEPHALY COMPLEX	0.07638890000000001	1.6328363566820037
LEGIONELLOSIS	0.07622667999999999	1.629368854024144
MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA	0.07588434	1.6220512306738075
HYDROXYKYNURENINURIA	0.07573640000000001	1.618888967431275
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.07565665	1.6171842865228523
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	0.07557798	1.615502690948362
PRIMROSE SYNDROME; PRIMS	0.07557798	1.615502690948362
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.07538383	1.611352674667858
TENORIO SYNDROME; TNORS	0.07537719000000001	1.6112107426147932
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.07493116	1.6016767134538694
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.07493116	1.6016767134538694
AFRICAN IRON OVERLOAD	0.07487767999999999	1.6005335619180394
CONGENITAL FACTOR XIII DEFICIENCY	0.0748538	1.6000231195344266
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0746965	1.5966607833978141
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.07456134	1.5937716966068125
INFANTILE REFSUM DISEASE	0.07432398000000001	1.588698053215927
POLAND SYNDROME	0.0740741	1.5833567909539006
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.07388091	1.5792272949702246
2Q23.1 MICRODUPLICATION SYNDROME	0.07382875	1.5781123588425343
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.07335221	1.567926168998025
INFANT BOTULISM	0.07288705000000001	1.5579832301721723
OPTIC PATHWAY GLIOMA	0.07271636000000001	1.5543346786454182
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.07220874	1.5434841441910807
BLACKFAN-DIAMOND ANEMIA	0.07217352	1.5427313058011796
VACTERL WITH HYDROCEPHALUS	0.07216120999999999	1.54246817574497
MONOSOMY 9P	0.07216120999999999	1.54246817574497
THALIDOMIDE EMBRYOPATHY	0.07216120999999999	1.54246817574497
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.0715198	1.5287578386732308
GAUCHER DISEASE TYPE 2	0.07142860000000001	1.5268084104745085
IDIOPATHIC ACUTE EOSINOPHILIC PNEUMONIA	0.07142860000000001	1.5268084104745085
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.07142860000000001	1.5268084104745085
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.07142860000000001	1.5268084104745085
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.07142860000000001	1.5268084104745085
FAMILIAL PARATHYROID ADENOMA	0.07142860000000001	1.5268084104745085
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.07142860000000001	1.5268084104745085
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.07142860000000001	1.5268084104745085
LEIGH SYNDROME; LS	0.07142860000000001	1.5268084104745085
CLEFT LIP AND ALVEOLUS	0.07142860000000001	1.5268084104745085
AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1	0.07142860000000001	1.5268084104745085
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.07082013000000001	1.5138021760877023
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.0706557	1.5102874339965184
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.0705882	1.5088446006257534
ADULT INTESTINAL BOTULISM	0.0705882	1.5088446006257534
WOUND BOTULISM	0.0705882	1.5088446006257534
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0704514	1.5059204583276693
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.0703703	1.5041869207518317
PERIODONTITIS, CHRONIC	0.0703703	1.5041869207518317
%162700 NEUTROPENIA, CHRONIC FAMILIAL;;LEUKOPENIA, BENIGN FAMILIAL	0.0703703	1.5041869207518317
ERYTHERMALGIA, PRIMARY	0.0703328	1.5033853466569622
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.07021091000000002	1.5007799102189987
2Q37 MICRODELETION SYNDROME	0.06974638	1.4908504378379392
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.06962831	1.4883266550811063
CENTRAL CORE DISEASE	0.06960463	1.4878204877593326
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.06949435	1.4854632186611405
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0693305	1.481960874249291
HOLOPROSENCEPHALY	0.06929600000000001	1.4812234260820112
SHPRINTZEN-GOLDBERG SYNDROME	0.06866101000000001	1.4676503184953131
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0686098	1.4665556889113593
ERDHEIM-CHESTER DISEASE	0.06840123000000001	1.4620974406722413
WITTEVEEN-KOLK SYNDROME	0.06829649	1.4598585907869979
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.06814387999999999	1.4565965048505167
BUTYRYLCHOLINESTERASE	0.06808276	1.4552900459524258
WOLF-HIRSCHHORN SYNDROME	0.06765747999999999	1.4461995544573298
7P22.1 MICRODUPLICATION SYNDROME	0.0674604	1.4419869085208799
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0673524	1.4396783751276558
CENTRONUCLEAR MYOPATHY	0.06694498	1.4309696466548096
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.06674089999999999	1.426607373553984
RETINITIS PIGMENTOSA 41	0.0666667	1.4250213256116022
RETINITIS PIGMENTOSA 58	0.0666667	1.4250213256116022
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0666667	1.4250213256116022
OTOMANDIBULAR SYNDROME	0.0666667	1.4250213256116022
MICROTIA	0.0666667	1.4250213256116022
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.0666667	1.4250213256116022
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.0666667	1.4250213256116022
RETINITIS PIGMENTOSA 75; RP75	0.0666667	1.4250213256116022
CONE-ROD DYSTROPHY 8; CORD8	0.0666667	1.4250213256116022
EAR-PATELLA-SHORT STATURE SYNDROME	0.0666667	1.4250213256116022
MICROTIA-ANOTIA	0.0666667	1.4250213256116022
HEMIFACIAL MICROSOMIA	0.0666667	1.4250213256116022
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.0666667	1.4250213256116022
JUVENILE GLAUCOMA	0.0666667	1.4250213256116022
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.0666667	1.4250213256116022
CONE-ROD DYSTROPHY 6; CORD6	0.0666667	1.4250213256116022
MYOTONIC DYSTROPHY 1	0.06645795	1.420559229816829
FRYNS MICROPHTHALMIA SYNDROME	0.0664488	1.420363645737681
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.06637255	1.4187337784114462
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.06630479	1.4172853874602902
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.06630479	1.4172853874602902
BRONCHOPULMONARY DYSPLASIA	0.06606988	1.4122641135769356
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0660461	1.4117558087242423
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.06585930000000001	1.4077629009663326
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.06578941	1.4062689806065878
BUSCHKE-OLLENDORFF SYNDROME	0.06566456	1.4036002732534023
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.065641	1.4030966709687325
DPM3-CDG	0.0656186	1.4026178640427303
HELLP SYNDROME	0.0655701	1.4015811615466993
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.06513462	1.3922726418977989
ACUTE INTERMITTENT PORPHYRIA	0.06495847	1.3885073811828321
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.06469379	1.382849764344697
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.06439215	1.376402116078659
INIENCEPHALY	0.06431801	1.374817350654829
CAT-EYE SYNDROME	0.06431801	1.374817350654829
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0642595	1.3735666813137406
WYBURN-MASON SYNDROME	0.06422017	1.3727259904030416
SECONDARY POLYCYTHEMIA	0.06419984000000001	1.3722914303670766
HYDROXYKYNURENINURIA	0.06419984000000001	1.3722914303670766
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.06412783	1.370752194351835
HYALINE FIBROMATOSIS SYNDROME; HFS	0.06385812	1.364987059708442
RABIES	0.06355789	1.358569550628371
MYASTHENIA GRAVIS; MG	0.06354113	1.358211300446237
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.06349059	1.357130992319445
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.06333330000000001	1.3537688699359247
CHÉDIAK-HIGASHI SYNDROME	0.06313517	1.3495337799248182
MAPLE SYRUP URINE DISEASE	0.062987	1.3463666003611698
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.06297288	1.3460647809953148
ALSTROM SYNDROME; ALMS	0.06287436	1.343958885533274
INTERMEDIATE NEMALINE MYOPATHY	0.06282729	1.3429527497293936
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.06268999	1.3400179197767115
BABESIOSIS	0.06267641	1.3397276430778229
LUJO HEMORRHAGIC FEVER	0.06267641	1.3397276430778229
LASSA FEVER	0.06267641	1.3397276430778229
NIPAH VIRUS DISEASE	0.06267641	1.3397276430778229
MARBURG HEMORRHAGIC FEVER	0.06267641	1.3397276430778229
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06266965000000001	1.3395831459876546
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.06266965000000001	1.3395831459876546
DIABETIC EMBRYOPATHY	0.0625	1.335956824782465
8P23.1 MICRODELETION SYNDROME	0.0625	1.335956824782465
DISTAL TRISOMY 14Q	0.0625	1.335956824782465
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0625	1.335956824782465
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0625	1.335956824782465
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.0625	1.335956824782465
UMBILICAL CORD ULCERATION-INTESTINAL ATRESIA SYNDROME	0.0625	1.335956824782465
PAGOD SYNDROME	0.0625	1.335956824782465
CHROMOSOME 16P13.2 DELETION SYNDROME	0.0625	1.335956824782465
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0625	1.335956824782465
HOLT-ORAM SYNDROME	0.0625	1.335956824782465
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0625	1.335956824782465
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.0625	1.335956824782465
FAMILIAL DYSAUTONOMIA	0.06245098	1.3349090071256515
HEPATOCELLULAR CARCINOMA	0.0623696	1.3331694844632387
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.062275319999999995	1.3311542203121907
HUNTINGTON DISEASE-LIKE 2	0.06227178	1.3310785517176351
EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM	0.06215541	1.3285911069864362
EPIDERMOLYSIS BULLOSA SIMPLEX, KOEBNER TYPE	0.06215541	1.3285911069864362
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.06215541	1.3285911069864362
BETHLEM MYOPATHY	0.062048200000000005	1.3262994600874773
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.06198806	1.3250139489923987
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.06198806	1.3250139489923987
AMISH NEMALINE MYOPATHY	0.0618541	1.322150512572433
OSTEOPETROSIS AND RELATED DISORDERS	0.061653639999999996	1.3178656180908985
ALG11-CDG	0.0615835	1.3163663539038548
PERIVENTRICULAR NODULAR HETEROTOPIA	0.06141195	1.3126994196111919
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.06134628	1.3112957030562564
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.06114587999999999	1.3070120910932739
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0611111	1.3062686578394191
MYOPATHY, DISTAL, 5; MPD5	0.06102228	1.304370102876584
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.06089606	1.3016721113497993
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0607986	1.2995888737155066
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.060750030000000003	1.2985506749478317
RHEUMATOID ARTHRITIS	0.0607197	1.2979023618199015
FUNCTIONING GONADOTROPIC ADENOMA	0.060690820000000006	1.297285042890306
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.060653139999999994	1.2964796212397809
RIGID SPINE SYNDROME	0.060628749999999995	1.2959582774484777
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.06046675	1.2924954773586417
PANHYPOPHYSITIS	0.060435840000000005	1.2918347665513772
ADENOHYPOPHYSITIS	0.060435840000000005	1.2918347665513772
ATTRV30M AMYLOIDOSIS	0.060267799999999996	1.288242859593994
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.06025293	1.287925008746242
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	1.2832859253913214
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.05988096	1.2799740349844124
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0598214	1.2787009215686678
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.05970874	1.276292779234588
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.05970874	1.276292779234588
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.05970874	1.276292779234588
ZIMMERMANN-LABAND SYNDROME 1	0.05970874	1.276292779234588
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.05970874	1.276292779234588
HEREDITARY GINGIVAL FIBROMATOSIS	0.05970874	1.276292779234588
CHRONIC GRAFT VERSUS HOST DISEASE	0.0594276	1.2702833248070784
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	1.2674446837457807
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0592592	1.2666837227383847
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.059210599999999995	1.2656448827114337
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.05904554	1.2621166741754564
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0588235	1.257370500521461
PROTEUS-LIKE SYNDROME	0.0588235	1.257370500521461
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.0588235	1.257370500521461
ALG12-CDG	0.0588235	1.257370500521461
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0588235	1.257370500521461
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0588235	1.257370500521461
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0588235	1.257370500521461
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	1.257370500521461
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	1.257370500521461
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.0588235	1.257370500521461
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0588235	1.257370500521461
JUNG SYNDROME	0.0588235	1.257370500521461
ADULT SYNDROME	0.0588235	1.257370500521461
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	1.257370500521461
FAMILIAL MULTIPLE NEVI FLAMMEI	0.0588235	1.257370500521461
VON WILLEBRAND DISEASE	0.0588235	1.257370500521461
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.0588235	1.257370500521461
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.0588235	1.257370500521461
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.0588235	1.257370500521461
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.0588235	1.257370500521461
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.0588235	1.257370500521461
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0588235	1.257370500521461
KLIPPEL-TRÉNAUNAY SYNDROME	0.0588235	1.257370500521461
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.0588235	1.257370500521461
DERMOODONTODYSPLASIA	0.0588235	1.257370500521461
RING CHROMOSOME 22 SYNDROME	0.0588235	1.257370500521461
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.0588235	1.257370500521461
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0588235	1.257370500521461
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.0588235	1.257370500521461
6P22 MICRODELETION SYNDROME	0.0588235	1.257370500521461
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.0588235	1.257370500521461
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0588235	1.257370500521461
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.058774480000000004	1.2563226828646479
FAMILIAL PANCREATIC CARCINOMA	0.058766570000000004	1.2561536041689034
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.058766570000000004	1.2561536041689034
FAMILIAL MEDITERRANEAN FEVER	0.058766570000000004	1.2561536041689034
SOMATOSTATINOMA	0.058766570000000004	1.2561536041689034
MERCURY POISONING	0.0584415	1.2492051324083906
FONTAINE PROGEROID SYNDROME; FPS	0.058349899999999996	1.2472471540859893
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.058021920000000005	1.240236480175715
SANDHOFF DISEASE	0.05800935	1.2399677925391148
SEVERE HEMOPHILIA A	0.05800794	1.2399376533531479
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.05798987	1.2395514015159665
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.05785421	1.236651627070367
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.057663610000000004	1.2325774931375104
AUTOSOMAL DOMINANT CUTIS LAXA	0.0575658	1.2304867741449985
SECONDARY SYRINGOMYELIA	0.0575658	1.2304867741449985
DISTAL TRISOMY 17Q	0.0573593	1.2260727727959175
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	1.2254336510509416
MYOPATHY, CENTRONUCLEAR, 5	0.05730892	1.2249958847185967
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.05725653	1.223876032269791
ALEXANDER DISEASE	0.0570638	1.219756368928346
NEMALINE MYOPATHY 10	0.05688145	1.2158585812963605
SPINOCEREBELLAR ATAXIA TYPE 18	0.05682582	1.214669472845758
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.05678098	1.213711003981386
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.05678098	1.213711003981386
MOEBIUS SYNDROME; MBS	0.056744119999999995	1.2129231100844025
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0566647	1.211225483028015
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.05664766	1.2108612477593064
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.05658083	1.2094327358457029
MACHADO-JOSEPH DISEASE; MJD	0.0565476	1.2087224343211027
PITUICYTOMA	0.05654144	1.2085907624164518
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.0561777	1.20081570744931
MYOTONIA FLUCTUANS	0.05591276	1.1951525330307842
ECTODERMAL DYSPLASIA SYNDROME	0.05588346	1.194526236471326
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.055864899999999995	1.1941295107326386
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.055864899999999995	1.1941295107326386
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.05579616	1.19266017197847
ALKAPTONURIA	0.0557276	1.1911946807799567
HOYERAAL-HREIDARSSON SYNDROME	0.05571802	1.1909899053178539
STEINERT MYOTONIC DYSTROPHY	0.05561476	1.1887826908902213
WILDERVANCK SYNDROME	0.055555600000000004	1.1875181275981554
ACROCRANIOFACIAL DYSOSTOSIS	0.055555600000000004	1.1875181275981554
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.055555600000000004	1.1875181275981554
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.055555600000000004	1.1875181275981554
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.055555600000000004	1.1875181275981554
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.1875181275981554
3P25.3 MICRODELETION SYNDROME	0.055555600000000004	1.1875181275981554
CHIME SYNDROME	0.055555600000000004	1.1875181275981554
17Q21.31 MICRODUPLICATION SYNDROME	0.055555600000000004	1.1875181275981554
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.055555600000000004	1.1875181275981554
ZIMMERMANN-LABAND SYNDROME	0.055494510000000004	1.18621230995934
OCULOPHARYNGEAL MUSCULAR DYSTROPHY	0.05520833	1.1800951239734798
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.05520833	1.1800951239734798
PURE AUTONOMIC FAILURE	0.0550595	1.1769138367057619
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0550595	1.1769138367057619
GLYCEROL KINASE DEFICIENCY; GKD	0.05481221	1.1716279364945548
USHER SYNDROME	0.05476463	1.1706108992829842
TSH-SECRETING PITUITARY ADENOMA	0.05459598	1.1670059533869914
PROLACTINOMA	0.05459598	1.1670059533869914
FASCIAL DYSTROPHY, CONGENITAL	0.0545894	1.166865303852478
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.053915529999999996	1.1524611242442195
FRAGILE X SYNDROME	0.05384615	1.1509781052921653
FELTY SYNDROME	0.05379184	1.1498172122497021
FOLATE MALABSORPTION, HEREDITARY	0.05379184	1.1498172122497021
19P13.3 MICRODUPLICATION SYNDROME	0.05345003	1.1425109178132398
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.053282220000000005	1.138923927176972
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.05323961000000001	1.1380131252521084
MUCOPOLYSACCHARIDOSIS TYPE 4	0.053216780000000005	1.1375251269431519
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.053166	1.1364396887421524
GOLDENHAR SYNDROME	0.05316456	1.1364089082969093
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.05310995	1.1352416026616876
NEONATAL MARFAN SYNDROME	0.05308642	1.1347386416362935
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.05300761999999999	1.1330542672716075
ACROOSTEOLYSIS DOMINANT TYPE	0.05273556	1.1272389006516026
INHERITED EPIDERMOLYSIS BULLOSA	0.0526316	1.1250167235075323
WHITE SPONGE NEVUS OF CANNON	0.0526316	1.1250167235075323
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0526316	1.1250167235075323
LETHAL ACANTHOLYTIC EPIDERMOLYSIS BULLOSA	0.0526316	1.1250167235075323
REVESZ SYNDROME	0.0526316	1.1250167235075323
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.0526316	1.1250167235075323
EHLERS-DANLOS SYNDROME, TYPE I	0.0526316	1.1250167235075323
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.1250167235075323
EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1	0.0526316	1.1250167235075323
ADENOCARCINOMA OF THE ANAL CANAL	0.0526316	1.1250167235075323
PACHYONYCHIA CONGENITA, TYPE 1	0.0526316	1.1250167235075323
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.1250167235075323
AUTOIMMUNE HEPATITIS	0.0526316	1.1250167235075323
PLASMA CLOT RETRACTION FACTOR, DEFICIENCY OF	0.0526316	1.1250167235075323
PEMPHIGUS VULGARIS, FAMILIAL	0.0526316	1.1250167235075323
LOCALIZED EPIDERMOLYSIS BULLOSA SIMPLEX	0.0526316	1.1250167235075323
NEUTROPHIL IMMUNODEFICIENCY SYNDROME	0.0526316	1.1250167235075323
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.0526316	1.1250167235075323
GALLBLADDER NEUROENDOCRINE TUMOR	0.0526316	1.1250167235075323
JUVENILE POLYPOSIS SYNDROME	0.0526316	1.1250167235075323
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.0526316	1.1250167235075323
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	1.1250167235075323
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.0526316	1.1250167235075323
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0526316	1.1250167235075323
JUNCTIONAL EPIDERMOLYSIS BULLOSA, NON-HERLITZ TYPE	0.0526316	1.1250167235075323
HEMOPHILIA B	0.0526316	1.1250167235075323
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0526316	1.1250167235075323
PACHYONYCHIA CONGENITA	0.0526316	1.1250167235075323
HEMANGIOBLASTOMA	0.05255101	1.1232940873393849
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.05227396	1.1173720579264892
NEUROFIBROMATOSIS TYPE 1	0.0520192	1.1119264841555838
GLYCOGEN STORAGE DISEASE IB	0.05176838	1.1065651291029128
MADRAS MOTOR NEURON DISEASE	0.05140606	1.09882042707483
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.051339300000000004	1.0973934114328703
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.05125113	1.0955087504210133
ADULT-ONSET STILL DISEASE	0.051165100000000005	1.0936698325708367
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.051165100000000005	1.0936698325708367
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.051055869999999996	1.0913350075473007
CADASIL	0.05089956	1.0879938329667929
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.05083084	1.086524921718808
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.05081308	1.0861452962274778
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.05081308	1.0861452962274778
SPINAL MUSCULAR ATROPHY, TYPE IV	0.05072468000000001	1.0842557188945057
POTASSIUM-AGGRAVATED MYOTONIA	0.050704429999999995	1.083822868883276
MYOTONIA PERMANENS	0.050704429999999995	1.083822868883276
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.05067907	1.0832807910420523
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.05065892	1.0828500785617425
ALKAPTONURIA	0.050520499999999996	1.0798913082627601
NON-FUNCTIONING PITUITARY ADENOMA	0.050446599999999994	1.0783116729131375
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.05037197	1.0767164335878012
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.05032494	1.0757111527962888
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.05027206000000001	1.074580826445977
SCLEROSTEOSIS 1; SOST1	0.05025516	1.0742195837205557
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.05	1.068765459825972
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.05	1.068765459825972
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.05	1.068765459825972
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.05	1.068765459825972
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.05	1.068765459825972
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.05	1.068765459825972
ORAL SUBMUCOUS FIBROSIS	0.05	1.068765459825972
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.05	1.068765459825972
RAMON SYNDROME	0.05	1.068765459825972
ISOLATED PIERRE ROBIN SYNDROME	0.05	1.068765459825972
HEC SYNDROME	0.05	1.068765459825972
RESTRICTIVE DERMOPATHY	0.05	1.068765459825972
CHROMOSOME 18Q DELETION SYNDROME	0.05	1.068765459825972
RAMON SYNDROME	0.05	1.068765459825972
TUBEROUS SCLEROSIS 2; TSC2	0.05	1.068765459825972
SPINOCEREBELLAR ATAXIA TYPE 14	0.05	1.068765459825972
XANTHOMA DISSEMINATUM	0.05	1.068765459825972
22Q11.2 MICRODUPLICATION SYNDROME	0.05	1.068765459825972
XK APROSENCEPHALY SYNDROME	0.05	1.068765459825972
FIBROMATOSIS, GINGIVAL, 1	0.05	1.068765459825972
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.05	1.068765459825972
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.05	1.068765459825972
PRIMARY BASILAR INVAGINATION	0.05	1.068765459825972
MARFAN SYNDROME; MFS	0.05	1.068765459825972
TUBEROUS SCLEROSIS-1	0.05	1.068765459825972
OPITZ G/BBB SYNDROME	0.05	1.068765459825972
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.049974250000000005	1.0682150456141615
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.04990427	1.0667192014765892
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.04989134	1.066442818728678
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.04989134	1.066442818728678
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.04976094	1.0636554784094518
PEROXISOME BIOGENESIS DISORDER 11B	0.04967581	1.0618357983375522
MERRF	0.04951463	1.0583905260012572
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0494894	1.057851226950229
THORACIC OUTLET SYNDROME	0.04948085	1.0576684680565989
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.049330490000000005	1.0544544765658102
SANDIFER SYNDROME	0.04930065	1.053816637339386
DUBOWITZ SYNDROME	0.04930065	1.053816637339386
NEURONAL CEROID LIPOFUSCINOSIS	0.049294489999999996	1.0536849654347353
GITELMAN SYNDROME	0.04894396	1.0461922783020794
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.048854640000000005	1.0442830356846464
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.048854640000000005	1.0442830356846464
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.04859917	1.0388222854442115
TRISOMY 20P	0.048294590000000005	1.0323117937691357
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.04806138	1.0273268579114152
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0479963	1.025935752788906
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.04795600999999999	1.025074541581378
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0478831	1.0235160677878599
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.04775458	1.0207689130499231
NONAKA MYOPATHY	0.04768129	1.0192023166389104
LICHTENSTEIN SYNDROME	0.047627680000000006	1.0180563863128849
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.047619	1.017870848629059
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.047619	1.017870848629059
MUCOCUTANEOUS ULCERATION, CHRONIC; CMCU	0.047619	1.017870848629059
YAO SYNDROME	0.047619	1.017870848629059
ORAL EROSIVE LICHEN	0.047619	1.017870848629059
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.047619	1.017870848629059
LINEAR IGA DERMATOSIS	0.047619	1.017870848629059
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.047619	1.017870848629059
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.047619	1.017870848629059
BEHCET SYNDROME	0.047619	1.017870848629059
MARSHALL-SMITH SYNDROME; MRSHSS	0.0475394	1.0161693740170163
SPINOCEREBELLAR ATAXIA TYPE 25	0.047494360000000006	1.015206630090805
POTOCKI-LUPSKI SYNDROME	0.04740675	1.0133339392520977
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0473422	1.0119541630434625
SLC35A2-CDG	0.047324450000000004	1.0115747513052245
TANGIER DISEASE; TGD	0.04702479	1.0051694261513953
SHWACHMAN-DIAMOND SYNDROME	0.04692658	1.0030701570352052
1P36 DELETION SYNDROME	0.04691731999999999	1.0028722216720451
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.046811109999999996	1.000601950082283
PERIODONTAL EHLERS-DANLOS SYNDROME	0.04674574	0.9992046461201066
OTODENTAL SYNDROME	0.04674574	0.9992046461201066
LYNCH SYNDROME	0.046742769999999996	0.9991411614517929
FAMILIAL COLORECTAL CANCER TYPE X	0.046742769999999996	0.9991411614517929
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0467182	0.9986159701048344
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.04664286	0.9970055543099687
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.04664286	0.9970055543099687
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.04656081	0.9952517101903942
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.046531	0.994614512223246
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.04648685	0.9936707923222197
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.046110700000000004	0.9856304697679489
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.045956699999999996	0.9823386721516848
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.04593105	0.981790395470794
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.04574992	0.9779186857160286
DUCHENNE MUSCULAR DYSTROPHY	0.045707880000000006	0.977020067717407
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.0455466	0.9735726578501922
WILLIAMS SYNDROME	0.04554543	0.9735476487384322
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	0.9716039918731928
ADENOCARCINOMA OF OVARY	0.0454545	0.9716039918731928
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0454545	0.9716039918731928
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0454545	0.9716039918731928
DUODENAL NEUROENDOCRINE TUMOR	0.0454545	0.9716039918731928
SNEDDON SYNDROME	0.0453352	0.969053917486048
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.04530146	0.9683327145537576
OTOONYCHOPERONEAL SYNDROME	0.0452848	0.9679766019025433
KOOLEN-DE VRIES SYNDROME; KDVS	0.04514361	0.9649586219970868
EPISODIC ATAXIA, TYPE 2	0.045011869999999995	0.9621426387635372
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.04488585	0.9594489222985919
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.04463445	0.954075169566587
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0444444	0.9500127920537884
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.044322349999999996	0.9474039355663532
THOMSEN AND BECKER DISEASE	0.0443063	0.947060861853749
LIPOSARCOMA	0.04416387000000001	0.9440163765648891
MYOPATHY, DISTAL, 1; MPD1	0.04407452	0.9421064926881798
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.043957539999999996	0.9396060090183709
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.043953519999999996	0.9395200802754009
ACUTE ADRENAL INSUFFICIENCY	0.043880920000000004	0.9379682328277338
ADDISON DISEASE	0.043880920000000004	0.9379682328277338
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.043880920000000004	0.9379682328277338
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.043718499999999993	0.9344964551080349
MARINESCO-SJOGREN SYNDROME; MSS	0.04366983	0.9334561188094405
PREPAPILLARY VASCULAR LOOPS	0.0435606	0.9311212937859045
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.043494099999999994	0.9296998357243359
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.043494099999999994	0.9296998357243359
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.9293621058390312
ADULT IDIOPATHIC NEUTROPENIA	0.043478300000000004	0.9293621058390312
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.043478300000000004	0.9293621058390312
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.043478300000000004	0.9293621058390312
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.043478300000000004	0.9293621058390312
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.9293621058390312
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.9293621058390312
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.9293621058390312
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.043478300000000004	0.9293621058390312
IMMUNODEFICIENCY 58; IMD58	0.043478300000000004	0.9293621058390312
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.9293621058390312
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	0.9293621058390312
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	0.9293621058390312
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.9293621058390312
WHITE FORELOCK WITH MALFORMATIONS	0.043478300000000004	0.9293621058390312
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	0.9293621058390312
CANDIDIASIS, FAMILIAL, 9; CANDF9	0.043478300000000004	0.9293621058390312
REACTIVE ARTHRITIS	0.043478300000000004	0.9293621058390312
HARTNUP DISEASE	0.043137220000000004	0.9220714153782823
POLYMYOSITIS	0.043122110000000005	0.9217484344563228
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.042937909999999996	0.9178111025023238
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.0426635	0.9119455039057071
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.0426635	0.9119455039057071
ACROCRANIOFACIAL DYSOSTOSIS	0.04253151	0.9091241768448585
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.042443749999999995	0.9072482797097717
CHERUBISM	0.04227	0.9035343197368767
300270 ADRENOMYODYSTROPHY	0.04224533	0.9030069908589985
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.04223922	0.9028763877198077
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.04219863	0.902008763919521
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.042003610000000004	0.8978401511200159
AMYLOIDOSIS, FINNISH TYPE	0.0419408	0.8964975679493824
WALDENSTRÖM MACROGLOBULINEMIA	0.04174506	0.8923135649272557
BRAIN-LUNG-THYROID SYNDROME	0.041729180000000005	0.8919741250172151
VIRAL HEMORRHAGIC FEVER	0.04170719	0.8915040819679835
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.04163201	0.889897086222589
NIEMANN-PICK DISEASE TYPE B	0.04157222	0.8886190564857294
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.04151506	0.8873972438120561
GERODERMA OSTEODYSPLASTICUM; GO	0.04118638	0.8803716071853442
CRANIOECTODERMAL DYSPLASIA	0.04118638	0.8803716071853442
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.04105306	0.8775218509632643
SPASTIC PARAPLEGIA TYPE 7	0.0410397	0.8772362768323987
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	0.8770295775924684
LESCH-NYHAN SYNDROME	0.041030029999999995	0.8770295775924684
DIENCEPHALIC SYNDROME	0.041030029999999995	0.8770295775924684
ISOLATED CEREBELLAR AGENESIS	0.041030029999999995	0.8770295775924684
HUNTINGTON DISEASE	0.041030029999999995	0.8770295775924684
BECKER MUSCULAR DYSTROPHY	0.04097875	0.8759334517368709
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.04095874	0.8755057317998485
OROFACIODIGITAL SYNDROME TYPE 1	0.040740700000000005	0.8708450593826396
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.04052457	0.8662252138059958
BLAU SYNDROME	0.04039421	0.8634387284991375
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.04020156	0.8593207751824279
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0401993	0.8592724669836438
WILSON DISEASE	0.04	0.8550123678607776
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.04	0.8550123678607776
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Z	0.04	0.8550123678607776
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	0.8543433206829263
PARKES WEBER SYNDROME	0.03985914	0.8520014418073558
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0397012	0.8486254254728576
CEDNIK SYNDROME	0.039691309999999994	0.8484140236649038
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2	0.0396491	0.8475117718637188
AORTIC VALVE DISEASE 2; AOVD2	0.0396491	0.8475117718637188
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.0396491	0.8475117718637188
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.039560450000000004	0.8456168507034475
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.039504479999999995	0.8444204746477181
WOLFRAM SYNDROME	0.03946084999999999	0.8434878699074739
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.03940818	0.8423620323720934
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.039223310000000004	0.838410378960933
SPINOCEREBELLAR ATAXIA TYPE 4	0.03916258	0.8371122564334282
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.03911096	0.8360088629727038
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.03899852	0.8336054232066472
PRIMARY BILIARY CHOLANGITIS	0.03894548	0.8324716768068637
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.038935609999999996	0.8322607025050941
ROSSELLI-GULIENETTI SYNDROME	0.038935609999999996	0.8322607025050941
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.03887033000000001	0.8308653223207455
RHOMBENCEPHALOSYNAPSIS	0.038856299999999996	0.8305654267327182
INDOLENT SYSTEMIC MASTOCYTOSIS	0.03880174	0.8293991898629562
SPINOCEREBELLAR ATAXIA TYPE 34	0.038792799999999995	0.8292080945987391
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.03873177	0.8279035594784757
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.03866415	0.8264581610706071
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03853449	0.8236866384801863
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.03849638	0.8228720254467069
DISTAL MONOSOMY 10Q	0.03849638	0.8228720254467069
HURLER SYNDROME	0.03849638	0.8228720254467069
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	0.8221264546619323
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0384615	0.8221264546619323
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	0.8221264546619323
LIP, MEDIAN NODULE OF UPPER	0.0384615	0.8221264546619323
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	0.8221264546619323
CYCLIC NEUTROPENIA	0.0384615	0.8221264546619323
LIP, HAMARTOMATOUS	0.0384615	0.8221264546619323
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	0.8221264546619323
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.0384615	0.8221264546619323
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	0.8221264546619323
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	0.8221264546619323
MAL DE MELEDA	0.0384615	0.8221264546619323
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0384615	0.8221264546619323
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	0.8221264546619323
JUVENILE MYOCLONIC EPILEPSY	0.0384615	0.8221264546619323
BAZEX SYNDROME; BZX	0.0384615	0.8221264546619323
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	0.8221264546619323
ACROCEPHALOPOLYDACTYLY	0.0384615	0.8221264546619323
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	0.8221264546619323
JUVENILE ABSENCE EPILEPSY	0.0384615	0.8221264546619323
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.038364	0.8200423620152717
LYMPHEDEMA, HEREDITARY, III	0.03832895	0.8192931574279336
JOHANSON-BLIZZARD SYNDROME; JBS	0.038095199999999996	0.8142966789032471
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.8138584850647187
CINCA SYNDROME	0.03800349	0.8123363492968345
NEURALGIC AMYOTROPHY	0.03786943	0.809470775345949
UNILATERAL POLYMICROGYRIA	0.03784211999999999	0.808887015651792
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.03767782	0.8053750523508039
EPISODIC ATAXIA TYPE 1	0.03763444	0.8044477914378589
TANGIER DISEASE	0.03753931	0.8024143582739941
MUSCULAR DYSTROPHY, BARNES TYPE	0.037466429999999995	0.8008565257397517
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.03743265	0.8001344677950932
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.03743265	0.8001344677950932
MARFANOID HYPERMOBILITY SYNDROME	0.0374269	0.8000115597672133
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA	0.03742284	0.7999247760118754
FAMILIAL HYPOALDOSTERONISM	0.037384970000000003	0.7991152930526033
PEYRONIE DISEASE	0.037037	0.7916773267114904
207620 APHALANGY WITH HEMIVERTEBRAE	0.037037	0.7916773267114904
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.037037	0.7916773267114904
SCIMITAR SYNDROME	0.037037	0.7916773267114904
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.037037	0.7916773267114904
DK PHOCOMELIA SYNDROME	0.037037	0.7916773267114904
TRISOMY 18	0.037037	0.7916773267114904
VISCERAL STEATOSIS, CONGENITAL	0.037037	0.7916773267114904
KINDLER SYNDROME; KNDLRS	0.037037	0.7916773267114904
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.037037	0.7916773267114904
CHARLIE M SYNDROME	0.037037	0.7916773267114904
ACROMELIC FRONTONASAL DYSPLASIA	0.037037	0.7916773267114904
NATHALIE SYNDROME	0.037037	0.7916773267114904
OVARIAN HYPERSTIMULATION SYNDROME	0.037037	0.7916773267114904
HYPERLYSINEMIA, TYPE I	0.037037	0.7916773267114904
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.037037	0.7916773267114904
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.037037	0.7916773267114904
MARTSOLF SYNDROME	0.037037	0.7916773267114904
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.037037	0.7916773267114904
LABIA MINORA, INCOMPLETE ADHESION OF	0.037037	0.7916773267114904
GALACTORRHEA	0.037037	0.7916773267114904
LELIS SYNDROME	0.037037	0.7916773267114904
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.037037	0.7916773267114904
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.037037	0.7916773267114904
KERATODERMA HEREDITARIUM MUTILANS	0.037037	0.7916773267114904
HEREDITARY OROTIC ACIDURIA	0.037037	0.7916773267114904
AUTOSOMAL RECESSIVE HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.037037	0.7916773267114904
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.037037	0.7916773267114904
LEUKONYCHIA TOTALIS	0.037037	0.7916773267114904
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.037037	0.7916773267114904
TESTICULAR TORSION	0.037037	0.7916773267114904
ADENOMYOSIS	0.037037	0.7916773267114904
URINARY BLADDER, ATONY OF	0.037037	0.7916773267114904
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.037037	0.7916773267114904
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.037037	0.7916773267114904
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.037037	0.7916773267114904
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.037037	0.7916773267114904
GENITOURINARY TRACT ANOMALIES	0.037037	0.7916773267114904
FAMILIAL SUPERNUMERARY NIPPLES	0.037037	0.7916773267114904
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.036756109999999995	0.78567321611128
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.03665818	0.7835799320816649
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.036575069999999994	0.7818034301343421
ADNP SYNDROME	0.0364761	0.7796879157831625
CONGENITAL HYPOTHYROIDISM	0.03636238	0.7772571156213344
KAGAMI-OGATA SYNDROME	0.0362408	0.7746583055292215
SAETHRE-CHOTZEN SYNDROME	0.03613173	0.7723269005551573
THUMBS, CONGENITAL CLASPED	0.0361093	0.7718474523698792
ATYPICAL RETT SYNDROME	0.03610425	0.7717395070584369
RIN2 SYNDROME	0.03602454	0.7700356811623823
BIOTINIDASE DEFICIENCY	0.03601861	0.7699089255788469
PERINEURAL CYST	0.036011659999999994	0.769760367179931
HYPOADRENOCORTICISM, FAMILIAL	0.03600262	0.7695671343847946
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	0.7653258455340212
MANGANESE POISONING	0.03579868	0.7652078538272564
ADRENOMYODYSTROPHY	0.03577503	0.7647023277647588
POSTERIOR MENINGOCELE	0.035714300000000004	0.7634042052372543
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.035714300000000004	0.7634042052372543
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.035714300000000004	0.7634042052372543
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.035714300000000004	0.7634042052372543
OPTIC ATROPHY 2	0.035714300000000004	0.7634042052372543
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.03570111	0.7631222649089521
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I	0.03570111	0.7631222649089521
BENIGN FAMILIAL INFANTILE EPILEPSY	0.03561399	0.7612600479717512
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.03557506	0.7604279071847307
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.03557506	0.7604279071847307
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.035522240000000004	0.7592988633529707
ARACHNOIDITIS	0.03551529	0.7591503049540548
GANGLIOCYTOMA	0.035475150000000004	0.7582923000429066
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.03543901	0.7575197963685443
FLYNN-AIRD SYNDROME	0.035422659999999995	0.7571703100631811
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035422659999999995	0.7571703100631811
MORQUIO SYNDROME A	0.03539938	0.7566726928650862
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.03539938	0.7566726928650862
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.7538229366430063
LATE-ONSET FAMILIAL HYPOALDOSTERONISM	0.03526606	0.7538229366430063
SANDHOFF DISEASE	0.035207949999999995	0.7525808174255963
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.035207949999999995	0.7525808174255963
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE PHOSPHOFRUCTOKINASE DEFICIENCY	0.035207949999999995	0.7525808174255963
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.03512597	0.7508284695776658
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.03512597	0.7508284695776658
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.0349752	0.7476057142101066
GYRATE ATROPHY OF CHOROID AND RETINA	0.0349752	0.7476057142101066
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.0349752	0.7476057142101066
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.03490131	0.7460262926135757
THYMOMA	0.034796099999999996	0.7437773963330099
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.034788139999999995	0.7436072488718056
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.03469828	0.7416864635874064
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03469828	0.7416864635874064
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03469828	0.7416864635874064
MCCUNE-ALBRIGHT SYNDROME	0.0346475	0.7406010253864072
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	0.7370805119617405
601095 HARROD SYNDROME	0.0344828	0.7370805119617405
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	0.7370805119617405
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	0.7370805119617405
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0344828	0.7370805119617405
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	0.7370805119617405
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	0.7370805119617405
CLAPO SYNDROME	0.0344828	0.7370805119617405
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	0.7370805119617405
LENNOX-GASTAUT SYNDROME	0.0344828	0.7370805119617405
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.0344828	0.7370805119617405
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0344828	0.7370805119617405
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0344828	0.7370805119617405
VARICOSE VEINS	0.0344828	0.7370805119617405
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0344828	0.7370805119617405
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0344828	0.7370805119617405
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0344828	0.7370805119617405
MEIGE DISEASE	0.0344828	0.7370805119617405
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0344828	0.7370805119617405
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	0.7370805119617405
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	0.7370805119617405
LYMPHATIC MALFORMATION 7; LMPHM7	0.0344828	0.7370805119617405
MUCOPOLYSACCHARIDOSIS TYPE 6	0.03441456	0.7356218608621699
ISOLATED GLYCEROL KINASE DEFICIENCY	0.03439291	0.7351590854180653
METACHROMATIC LEUKODYSTROPHY	0.0343299	0.7338122271855927
CUTIS LAXA	0.03419985	0.7310323682245853
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.034127	0.7294751769496187
OROFACIODIGITAL SYNDROME I; OFD1	0.034127	0.7294751769496187
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.034085	0.728577413963365
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0339719	0.7261598664932386
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.03393871	0.7254504199810061
NARP SYNDROME	0.03389932	0.7246084465517553
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0338384	0.7233062627155032
SILVER-RUSSELL SYNDROME	0.033819829999999995	0.7229093232237239
BETHLEM MYOPATHY 2; BTHLM2	0.033799180000000005	0.7224679230888159
CUSHING DISEASE	0.03379099	0.7222928593064963
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.033771380000000004	0.7218736894931527
DENGUE FEVER	0.03373351	0.7210642065338805
MARSHALL-SMITH SYNDROME	0.03372175	0.7208128328977293
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.033613420000000005	0.7184972456524705
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.033613420000000005	0.7184972456524705
7Q11.23 MICRODUPLICATION SYNDROME	0.03356218	0.7174019748092407
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.033561179999999996	0.7173805995000442
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.033540839999999995	0.7169458257109869
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.03349057	0.7158712889176779
EPIDERMAL NEVUS SYNDROME	0.03335633	0.7130018674111371
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0333335	0.7125138691021807
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0333333	0.7125095940403414
FAMILIAL TUMORAL CALCINOSIS	0.0333333	0.7125095940403414
MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL	0.0333333	0.7125095940403414
CHRONIC GRANULOMATOUS DISEASE	0.0333333	0.7125095940403414
CORNEODERMATOOSSEOUS SYNDROME	0.0333333	0.7125095940403414
15Q13.3 MICRODELETION SYNDROME	0.03327231	0.7112059139324456
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0330413	0.7062680037549577
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.03300972	0.7055929714905316
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.03288738000000001	0.7029779161634296
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.03288738000000001	0.7029779161634296
METACHROMATIC LEUKODYSTROPHY	0.0328505	0.7021895947602618
INSULINOMA	0.0326621	0.6981624865076375
13Q12.3 MICRODELETION SYNDROME	0.03258746	0.6965670334292092
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.0325126	0.6949668777827579
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.03241755	0.6929351546436288
TURNPENNY-FRY SYNDROME; TPFS	0.03241755	0.6929351546436288
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.032344609999999996	0.6913760395908345
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.032274449999999996	0.6898763478976067
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.032258220000000004	0.6895294266293474
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.6895268615922436
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.6895268615922436
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	0.6895268615922436
PYRIDOXINE-DEPENDENT EPILEPSY	0.0322581	0.6895268615922436
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.6895268615922436
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0322581	0.6895268615922436
TAY-SACHS DISEASE	0.0322581	0.6895268615922436
YOU-HOOVER-FONG SYNDROME; YHFS	0.0322581	0.6895268615922436
DESMOID TUMOR	0.0322581	0.6895268615922436
THROMBOCYTOPENIA 1	0.0322581	0.6895268615922436
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	0.6895268615922436
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.6895268615922436
NETHERTON SYNDROME; NETH	0.0322581	0.6895268615922436
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.6895268615922436
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.6895268615922436
MYOTONIA, POTASSIUM-AGGRAVATED	0.0322581	0.6895268615922436
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.6895268615922436
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.6895268615922436
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	0.6895268615922436
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0322581	0.6895268615922436
OXOGLUTARIC ACIDURIA	0.0322581	0.6895268615922436
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	0.6895268615922436
LEIGH SYNDROME	0.0322581	0.6895268615922436
PROXIMAL MYOTONIC MYOPATHY	0.0322581	0.6895268615922436
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0322581	0.6895268615922436
GRISCELLI SYNDROME TYPE 1	0.0322581	0.6895268615922436
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	0.6895268615922436
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	0.6895268615922436
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.6895268615922436
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0322581	0.6895268615922436
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.6895268615922436
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	0.6895268615922436
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.0322581	0.6895268615922436
NORMOKALEMIC PERIODIC PARALYSIS	0.0322581	0.6895268615922436
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.6895268615922436
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	0.6895268615922436
PEROXISOME BIOGENESIS DISORDER 14B	0.032254740000000004	0.6894550405533434
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.03225111	0.68937744818096
BERNARD-SOULIER SYNDROME	0.032026120000000005	0.6845682173648352
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.032001999999999996	0.684052644907015
WISKOTT-ALDRICH SYNDROME	0.03194114	0.6827517435893149
MIYOSHI MUSCULAR DYSTROPHY 3; MMD3	0.03193031	0.6825202489907166
MENKES DISEASE	0.03192718	0.6824533442729314
PEROXISOME BIOGENESIS DISORDER 5B	0.03189198	0.6817009333892139
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.03186128	0.6810447113968808
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.03175705	0.6788167629193276
AICARDI-GOUTIÈRES SYNDROME	0.03169214	0.6774292915993815
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.03143333	0.6718971478262303
FRANK-TER HAAR SYNDROME; FTHS	0.03125743	0.6681372309385626
PSEUDOAMINOPTERIN SYNDROME	0.03125	0.6679784123912325
OPTIC ATROPHY 11; OPA11	0.03125	0.6679784123912325
CUTIS LAXA-MARFANOID SYNDROME	0.03125	0.6679784123912325
GOOD SYNDROME	0.03125	0.6679784123912325
MOSAIC TRISOMY 9	0.03125	0.6679784123912325
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.03125	0.6679784123912325
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.03125	0.6679784123912325
ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE	0.03125	0.6679784123912325
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.03125	0.6679784123912325
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.03125	0.6679784123912325
ORTHOSTATIC HYPOTENSION 2; ORTHYP2	0.03125	0.6679784123912325
OTOPALATODIGITAL SYNDROME TYPE 2	0.03125	0.6679784123912325
HURLER-SCHEIE SYNDROME	0.03125	0.6679784123912325
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.03125	0.6679784123912325
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.03125	0.6679784123912325
AORTO-VENTRICULAR TUNNEL	0.03125	0.6679784123912325
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.03125	0.6679784123912325
POLYCYTHEMIA VERA	0.03114464	0.6657263098142872
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.03114464	0.6657263098142872
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.03094232	0.6614016572576473
HEMOCHROMATOSIS TYPE 2	0.030908730000000002	0.6606836606217362
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0307956	0.658265471892334
ROLANDIC EPILEPSY	0.03063722	0.6548800504217892
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.030566700000000002	0.6533726636172508
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.03054204	0.6528455484924645
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.03053454	0.6526852336734906
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.03048666	0.6516617838691613
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.030476120000000002	0.6514364881102299
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.03046518	0.65120264222762
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03045445	0.6509732851599415
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.03042885	0.6504260772445105
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.03030165	0.6477071379147132
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.03019177	0.6453584189401996
SPINOCEREBELLAR ATAXIA 1	0.03019177	0.6453584189401996
17P11.2 MICRODUPLICATION SYNDROME	0.03017396	0.6449777246834096
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.030092559999999997	0.6432377745148129
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	0.6408103944024561
DARWINIAN POINT OF PINNA	0.0294118	0.6286863190261903
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.6286863190261903
HAIRY EARS, Y-LINKED	0.0294118	0.6286863190261903
MUSICAL PERFECT PITCH	0.0294118	0.6286863190261903
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.6286863190261903
EAR MALFORMATION	0.0294118	0.6286863190261903
AREDYLD	0.0294118	0.6286863190261903
EAR WAX, WET/DRY	0.0294118	0.6286863190261903
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0294118	0.6286863190261903
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	0.6286863190261903
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.6286863190261903
OSTEOMA OF MIDDLE EAR	0.0294118	0.6286863190261903
OSSIFIED EAR CARTILAGES	0.0294118	0.6286863190261903
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.0294118	0.6286863190261903
VELOCARDIOFACIAL SYNDROME	0.0294118	0.6286863190261903
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.6286863190261903
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.6286863190261903
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.6286863190261903
EAR FOLDING	0.0294118	0.6286863190261903
BLAU SYNDROME	0.0294118	0.6286863190261903
EAR WITHOUT HELIX	0.0294118	0.6286863190261903
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.02940222	0.6284815435640878
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02940222	0.6284815435640878
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.02940222	0.6284815435640878
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.02940222	0.6284815435640878
REFSUM DISEASE	0.029395249999999998	0.628332557658988
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.02933082	0.6269553464874562
AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1	0.02926565	0.6255623175871191
CRANIOSYNOSTOSIS 2	0.02918584	0.6238563541601448
FAMILIAL THROMBOCYTOSIS	0.02918584	0.6238563541601448
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.02918584	0.6238563541601448
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.029176360000000002	0.6236537162289618
LINEAR NEVUS SEBACEUS SYNDROME	0.029115999999999996	0.6223635025658598
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02909776	0.6219736169261154
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.02909776	0.6219736169261154
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.028876699999999998	0.6172483910751327
PREECLAMPSIA	0.028751719999999998	0.6145769049317518
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.02869551	0.6133753988018155
MACROPHAGIC MYOFASCIITIS	0.028581300000000004	0.6109341247384811
WILLIAMS-BEUREN SYNDROME; WBS	0.02857521	0.6108039491054742
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0285714	0.6107225091774354
HURLER-SCHEIE SYNDROME	0.0285714	0.6107225091774354
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0285714	0.6107225091774354
SCHEIE SYNDROME	0.0285714	0.6107225091774354
COSTELLO SYNDROME; CSTLO	0.0285714	0.6107225091774354
XIA-GIBBS SYNDROME	0.0285714	0.6107225091774354
ACHONDROPLASIA	0.0285714	0.6107225091774354
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.6107225091774354
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.6107225091774354
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.6107225091774354
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.6107225091774354
DYSOSTEOSCLEROSIS	0.0285714	0.6107225091774354
APNEA, OBSTRUCTIVE SLEEP	0.0285714	0.6107225091774354
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.028564199999999998	0.6105686069512205
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.028563500000000002	0.610553644234783
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.02852298	0.60968751670614
NEUROLEPTIC MALIGNANT SYNDROME	0.02839546	0.6069617372773999
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.02839504	0.6069527596475373
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.028352500000000003	0.6060434539943175
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.02819957	0.6027745279588936
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.02816527	0.602041354853453
16P13.2 MICRODELETION SYNDROME	0.02812773	0.6012389257462156
PARKINSONIAN-PYRAMIDAL SYNDROME	0.02807968	0.6002118421393229
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.02807968	0.6002118421393229
PARKINSON DISEASE, LATE-ONSET; PD	0.02807968	0.6002118421393229
DUANE-RADIAL RAY SYNDROME; DRRS	0.028036150000000003	0.5992813749299984
HEMOCHROMATOSIS, TYPE 1	0.027958880000000002	0.5976297047883834
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.027958880000000002	0.5976297047883834
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.027958880000000002	0.5976297047883834
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.02793598	0.5971402102077831
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.02793563	0.5971327288495643
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0278559	0.5954284754473258
BAKER-GORDON SYNDROME; BAGOS	0.02784401	0.5951743230209792
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.5937590637990777
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.5937590637990777
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.5937590637990777
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.5937590637990777
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.5937590637990777
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.5937590637990777
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.5937590637990777
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.5937590637990777
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.5937590637990777
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.5937590637990777
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.5937590637990777
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.5937590637990777
DWARFISM, LEVI TYPE	0.027777800000000002	0.5937590637990777
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.5937590637990777
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.5937590637990777
DIMPLES, FACIAL	0.027777800000000002	0.5937590637990777
CLEFT CHIN	0.027777800000000002	0.5937590637990777
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.5937590637990777
OROFACIAL CLEFT 3	0.027777800000000002	0.5937590637990777
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.5937590637990777
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.5937590637990777
NASAL BONES, ABSENCE OF	0.027777800000000002	0.5937590637990777
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.5937590637990777
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.5937590637990777
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.027777800000000002	0.5937590637990777
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.5937590637990777
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.027749450000000002	0.5931530737833564
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.02768547	0.591785481500963
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.02765565	0.5911480697807228
VON HIPPEL-LINDAU DISEASE	0.027651630000000003	0.5910621410377528
CENTRAL NEUROCYTOMA	0.027640309999999998	0.5908201725376481
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.02759854	0.5899273258725096
HEMOCHROMATOSIS, TYPE 4; HFE4	0.0273556	0.5847344082563071
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0273556	0.5847344082563071
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.0272529	0.5825391640018246
ADULT POLYGLUCOSAN BODY DISEASE	0.02721826	0.5817987232912571
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.02719142	0.5812250099924225
HALLERMANN-STREIFF SYNDROME	0.02717757	0.5809289619600507
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.027090549999999998	0.5790688825537695
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.027090549999999998	0.5790688825537695
DYSAUTONOMIA-LIKE DISORDER	0.027006139999999998	0.5772645927044914
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02689592	0.5749086061248511
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.02687668	0.57449734517591
CAMPOMELIC DYSPLASIA	0.02665857	0.5698351764870572
MELKERSSON-ROSENTHAL SYNDROME	0.026647249999999997	0.5695932079869525
MELKERSSON-ROSENTHAL SYNDROME	0.026647249999999997	0.5695932079869525
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.02655505	0.5676224044790336
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.02652261	0.5669289894486984
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.026500660000000002	0.5664598014118348
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.026393629999999998	0.5641720020685312
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.0263158	0.5625083617537662
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0263158	0.5625083617537662
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.0263158	0.5625083617537662
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0263158	0.5625083617537662
TEMTAMY SYNDROME	0.0263158	0.5625083617537662
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.0263158	0.5625083617537662
TEMTAMY SYNDROME; TEMTYS	0.0263158	0.5625083617537662
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.5625083617537662
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.0263158	0.5625083617537662
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0263158	0.5625083617537662
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.0263158	0.5625083617537662
OSTEOGENESIS IMPERFECTA, TYPE I	0.0263158	0.5625083617537662
LOEYS-DIETZ SYNDROME	0.0263158	0.5625083617537662
MYASTHENIA GRAVIS	0.0263158	0.5625083617537662
MONOSOMY 18Q	0.0263158	0.5625083617537662
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.02626232	0.5613652102179363
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.02623826	0.5608509202786681
CAROLI DISEASE, ISOLATED	0.02623826	0.5608509202786681
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.02622563	0.560580950123516
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.026193189999999998	0.5598875350931809
SPINOCEREBELLAR ATAXIA 18	0.026193189999999998	0.5598875350931809
BAND HETEROTOPIA; BH	0.02611428	0.5582008094444836
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.02609817	0.5578564532133277
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.02606835	0.5572190414930874
ISOLATED POLYCYSTIC LIVER DISEASE	0.02606835	0.5572190414930874
45,X/46,XY MIXED GONADAL DYSGENESIS	0.02602167	0.556221242059794
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0258826	0.5532485778098339
CARTILAGE-HAIR HYPOPLASIA	0.025860300000000003	0.5527719084147517
RECOMBINANT 8 SYNDROME	0.025837739999999998	0.552289681439278
GAUCHER DISEASE	0.0257683	0.5508053799686718
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.025677329999999998	0.5488608680910644
OSGOOD-SCHLATTER DISEASE	0.025641000000000004	0.548084303107955
SPINOCEREBELLAR ATAXIA TYPE 13	0.025641000000000004	0.548084303107955
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.025613820000000002	0.5475033222039936
MACHADO-JOSEPH DISEASE TYPE 3	0.02558389	0.5468635591997417
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.02553724	0.5458664010257239
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.02544477	0.5438898261843218
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02539681	0.5428646663552568
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.02539681	0.5428646663552568
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.025388259999999996	0.5426819074616265
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.02538752	0.5426660897328212
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.02538676	0.5426498444978318
PSEUDOXANTHOMA ELASTICUM	0.02538676	0.5426498444978318
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.02537185	0.5423311386377117
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.025305030000000003	0.5409028404772003
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.02529266	0.5406384279024393
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0252782	0.5403293409314576
CEREBROTENDINOUS XANTHOMATOSIS	0.025251689999999997	0.5397626814846578
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.025231049999999998	0.5393214951028417
MEDULLOBLASTOMA	0.02520991	0.5388696210664272
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.02520721	0.5388119077315967
MULTIPLE OSTEOCHONDROMAS	0.02517205	0.5380603518602471
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 10; LGMDR10	0.02516359	0.5378795167444445
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.02512743	0.5371065855638983
THALIDOMIDE SUSCEPTIBILITY	0.02504074	0.5352535600096522
PROXIMAL SPINAL MUSCULAR ATROPHY	0.0250352	0.5351351407967034
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0250352	0.5351351407967034
KEARNS-SAYRE SYNDROME	0.0250352	0.5351351407967034
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.0250352	0.5351351407967034
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.02500073	0.5343983338886993
CLEIDOCRANIAL DYSPLASIA	0.02498268	0.5340125095577022
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.02493688	0.5330335203965016
HEREDITARY FOLATE MALABSORPTION	0.02492589	0.5327986057484319
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.024868150000000002	0.5315643953954249
HYPERCALCEMIA, INFANTILE, 1	0.02484936	0.5311627533356222
FAMILIAL PAROXYSMAL ATAXIA	0.02471082	0.5282014179995365
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.024688230000000002	0.5277185497647872
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.02467945	0.5275308745500416
SCHAAF-YANG SYNDROME; SHFYNG	0.02467945	0.5275308745500416
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.02467945	0.5275308745500416
PITT-HOPKINS SYNDROME	0.02467945	0.5275308745500416
16P11.2P12.2 MICRODELETION SYNDROME	0.02467945	0.5275308745500416
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.02467945	0.5275308745500416
PITT-HOPKINS SYNDROME	0.02467945	0.5275308745500416
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.02467945	0.5275308745500416
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.024614900000000002	0.5261510983414064
OROFACIODIGITAL SYNDROME TYPE 6	0.02461234	0.5260963775498632
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02451964	0.5241148863873458
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.0244877	0.5234321590116091
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.0244877	0.5234321590116091
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.0244877	0.5234321590116091
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.0244877	0.5234321590116091
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.024487699999999998	0.523432159011609
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.024487699999999998	0.523432159011609
LATERAL MENINGOCELE SYNDROME	0.024444399999999998	0.5225066081233997
RETINAL CONE DYSTROPHY 4	0.02444116	0.522437352121603
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.02443913	0.5223939602439341
KLEEFSTRA SYNDROME	0.02442583	0.5221096686316203
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.02436817	0.5208771683033491
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.02436302	0.5207670854609869
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0243628	0.5207623828929637
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.5207540465223771
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0242957	0.5193280996458773
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.02428158	0.5190262802800224
TYROSINEMIA TYPE 2	0.02413746	0.51594567071862
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.02401269	0.5132786733901704
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.02401269	0.5132786733901704
SALIH MYOPATHY; SALMY	0.02400928	0.5132057835858103
CROUZON SYNDROME	0.02399786	0.5129616775547859
PRADER-WILLI-LIKE SYNDROME	0.02399786	0.5129616775547859
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.02394636	0.5118608491311653
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.02391972	0.51129141089417
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.02386937	0.5102151640761251
MUSCLE-EYE-BRAIN DISEASE	0.02386937	0.5102151640761251
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0238095	0.5089354243145295
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0238095	0.5089354243145295
ADULT-ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY	0.0238095	0.5089354243145295
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0238095	0.5089354243145295
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0238095	0.5089354243145295
IDIOPATHIC UVEAL EFFUSION SYNDROME	0.0238095	0.5089354243145295
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0238095	0.5089354243145295
PUDENDAL NEURALGIA	0.0238095	0.5089354243145295
SPINOCEREBELLAR ATAXIA TYPE 42	0.0238095	0.5089354243145295
SPINOCEREBELLAR ATAXIA TYPE 8	0.0238095	0.5089354243145295
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.0238095	0.5089354243145295
USHER SYNDROME, TYPE IIIA	0.0238095	0.5089354243145295
RETINITIS PIGMENTOSA 62; RP62	0.0238095	0.5089354243145295
RETINITIS PIGMENTOSA 4; RP4	0.0238095	0.5089354243145295
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.0238095	0.5089354243145295
CAVITARY OPTIC DISC ANOMALIES; CODA	0.0238095	0.5089354243145295
ISOLATED PLAGIOCEPHALY	0.0238095	0.5089354243145295
BEST VITELLIFORM MACULAR DYSTROPHY	0.0238095	0.5089354243145295
RETINITIS PIGMENTOSA 78; RP78	0.0238095	0.5089354243145295
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.0238095	0.5089354243145295
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.02378315	0.5083721849172013
INHERITED CREUTZFELDT-JAKOB DISEASE	0.02378315	0.5083721849172013
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.02378315	0.5083721849172013
AMYOTROPHIC LATERAL SCLEROSIS 1	0.02378315	0.5083721849172013
EPENDYMOMA	0.02355757	0.5035503426686504
SUBEPENDYMOMA	0.02355757	0.5035503426686504
GITELMAN SYNDROME	0.02349901	0.5022986045621023
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.02335785	0.49928126591592153
RIFT VALLEY FEVER	0.02332187	0.4985121822910308
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.02314834	0.49480292488615873
SMITH-MAGENIS SYNDROME	0.023121740000000002	0.49423434166153135
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.02304204	0.4925307295185687
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.02293839	0.49031517872034946
PEROXISOME BIOGENESIS DISORDER 3B	0.0228608	0.48865666847979156
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.02277276	0.4867747862581299
MILLER-DIEKER SYNDROME	0.0227273	0.48580306470205614
COWDEN SYNDROME 6; CWS6	0.0227273	0.48580306470205614
ACRORENAL-MANDIBULAR SYNDROME	0.0227273	0.48580306470205614
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.48580306470205614
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.48580306470205614
ARTERIES, ANOMALIES OF	0.0227273	0.48580306470205614
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.48580306470205614
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.48580306470205614
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.48580306470205614
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.48580306470205614
FETAL HYDANTOIN SYNDROME	0.0227273	0.48580306470205614
LARSEN SYNDROME	0.0227273	0.48580306470205614
COWDEN SYNDROME 5; CWS5	0.0227273	0.48580306470205614
COCAINE EMBRYOFETOPATHY	0.0227273	0.48580306470205614
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.48580306470205614
THUMB DEFORMITY	0.0227273	0.48580306470205614
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.48580306470205614
WATSON SYNDROME	0.0227273	0.48580306470205614
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.48580306470205614
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.48580306470205614
SILVER-RUSSELL SYNDROME; SRS	0.0227273	0.48580306470205614
SIRENOMELIA	0.0227273	0.48580306470205614
FATCO SYNDROME	0.0227273	0.48580306470205614
SUSAC SYNDROME	0.022725620000000002	0.4857671541826061
XERODERMA PIGMENTOSUM	0.02270594	0.48534648809761854
CHYLOMICRON RETENTION DISEASE	0.02268449	0.48488798771535324
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.022608120000000002	0.48325555535201503
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.02259191	0.4829090615899394
MYOPATHY, CONGENITAL	0.02244973	0.4798699201283783
POSTENCEPHALITIC PARKINSONISM	0.0223794	0.4783665946325871
STICKLER SYNDROME	0.02236465	0.4780513088219384
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.02235835	0.47791664437400033
CYSTINOSIS	0.02233318	0.477378627841524
COFS SYNDROME	0.0223244	0.4771909526267786
REFSUM DISEASE	0.02231722	0.47703747790674744
CONGENITAL DISORDER OF GLYCOSYLATION	0.022301839999999996	0.4767087256513049
MULTIPLE CARBOXYLASE DEFICIENCY	0.022263969999999998	0.4758992426920328
STORMORKEN SYNDROME; STRMK	0.02225863	0.47578509854092343
NEUROFIBROMATOSIS TYPE 2	0.02223071	0.47518829990815664
GASTRITIS, FAMILIAL GIANT HYPERTROPHIC	0.0222222	0.4750063960268942
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0222222	0.4750063960268942
CONGENITAL FACTOR X DEFICIENCY	0.0222222	0.4750063960268942
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0222222	0.4750063960268942
GLANZMANN THROMBASTHENIA	0.0222222	0.4750063960268942
FAMILIAL HYPOFIBRINOGENEMIA	0.0222222	0.4750063960268942
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0222222	0.4750063960268942
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.0222222	0.4750063960268942
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0222222	0.4750063960268942
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0222222	0.4750063960268942
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0222222	0.4750063960268942
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0222222	0.4750063960268942
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0222222	0.4750063960268942
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0222222	0.4750063960268942
ANEURYSM OF INTERVENTRICULAR SEPTUM	0.0222222	0.4750063960268942
TELANGIECTASIA, HEREDITARY BENIGN	0.0222222	0.4750063960268942
CONGENITAL FACTOR VII DEFICIENCY	0.0222222	0.4750063960268942
GAUCHER DISEASE TYPE 1	0.0222222	0.4750063960268942
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0222222	0.4750063960268942
CARDIOMYOPATHY, DILATED, 1B; CMD1B	0.0222222	0.4750063960268942
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.0222222	0.4750063960268942
CONGENITAL ALPHA2-ANTIPLASMIN DEFICIENCY	0.0222222	0.4750063960268942
VASCULAR HYALINOSIS	0.0222222	0.4750063960268942
CHEILITIS GLANDULARIS	0.0222222	0.4750063960268942
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.0222222	0.4750063960268942
IDIOPATHIC APLASTIC ANEMIA	0.0222222	0.4750063960268942
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.0222222	0.4750063960268942
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0222222	0.4750063960268942
FAMILIAL DYSFIBRINOGENEMIA	0.0222222	0.4750063960268942
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0222222	0.4750063960268942
FAMILIAL AFIBRINOGENEMIA	0.0222222	0.4750063960268942
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0222222	0.4750063960268942
CONGENITAL PROTHROMBIN DEFICIENCY	0.0222222	0.4750063960268942
CURRARINO SYNDROME	0.0222222	0.4750063960268942
MECKEL SYNDROME, TYPE 1; MKS1	0.0222222	0.4750063960268942
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.0222222	0.4750063960268942
CONGENITAL FIBRINOGEN DEFICIENCY	0.0222222	0.4750063960268942
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9	0.0222222	0.4750063960268942
COACH SYNDROME	0.0222222	0.4750063960268942
IMMUNE THROMBOCYTOPENIC PURPURA	0.0222222	0.4750063960268942
CONGENITAL FACTOR V DEFICIENCY	0.0222222	0.4750063960268942
PRIMARY PARATHYROID HYPERPLASIA	0.022156640000000002	0.47360503075597044
PARATHYROID CARCINOMA	0.022156640000000002	0.47360503075597044
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.022156640000000002	0.47360503075597044
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.02210523	0.4725061261101774
ACRODYSOSTOSIS	0.022045839999999997	0.471236646496996
COCKAYNE SYNDROME A; CSA	0.022023130000000002	0.4707512132251432
FREE SIALIC ACID STORAGE DISEASE	0.02196678	0.4695467145519193
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.02196678	0.4695467145519193
RICHARDS-RUNDLE SYNDROME	0.02196678	0.4695467145519193
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.02192979	0.46875604186474
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.021909440000000002	0.46832105432259086
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.02177796	0.46551062866943244
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.02173941	0.4646866104999066
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.02168306	0.46348211182668275
PROLIDASE DEFICIENCY	0.02168306	0.46348211182668275
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.02166127	0.4630163438392906
6Q25 MICRODELETION SYNDROME	0.02162351	0.46220921216403
WAARDENBURG SYNDROME TYPE 1	0.02162351	0.46220921216403
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.02156081	0.46086898027740825
PELIZAEUS-MERZBACHER DISEASE	0.02155761	0.4608005792879794
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.02153978	0.46041945752500546
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.021472520000000002	0.45898175422844756
BETA-THALASSEMIA	0.02146835	0.45889261918909807
PYLE DISEASE; PYL	0.02146835	0.45889261918909807
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.02140128	0.45745897720128753
SICKLE CELL ANEMIA	0.02139078	0.45723453645472406
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.02136987	0.45678757873942477
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.02136751	0.4567371330097211
ERYTHROKERATODERMIA VARIABILIS	0.02136751	0.4567371330097211
GLAUCOMA 1, OPEN ANGLE, M	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 6	0.0212766	0.45479390365066547
BARDET-BIEDL SYNDROME 21; BBS21	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 14	0.0212766	0.45479390365066547
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.0212766	0.45479390365066547
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 74; RP74	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 11	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 1	0.0212766	0.45479390365066547
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 13; RP13	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 10; RP10	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 79	0.0212766	0.45479390365066547
SPINOCEREBELLAR ATAXIA TYPE 35	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 73; RP73	0.0212766	0.45479390365066547
CHERUBISM	0.0212766	0.45479390365066547
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 83; RP83	0.0212766	0.45479390365066547
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 69	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 25; RP25	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 19	0.0212766	0.45479390365066547
RETINITIS PIGMENTOSA 72; RP72	0.0212766	0.45479390365066547
CONE-ROD DYSTROPHY 20; CORD20	0.0212766	0.45479390365066547
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.02126082	0.4544566012715444
MAST SYNDROME	0.02124902	0.4542043726230255
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.021245459999999997	0.4541282765222858
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.02108133	0.4506199470238611
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.02108133	0.4506199470238611
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.02100134	0.44891013604123153
JOUBERT SYNDROME WITH OCULAR DEFECT	0.020971999999999998	0.44828298446940557
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.02094498	0.4477054236149156
PELGER-HUET ANOMALY; PHA	0.02094474	0.4477002935407085
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.02085994	0.4458876673208437
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.02083333	0.44531887034312434
BECKWITH-WIEDEMANN SYNDROME	0.0208333	0.4453182290838483
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.4453182290838483
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0208333	0.4453182290838483
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.4453182290838483
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.0208333	0.4453182290838483
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.4453182290838483
ROMANO-WARD SYNDROME	0.0208333	0.4453182290838483
RAMOS-ARROYO SYNDROME	0.0208333	0.4453182290838483
HYPOCHONDROPLASIA	0.0208333	0.4453182290838483
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.4453182290838483
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.0208333	0.4453182290838483
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.4453182290838483
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.4453182290838483
CRANDALL SYNDROME	0.0208333	0.4453182290838483
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.4453182290838483
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.4453182290838483
OROFACIODIGITAL SYNDROME TYPE 14	0.0208333	0.4453182290838483
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.4453182290838483
TYSHCHENKO SYNDROME	0.0208333	0.4453182290838483
BARATELA-SCOTT SYNDROME	0.0208333	0.4453182290838483
GAUCHER DISEASE, TYPE I	0.0208333	0.4453182290838483
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.4453182290838483
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.4453182290838483
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.4453182290838483
APNEA, CENTRAL SLEEP	0.0208333	0.4453182290838483
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.4453182290838483
PUPIL, EGG-SHAPED	0.0208333	0.4453182290838483
UNIQUE GREEN PHENOMENON	0.0208333	0.4453182290838483
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.4453182290838483
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.4453182290838483
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.4453182290838483
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.4453182290838483
DERMOIDS OF CORNEA	0.0208333	0.4453182290838483
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.0208333	0.4453182290838483
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0208333	0.4453182290838483
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.0208333	0.4453182290838483
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0208333	0.4453182290838483
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.4453182290838483
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.0208333	0.4453182290838483
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0208333	0.4453182290838483
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0208333	0.4453182290838483
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY (ADLD)	0.0208333	0.4453182290838483
IMINOGLYCINURIA	0.0208333	0.4453182290838483
EPISODIC PAIN SYNDROME, FAMILIAL, 3	0.0208333	0.4453182290838483
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.4453182290838483
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0208333	0.4453182290838483
STICKLER SYNDROME, TYPE III	0.0208333	0.4453182290838483
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.4453182290838483
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.4453182290838483
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.4453182290838483
GLAUCOMA - SLEEP APNEA	0.0208333	0.4453182290838483
611426 TENTED EYEBROWS	0.0208333	0.4453182290838483
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.4453182290838483
SIALURIA	0.0208333	0.4453182290838483
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.4453182290838483
GM1 GANGLIOSIDOSIS	0.02081984	0.44503051742206323
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.02075988	0.44374885388264
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.02075988	0.44374885388264
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.02074347	0.443398085058725
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.02069412	0.4423432135498768
TONNE-KALSCHEUER SYNDROME; TOKAS	0.020676729999999997	0.44197149692294924
BOUCHER-NEUHAUSER SYNDROME	0.020660989999999997	0.4416350495561961
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.02063032	0.44097946882313893
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.02063032	0.44097946882313893
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.02063032	0.44097946882313893
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.02061598	0.4406729468892608
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02061173	0.4405821018251756
COFFIN-SIRIS SYNDROME 3; CSS3	0.020563869999999998	0.43955907952703016
COFFIN-SIRIS SYNDROME 4; CSS4	0.020563869999999998	0.43955907952703016
COFFIN-SIRIS SYNDROME 2; CSS2	0.020563869999999998	0.43955907952703016
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.020524419999999998	0.4387158235792274
LARYNGOTRACHEAL ANGIOMA	0.0205217	0.43865768273821293
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.02049375	0.4380602428461703
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.02044607	0.43704106810368015
CHROMOSOME 1P36 DELETION SYNDROME	0.02034401	0.43485950404708335
FARBER DISEASE	0.02027838	0.43345664250451577
GERODERMA OSTEODYSPLASTICA	0.02027838	0.43345664250451577
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.020233380000000002	0.4324947535906725
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02019125	0.4315942118142231
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.020169259999999998	0.43112416876499154
GLIOBLASTOMA	0.020136750000000002	0.43042925746301286
SIALIDOSIS TYPE 1	0.02009673	0.42957381758896807
LYSINURIC PROTEIN INTOLERANCE	0.02007024	0.4290075856483523
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.02005945	0.42877694606212174
PORPHYRIA	0.0198773	0.4248834334919759
NATIVE AMERICAN MYOPATHY	0.019783000000000002	0.4228677418347441
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.01977438	0.4226834866694701
WILSON DISEASE	0.01977438	0.4226834866694701
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.019734869999999998	0.4218389482031155
FOCAL DERMAL HYPOPLASIA	0.019719149999999998	0.4215029283425462
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.019641060000000002	0.4198337304473901
DYSEQUILIBRIUM SYNDROME	0.01957728	0.41847041322683604
CLASSIC HODGKIN LYMPHOMA	0.01952286	0.4173071689003614
WOLCOTT-RALLISON SYNDROME	0.01950246	0.4168711125927525
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.01950097	0.4168392633820496
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.01945155	0.41578289560155773
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.01942454	0.4152055485001597
X-LINKED CENTRONUCLEAR MYOPATHY	0.019372450000000003	0.414092108644113
SEVERE CANAVAN DISEASE	0.019356989999999998	0.41376164636393475
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.01934964	0.4136045378413404
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.01934964	0.4136045378413404
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.019294580000000002	0.41242761331698
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.019294580000000002	0.41242761331698
ADENOSINE MONOPHOSPHATE DEAMINASE DEFICIENCY	0.0192308	0.411064296096426
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.0192308	0.411064296096426
CUTANEOUS MASTOCYTOSIS	0.01920679	0.41055107492261755
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.019196320000000003	0.4103272754353301
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.01895215	0.40510806618881584
WIEACKER-WOLFF SYNDROME	0.01894918	0.4050445815205022
IMMUNOGLOBULIN A VASCULITIS	0.01888874	0.40375265783266456
ATYPICAL TERATOID RHABDOID TUMOR	0.01888874	0.40375265783266456
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.4033071963890091
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.4033071963890091
TRACHEOBRONCHOMEGALY	0.0188679	0.4033071963890091
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.4033071963890091
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.4033071963890091
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.4033071963890091
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.4033071963890091
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.4033071963890091
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.4033071963890091
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.4033071963890091
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.4033071963890091
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.4033071963890091
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.4033071963890091
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.4033071963890091
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.4033071963890091
THROMBOCYTOPENIA 3	0.0188679	0.4033071963890091
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.4033071963890091
MONOPHALANGY OF GREAT TOE	0.0188679	0.4033071963890091
SPINAL ARACHNOIDITIS	0.0188679	0.4033071963890091
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.4033071963890091
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.4033071963890091
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.4033071963890091
VESICOURETERAL REFLUX 1	0.0188679	0.4033071963890091
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0188679	0.4033071963890091
TOE, MISSHAPEN	0.0188679	0.4033071963890091
CARPAL DISPLACEMENT	0.0188679	0.4033071963890091
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.4033071963890091
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.4033071963890091
KNUCKLE PADS	0.0188679	0.4033071963890091
NEPHROSIALIDOSIS	0.0188679	0.4033071963890091
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.4033071963890091
HHHH SYNDROME	0.0188679	0.4033071963890091
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.4033071963890091
PUBIC BONE DYSPLASIA	0.0188679	0.4033071963890091
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.4033071963890091
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.4033071963890091
RAYNAUD DISEASE	0.0188679	0.4033071963890091
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.4033071963890091
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.4033071963890091
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.4033071963890091
VAN DEN BOSCH SYNDROME	0.0188679	0.4033071963890091
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01885284	0.40298528423250946
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.01883737	0.40265460819923937
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.01872183	0.40018490497467346
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.01872183	0.40018490497467346
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.01871142	0.3999623880059377
KRABBE DISEASE	0.018661040000000004	0.3988854999286171
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.01861931	0.3979935082758463
48,XXYY SYNDROME	0.01859992	0.39757904103052577
ABETAL34V AMYLOIDOSIS	0.01857585	0.39706453733816566
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.01857485	0.3970431620289691
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.01856025	0.3967310825146999
JUVENILE DERMATOMYOSITIS	0.018544150000000002	0.396386940036636
COXOAURICULAR SYNDROME	0.0185185	0.3958386633557452
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.0185185	0.3958386633557452
COOPER-JABS SYNDROME	0.0185185	0.3958386633557452
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0185185	0.3958386633557452
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.0185185	0.3958386633557452
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0185185	0.3958386633557452
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.0185185	0.3958386633557452
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0185185	0.3958386633557452
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0185185	0.3958386633557452
LINEAR VERRUCOUS NEVUS SYNDROME	0.0185185	0.3958386633557452
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0185185	0.3958386633557452
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0185185	0.3958386633557452
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0185185	0.3958386633557452
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.0185185	0.3958386633557452
PHAKOMATOSIS PIGMENTOVASCULARIS	0.0185185	0.3958386633557452
PEARSON SYNDROME	0.0185185	0.3958386633557452
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.0185185	0.3958386633557452
MYOPATHY, DISTAL, 4; MPD4	0.01849098	0.39525041484665696
CAUDAL REGRESSION SEQUENCE	0.01848151	0.39504799066856594
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.01836334	0.39252207038081327
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.01836334	0.39252207038081327
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.01834356	0.3920992667649061
9Q33.3Q34.11 MICRODELETION SYNDROME	0.01829574	0.3910770994791286
JOUBERT SYNDROME WITH RENAL DEFECT	0.01820205	0.3890744467605066
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.01819839	0.38899621312884736
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.01819839	0.38899621312884736
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.01819839	0.38899621312884736
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.01819839	0.38899621312884736
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.01819533	0.38893080468270597
LYME DISEASE	0.01800726	0.38491075028211663
COLD AGGLUTININ DISEASE	0.01800726	0.38491075028211663
PEHO SYNDROME	0.0179732	0.38418270725088316
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0179621	0.3839454413188018
TOXIC EPIDERMAL NECROLYSIS	0.01794553	0.3835912524454155
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.01791721	0.38298590368897
INTESTINAL BOTULISM	0.01789967	0.3826109807656631
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.01784798	0.38150609103329497
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.01780074	0.38049632142685136
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.01780074	0.38049632142685136
NEUROPATHY, PAINFUL	0.01780074	0.38049632142685136
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.01780074	0.38049632142685136
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.01780074	0.38049632142685136
CITRULLINEMIA TYPE I	0.017666130000000002	0.37761899105590796
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.017544749999999998	0.37502445602563433
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0175439	0.37500628701281735
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0175439	0.37500628701281735
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.0175439	0.37500628701281735
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.0175439	0.37500628701281735
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0175439	0.37500628701281735
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0175439	0.37500628701281735
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.0175439	0.37500628701281735
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.0175439	0.37500628701281735
FACIOSCAPULOHUMERAL DYSTROPHY	0.017542710000000003	0.37498085039487355
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.01752956	0.37469976507893926
ISOLATED COMPLEX I DEFICIENCY	0.01752956	0.37469976507893926
MYOPATHY, DISTAL, INFANTILE-ONSET	0.01752531	0.374608920014854
MOSAIC MONOSOMY X	0.01748268	0.3736976905838064
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01748268	0.3736976905838064
X SMALL RINGS	0.01748268	0.3736976905838064
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.01748268	0.3736976905838064
MONOSOMY X	0.01748268	0.3736976905838064
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.01748268	0.3736976905838064
CRANIOECTODERMAL DYSPLASIA 1	0.01748268	0.3736976905838064
TURNER SYNDROME	0.01748268	0.3736976905838064
PROPIONIC ACIDEMIA	0.0174247	0.37245835015659223
PMM2-CDG	0.0174247	0.37245835015659223
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.01741166	0.3721796161246696
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.017399309999999998	0.37191563105609254
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.017399309999999998	0.37191563105609254
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.017399309999999998	0.37191563105609254
ZTTK SYNDROME; ZTTKS	0.017399309999999998	0.37191563105609254
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	0.37191563105609254
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.017399309999999998	0.37191563105609254
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	0.37191563105609254
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.017399309999999998	0.37191563105609254
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	0.37191563105609254
184705 STEINFELD SYNDROME	0.017399309999999998	0.37191563105609254
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	0.37191563105609254
FANCONI ANEMIA	0.017399309999999998	0.37191563105609254
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.017399309999999998	0.37191563105609254
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.017399309999999998	0.37191563105609254
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.01738947	0.37170529801359886
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.01735965	0.3710678862933587
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.01728394	0.3694495616340902
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01726826	0.36911439678588875
NAVAJO NEUROHEPATOPATHY	0.01726776	0.3691037091312905
CORNELIA DE LANGE SYNDROME	0.01726537	0.36905262214231077
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.017256530000000003	0.36886366440901364
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.017256530000000003	0.36886366440901364
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.017256530000000003	0.36886366440901364
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.36854025598087026
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.36854025598087026
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.36854025598087026
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.36854025598087026
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.36854025598087026
269800 SENILE PLAQUE FORMATION	0.0172414	0.36854025598087026
CARDIAC ARRHYTHMIA	0.0172414	0.36854025598087026
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.36854025598087026
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.36854025598087026
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.36854025598087026
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.36854025598087026
CERVICAL RIB	0.0172414	0.36854025598087026
JUMPING FRENCHMAN OF MAINE	0.0172414	0.36854025598087026
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.36854025598087026
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.36854025598087026
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.36854025598087026
MOSAIC TRISOMY 15	0.0172414	0.36854025598087026
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.36854025598087026
TRANSSEXUALITY	0.0172414	0.36854025598087026
PALMOMENTAL REFLEX	0.0172414	0.36854025598087026
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.36854025598087026
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.36854025598087026
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.36854025598087026
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.36854025598087026
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.36854025598087026
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.36854025598087026
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.36854025598087026
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.36854025598087026
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.36854025598087026
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.36854025598087026
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.36854025598087026
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.36854025598087026
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.36854025598087026
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.36854025598087026
MOTION SICKNESS	0.0172414	0.36854025598087026
ALCOHOL DEPENDENCE	0.0172414	0.36854025598087026
DIASTEMATOMYELIA	0.0172414	0.36854025598087026
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.36854025598087026
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.36854025598087026
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.36854025598087026
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.36854025598087026
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.36854025598087026
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.01720927	0.367853467296386
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01717945	0.36721605557614584
CORNELIA DE LANGE SYNDROME 3	0.01717945	0.36721605557614584
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.01717945	0.36721605557614584
BEHR SYNDROME	0.01714688	0.36651986175561524
HSD10 DISEASE	0.01714688	0.36651986175561524
NANCE-HORAN SYNDROME	0.01703639	0.36415810384249175
CHYLOMICRON RETENTION DISEASE	0.01700306	0.36344566478697177
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.01700306	0.36344566478697177
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.01700306	0.36344566478697177
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.01698397	0.36303761013441027
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.01698138	0.36298224808359125
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.01697303	0.3628037642518003
ASPARTYLGLUCOSAMINURIA	0.01695512	0.36242093246409063
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.01686297	0.36045119772163137
CYCLIC VOMITING SYNDROME	0.01676983	0.3584603014230675
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.01669998	0.35696723607569064
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.016678059999999998	0.35649868929810297
NEURAMINIDASE DEFICIENCY	0.01664845	0.355865766392794
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.01662974	0.35546583435772716
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.016622110000000002	0.3553027407485578
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.01660561	0.35495004814681513
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.01660561	0.35495004814681513
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.01659992	0.35482842263748693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.01659992	0.35482842263748693
KUFOR-RAKEB SYNDROME	0.016533100000000002	0.35340012447697555
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.016505640000000002	0.3528131584864391
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.01648972	0.35247286356403046
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.01643528	0.351309191731372
MULTIPLE SYMMETRIC LIPOMATOSIS	0.01643528	0.351309191731372
KUSKOKWIM SYNDROME	0.01643528	0.351309191731372
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.01641972	0.3509765919202741
ADIPOSIS DOLOROSA	0.01616882	0.3456135268428674
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.01615156	0.34524458900613547
ZELLWEGER SYNDROME	0.01615156	0.34524458900613547
ABETALIPOPROTEINEMIA	0.01615156	0.34524458900613547
BLEPHARO-CHEILO-ODONTIC SYNDROME	0.016128999999999998	0.34476236203066196
NARCOLEPSY TYPE 1	0.016128999999999998	0.34476236203066196
ACRORENAL SYNDROME	0.016128999999999998	0.34476236203066196
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.016128999999999998	0.34476236203066196
MULTIPLE EPIPHYSEAL DYSPLASIA	0.016128999999999998	0.34476236203066196
GORLIN-CHAUDHRY-MOSS SYNDROME	0.016128999999999998	0.34476236203066196
STERNAL CLEFT	0.016128999999999998	0.34476236203066196
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.016128999999999998	0.34476236203066196
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.016128999999999998	0.34476236203066196
X-LINKED RETINOSCHISIS	0.016128999999999998	0.34476236203066196
FAMILIAL PTERYGIUM OF THE CONJUNCTIVA	0.016128999999999998	0.34476236203066196
SILENT SINUS SYNDROME	0.016128999999999998	0.34476236203066196
WAARDENBURG SYNDROME	0.016128999999999998	0.34476236203066196
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.016128999999999998	0.34476236203066196
TRISOMY 13	0.016128999999999998	0.34476236203066196
CONGENITAL PRIMARY APHAKIA	0.016128999999999998	0.34476236203066196
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.016128999999999998	0.34476236203066196
1P21.3 MICRODELETION SYNDROME	0.016128999999999998	0.34476236203066196
EEM SYNDROME	0.016128999999999998	0.34476236203066196
DIPROSOPUS	0.016128999999999998	0.34476236203066196
FETAL PARVOVIRUS SYNDROME	0.016128999999999998	0.34476236203066196
DPM1-CDG	0.016128999999999998	0.34476236203066196
ALG3-CDG	0.016128999999999998	0.34476236203066196
MPDU1-CDG	0.016128999999999998	0.34476236203066196
FETAL CYTOMEGALOVIRUS SYNDROME	0.016128999999999998	0.34476236203066196
WAARDENBURG-SHAH SYNDROME	0.016128999999999998	0.34476236203066196
TOWNES-BROCKS SYNDROME	0.016128999999999998	0.34476236203066196
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.016128999999999998	0.34476236203066196
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	0.016128999999999998	0.34476236203066196
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.01607342	0.3435743223455195
EPISODIC ATAXIA TYPE 6	0.01593889	0.34069870199931174
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.01593685	0.34065509636855074
GLYCOGEN STORAGE DISEASE IV	0.01593685	0.34065509636855074
MOWAT-WILSON SYNDROME; MOWS	0.01592086	0.3403133051744984
RABSON-MENDENHALL SYNDROME	0.01588158	0.3394736830292591
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.015872999999999998	0.339290282876353
NAIL LOW-SULFUR PROTEIN	0.015872999999999998	0.339290282876353
NAIL HIGH-SULFUR PROTEIN	0.015872999999999998	0.339290282876353
NAILBEDS, PIGMENTATION OF	0.015872999999999998	0.339290282876353
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.015872999999999998	0.339290282876353
HEREDITARY METHEMOGLOBINEMIA	0.015872999999999998	0.339290282876353
STRIATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.339290282876353
MULTIPLE SYNOSTOSES SYNDROME	0.015872999999999998	0.339290282876353
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.015872999999999998	0.339290282876353
OTOONYCHOPERONEAL SYNDROME	0.015872999999999998	0.339290282876353
GROWTH HORMONE INSENSITIVITY SYNDROME	0.015872999999999998	0.339290282876353
INTELLECTUAL DISABILITY, WOLFF TYPE	0.015872999999999998	0.339290282876353
MONILETHRIX	0.015872999999999998	0.339290282876353
CHILBLAIN LUPUS 1	0.015872999999999998	0.339290282876353
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.015872999999999998	0.339290282876353
PILI TORTI	0.015872999999999998	0.339290282876353
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.015872999999999998	0.339290282876353
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.015872999999999998	0.339290282876353
LAMELLAR ICHTHYOSIS	0.015872999999999998	0.339290282876353
LUNULAE OF FINGERNAILS	0.015872999999999998	0.339290282876353
SILLENCE SYNDROME	0.015872999999999998	0.339290282876353
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.015872999999999998	0.339290282876353
FLOTCH SYNDROME	0.015872999999999998	0.339290282876353
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.015872999999999998	0.339290282876353
FUCOSIDOSIS	0.015872999999999998	0.339290282876353
PROGEROID SYNDROME, PETTY TYPE	0.015872999999999998	0.339290282876353
TOE, ROTATED FIFTH	0.015872999999999998	0.339290282876353
PSEUDOPELADE OF BROCQ	0.015872999999999998	0.339290282876353
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.015872999999999998	0.339290282876353
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.015872999999999998	0.339290282876353
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.015872999999999998	0.339290282876353
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.015872999999999998	0.339290282876353
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.015872999999999998	0.339290282876353
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.015872999999999998	0.339290282876353
CLASSIC MYCOSIS FUNGOIDES	0.015872999999999998	0.339290282876353
NASODIGITOACOUSTIC SYNDROME	0.015872999999999998	0.339290282876353
PUNCTATE PALMOPLANTAR KERATODERMA TYPE 1	0.015872999999999998	0.339290282876353
ISOLATED PUNCTATE PALMOPLANTAR KERATODERMA	0.015872999999999998	0.339290282876353
ADACTYLIA, UNILATERAL	0.015872999999999998	0.339290282876353
ACROKERATOELASTOIDOSIS OF COSTA	0.015872999999999998	0.339290282876353
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0158721	0.33927104509807615
BRITTLE CORNEA SYNDROME	0.01586212	0.3390577195122949
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.01585366	0.33887688439649233
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.01578077	0.337318838109158
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.01576631	0.33700975113817633
SYSTEMIC MASTOCYTOSIS	0.01566069	0.33475209098084
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.015640670000000002	0.33432415729072573
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.015640670000000002	0.33432415729072573
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.015625	0.33398920619561623
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.015625	0.33398920619561623
SPINOCEREBELLAR ATAXIA 23; SCA23	0.015625	0.33398920619561623
MONONEUROPATHY OF THE MEDIAN NERVE, MILD	0.015625	0.33398920619561623
WERNICKE-KORSAKOFF SYNDROME	0.015625	0.33398920619561623
APOLIPOPROTEIN A-I; APOA1	0.015625	0.33398920619561623
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.015625	0.33398920619561623
WAARDENBURG-SHAH SYNDROME	0.015625	0.33398920619561623
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	0.015625	0.33398920619561623
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.015625	0.33398920619561623
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.015625	0.33398920619561623
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.015625	0.33398920619561623
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.015625	0.33398920619561623
46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY	0.015625	0.33398920619561623
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.015625	0.33398920619561623
FAMILIAL CERVICAL ARTERY DISSECTION	0.01561787	0.333836800241045
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.015548570000000001	0.33235549131372627
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.01554113	0.33219645901330414
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.015496480000000002	0.33124205145767954
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.015496480000000002	0.33124205145767954
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.015496480000000002	0.33124205145767954
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.015496480000000002	0.33124205145767954
XP21 MICRODELETION SYNDROME	0.015492680000000002	0.3311608252827328
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0154321	0.3298659090516076
SCLEROSTEOSIS 2; SOST2	0.01533776	0.32784936238200796
NON-HISTAMINIC ANGIOEDEMA	0.01525766	0.32613720011536673
C SYNDROME	0.015203250000000001	0.32497416954198416
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.015174	0.32434894174798595
PERIPHERAL MOTOR NEUROPATHY-DYSAUTONOMIA SYNDROME	0.015134620000000001	0.32350718207182705
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.015111969999999999	0.32302303131852583
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.015111969999999999	0.32302303131852583
HODGKIN LYMPHOMA	0.015095279999999999	0.32266627740803594
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.01507618	0.3222580090023824
HELSMOORTEL-VAN DER AA SYNDROME	0.015069359999999999	0.3221122293936621
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.015069359999999999	0.3221122293936621
SPINOCEREBELLAR ATAXIA TYPE 38	0.01506124	0.3219386618829864
FAMILIAL COLD URTICARIA	0.01505741	0.32185679444876375
HUGHES-STOVIN SYNDROME	0.01505741	0.32185679444876375
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.01505741	0.32185679444876375
CARNEY TRIAD	0.01505741	0.32185679444876375
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.01502291	0.3211193462814838
ANTISYNTHETASE SYNDROME	0.014998050000000002	0.3205879560948584
MONOMELIC AMYOTROPHY	0.014998050000000002	0.3205879560948584
NEUROGENIC THORACIC OUTLET SYNDROME	0.014998050000000002	0.3205879560948584
SPINAL MUSCULAR ATROPHY, TYPE II	0.014998050000000002	0.3205879560948584
L1 SYNDROME	0.01495959	0.3197658617031602
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.014868429999999998	0.31781728851680546
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.01485112	0.31744728191461374
SPASTIC PARAPLEGIA 16, X-LINKED	0.01479246	0.3161934062771459
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.01475377	0.31536639556433255
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.01468428	0.3138810253282664
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.01457775	0.31160391363956125
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.01455938	0.3112112492096212
HEREDITARY HYPEREKPLEXIA	0.014540810000000001	0.31081430971784185
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.014467589999999999	0.30924920957847263
LEBER OPTIC ATROPHY AND DYSTONIA	0.0144373	0.3086017514629101
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0144373	0.3086017514629101
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.01435485	0.30683935721965705
KEIPERT SYNDROME	0.014266440000000002	0.3049495661335928
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.014266440000000002	0.3049495661335928
MONOSOMY 18P	0.014266440000000002	0.3049495661335928
NIEMANN-PICK DISEASE, TYPE A	0.01420171	0.303565942369302
SPINOCEREBELLAR ATAXIA 34; SCA34	0.01419752	0.3034763798237686
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.01418134	0.303130527320969
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.014148270000000001	0.3024236458458401
PINEOBLASTOMA	0.014148270000000001	0.3024236458458401
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014148270000000001	0.3024236458458401
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.01407841	0.3009303667453712
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.014060950000000001	0.3005571538468
MACS SYNDROME	0.013858120000000002	0.29622159988247
INFANTILE SYSTEMIC HYALINOSIS	0.013858120000000002	0.29622159988247
LATHOSTEROLOSIS	0.013858120000000002	0.29622159988247
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.013830450000000001	0.29563014507700225
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.013830450000000001	0.29563014507700225
MASTOCYTOSIS	0.013830450000000001	0.29563014507700225
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.01381998	0.29540634558971474
EPISODIC ATAXIA, TYPE 6	0.01381998	0.29540634558971474
SRD5A3-CDG	0.013758969999999999	0.294102237975635
CLASSIC GALACTOSEMIA	0.01373263	0.2935392123313987
BASAL LAMINAR DRUSEN	0.013698599999999998	0.2928118105594411
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.013698599999999998	0.2928118105594411
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	0.013698599999999998	0.2928118105594411
CHOROIDEREMIA	0.013698599999999998	0.2928118105594411
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.013698599999999998	0.2928118105594411
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.013698599999999998	0.2928118105594411
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.013698599999999998	0.2928118105594411
CONE DYSTROPHY 3	0.013698599999999998	0.2928118105594411
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	0.013698599999999998	0.2928118105594411
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.013698599999999998	0.2928118105594411
KNOBLOCH SYNDROME	0.013698599999999998	0.2928118105594411
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.013698599999999998	0.2928118105594411
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.013698599999999998	0.2928118105594411
RETINAL CAPILLARY MALFORMATION	0.013698599999999998	0.2928118105594411
RETINAL CONE DYSTROPHY 1; RCD1	0.013698599999999998	0.2928118105594411
DONNAI-BARROW SYNDROME	0.013698599999999998	0.2928118105594411
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.013698599999999998	0.2928118105594411
CONE-ROD DYSTROPHY 16	0.013698599999999998	0.2928118105594411
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.013698599999999998	0.2928118105594411
ALSTRÖM SYNDROME	0.013698599999999998	0.2928118105594411
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.013698599999999998	0.2928118105594411
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.013698599999999998	0.2928118105594411
RETINITIS PIGMENTOSA 80; RP80	0.013698599999999998	0.2928118105594411
ANIRIDIA 3	0.013698599999999998	0.2928118105594411
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.013698599999999998	0.2928118105594411
JOUBERT SYNDROME 35; JBTS35	0.013698599999999998	0.2928118105594411
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013698599999999998	0.2928118105594411
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.013698599999999998	0.2928118105594411
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.013698599999999998	0.2928118105594411
CORNEAL DYSTROPHY, LATTICE TYPE I	0.013698599999999998	0.2928118105594411
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.013698599999999998	0.2928118105594411
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.013698599999999998	0.2928118105594411
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.013698599999999998	0.2928118105594411
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.013673190000000002	0.29226866395275763
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.013673190000000002	0.29226866395275763
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.0136408	0.29157631768788234
MIXED CONNECTIVE TISSUE DISEASE	0.01356509	0.28995799302861386
SMITH-LEMLI-OPITZ SYNDROME	0.01355489	0.28973996487480935
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01355489	0.28973996487480935
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.01355489	0.28973996487480935
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.01353987	0.28941890773067763
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01353569	0.28932955893823614
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.01353569	0.28932955893823614
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0135135	0.2888552408271654
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0135135	0.2888552408271654
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0135135	0.2888552408271654
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.0135135	0.2888552408271654
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0135135	0.2888552408271654
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0135135	0.2888552408271654
20P13 MICRODELETION SYNDROME	0.0135135	0.2888552408271654
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0135135	0.2888552408271654
TAY-SACHS DISEASE; TSD	0.0135135	0.2888552408271654
ALG13-CDG	0.0135135	0.2888552408271654
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0135135	0.2888552408271654
COG8-CDG	0.0135135	0.2888552408271654
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.0135135	0.2888552408271654
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0135135	0.2888552408271654
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0135135	0.2888552408271654
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0135135	0.2888552408271654
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0135135	0.2888552408271654
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0135135	0.2888552408271654
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0135135	0.2888552408271654
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0135135	0.2888552408271654
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0135135	0.2888552408271654
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.0135135	0.2888552408271654
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.0135135	0.2888552408271654
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0135135	0.2888552408271654
SLC39A8-CDG	0.0135135	0.2888552408271654
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0135135	0.2888552408271654
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0135135	0.2888552408271654
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0135135	0.2888552408271654
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.01346727	0.28786706028301035
GALACTOSEMIA	0.013448910000000001	0.2874746096061623
ATAXIA WITH VITAMIN E DEFICIENCY	0.01343866	0.2872555126868979
MACHADO-JOSEPH DISEASE TYPE 1	0.013419219999999999	0.28683997667611755
MACHADO-JOSEPH DISEASE TYPE 2	0.013419219999999999	0.28683997667611755
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.01336996	0.28578702894509705
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01335002	0.2853608052797184
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.0133333	0.28500341010995256
GRANGE SYNDROME; GRNG	0.0133333	0.28500341010995256
BARDET-BIEDL SYNDROME 2	0.0133333	0.28500341010995256
CHRONIC ATRIAL AND INTESTINAL DYSRHYTHMIA; CAID	0.0133333	0.28500341010995256
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.0133333	0.28500341010995256
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0133333	0.28500341010995256
MICROPHTHALMIA, SYNDROMIC 1	0.0133333	0.28500341010995256
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0133333	0.28500341010995256
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0133333	0.28500341010995256
SYNDROMIC DIARRHEA	0.0133333	0.28500341010995256
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.0133333	0.28500341010995256
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.0133333	0.28500341010995256
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0133333	0.28500341010995256
FAMILIAL BICUSPID AORTIC VALVE	0.0133333	0.28500341010995256
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0133333	0.28500341010995256
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0133333	0.28500341010995256
AORTIC VALVE DISEASE 3; AOVD3	0.0133333	0.28500341010995256
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.0133333	0.28500341010995256
KOOLEN-DE VRIES SYNDROME	0.0133333	0.28500341010995256
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0133333	0.28500341010995256
PARTIAL ATRIOVENTRICULAR CANAL	0.0133333	0.28500341010995256
ATRIAL SEPTAL DEFECT 1	0.0133333	0.28500341010995256
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0133333	0.28500341010995256
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0133333	0.28500341010995256
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0133333	0.28500341010995256
ADAMS-OLIVER SYNDROME 1; AOS1	0.0133333	0.28500341010995256
DISTAL MONOSOMY 15Q	0.0133333	0.28500341010995256
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0133333	0.28500341010995256
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.0133333	0.28500341010995256
HUNTER-MACDONALD SYNDROME	0.0133333	0.28500341010995256
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0133333	0.28500341010995256
AORTA COARCTATION	0.0133333	0.28500341010995256
AORTIC VALVE DISEASE 1; AOVD1	0.0133333	0.28500341010995256
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0133333	0.28500341010995256
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.0133333	0.28500341010995256
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.0133333	0.28500341010995256
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.013329839999999999	0.2849294515401326
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.01328265	0.2839207506991489
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.01327532	0.28376406968273843
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.01327532	0.28376406968273843
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.01327532	0.28376406968273843
HYPOPHOSPHATASIA, INFANTILE	0.01327532	0.28376406968273843
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.0132517	0.2832591848795166
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.0132517	0.2832591848795166
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.0132517	0.2832591848795166
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.0132517	0.2832591848795166
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.0132517	0.2832591848795166
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.0132517	0.2832591848795166
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.0132517	0.2832591848795166
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0132517	0.2832591848795166
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.013213369999999999	0.282439869278014
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.01315702	0.28123537060479015
DEND SYNDROME	0.013138750000000001	0.2808448437057698
GENITOPATELLAR SYNDROME	0.01310541	0.2801321908971578
RETT SYNDROME; RTT	0.01310541	0.2801321908971578
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.01306033	0.27916859195857874
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.01306033	0.27916859195857874
ISOTRETINOIN SYNDROME	0.012987	0.27760114053519797
TETRASOMY 12P	0.012987	0.27760114053519797
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.012987	0.27760114053519797
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.012987	0.27760114053519797
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.012987	0.27760114053519797
POSTERIOR COLUMN ATAXIA	0.012987	0.27760114053519797
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.012987	0.27760114053519797
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.012987	0.27760114053519797
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.012987	0.27760114053519797
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.012987	0.27760114053519797
GRISCELLI SYNDROME	0.012987	0.27760114053519797
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.012987	0.27760114053519797
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.012987	0.27760114053519797
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.012987	0.27760114053519797
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.012987	0.27760114053519797
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.012987	0.27760114053519797
MULIBREY NANISM	0.012987	0.27760114053519797
HYPOMAGNESEMIA 2, RENAL	0.012987	0.27760114053519797
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.012987	0.27760114053519797
SYMMETRICAL THALAMIC CALCIFICATIONS	0.012987	0.27760114053519797
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.012987	0.27760114053519797
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.012987	0.27760114053519797
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.012968480000000001	0.2772052698088784
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.012968480000000001	0.2772052698088784
ALPORT SYNDROME	0.0129385	0.27656443803916675
ACQUIRED METHEMOGLOBINEMIA	0.0129385	0.27656443803916675
RELAPSING FEVER	0.0129385	0.27656443803916675
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.01293097	0.27640348196091696
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0128733	0.2751707678795537
FOUNTAIN SYNDROME	0.0128733	0.2751707678795537
MALT LYMPHOMA	0.01284563	0.274579313074086
STEVENS-JOHNSON SYNDROME	0.01284563	0.274579313074086
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.01279516	0.2735005012189376
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.01279516	0.2735005012189376
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.01279516	0.2735005012189376
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.01278799	0.27334724025199864
EPISODIC ATAXIA WITH SLURRED SPEECH	0.012753770000000001	0.27261577717129376
EPISODIC ATAXIA TYPE 7	0.012753770000000001	0.27261577717129376
JOUBERT SYNDROME	0.01270754	0.2716275966271386
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.012688370000000001	0.27121783194984134
INHALATIONAL BOTULISM	0.01263092	0.26998982043650127
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.01262272	0.2698145429010898
LAFORA DISEASE	0.01262272	0.2698145429010898
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01261808	0.26971536146641795
CORNELIA DE LANGE SYNDROME 1	0.01261808	0.26971536146641795
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.01257097	0.26870837065017
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.012473660000000001	0.26662833931225666
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01245471	0.2662232772029826
AXIAL OSTEOMALACIA	0.01245471	0.2662232772029826
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 3; IBMPFD3	0.01245471	0.2662232772029826
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.01245471	0.2662232772029826
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.01245471	0.2662232772029826
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.01245471	0.2662232772029826
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.01245471	0.2662232772029826
2P15P16.1 MICRODELETION SYNDROME	0.01242679	0.26562647857021576
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.01242382	0.2655629939019021
LOWRY-MACLEAN SYNDROME	0.012413839999999999	0.26534966831612083
SPONDYLO-OCULAR SYNDROME	0.012413839999999999	0.26534966831612083
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01234568	0.26389272724128604
EPISODIC ATAXIA, TYPE 3	0.01234225	0.26381940993074204
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.01228052	0.26249991209404083
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.2612107671963988
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.2612107671963988
NEUROFERRITINOPATHY	0.01222021	0.2612107671963988
CORTICOBASAL SYNDROME	0.01222021	0.2612107671963988
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.2612107671963988
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.01220911	0.26097350126431745
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.01220911	0.26097350126431745
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012209109999999999	0.2609735012643174
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.01217424	0.2602281442326348
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.012140429999999999	0.25950544502870043
CERVICAL HYPERTRICHOSIS-PERIPHERAL NEUROPATHY SYNDROME	0.012048200000000002	0.2575340002615055
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.012048200000000002	0.2575340002615055
GEMIGNANI SYNDROME	0.012048200000000002	0.2575340002615055
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.012048200000000002	0.2575340002615055
PRIMARY ORTHOSTATIC TREMOR	0.012048200000000002	0.2575340002615055
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012048200000000002	0.2575340002615055
APOLIPOPROTEIN A-I DEFICIENCY	0.012048200000000002	0.2575340002615055
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.012048200000000002	0.2575340002615055
MCLEOD SYNDROME; MCLDS	0.01203415	0.2572336771672944
CRANIAL NERVES, RECURRENT PARESIS OF	0.01198679	0.25622134252374723
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011904799999999998	0.25446878092272457
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.25446878092272457
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.011904799999999998	0.25446878092272457
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.011904799999999998	0.25446878092272457
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.011904799999999998	0.25446878092272457
MILLER-DIEKER SYNDROME (MDS)	0.011904799999999998	0.25446878092272457
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.25446878092272457
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.25446878092272457
CONGENITAL HYDROCEPHALUS	0.011904799999999998	0.25446878092272457
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.25446878092272457
9Q SUBTELOMERIC DELETION SYNDROME	0.011904799999999998	0.25446878092272457
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.011904799999999998	0.25446878092272457
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.011904799999999998	0.25446878092272457
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.011904799999999998	0.25446878092272457
TRANSIENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.25446878092272457
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.011904799999999998	0.25446878092272457
LOWRY-MACLEAN SYNDROME	0.011904799999999998	0.25446878092272457
PERMANENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.25446878092272457
9Q21.13 MICRODELETION SYNDROME	0.011904799999999998	0.25446878092272457
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.25446878092272457
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011904799999999998	0.25446878092272457
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.25446878092272457
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.011904799999999998	0.25446878092272457
PLACENTAL INSUFFICIENCY	0.011904799999999998	0.25446878092272457
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.011904799999999998	0.25446878092272457
CEREBROFACIOARTICULAR SYNDROME	0.011904799999999998	0.25446878092272457
MEND SYNDROME	0.011904799999999998	0.25446878092272457
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011904799999999998	0.25446878092272457
AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2537738696207458
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.01187229	0.2537738696207458
POSTORGASMIC ILLNESS SYNDROME	0.01187229	0.2537738696207458
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.01187229	0.2537738696207458
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.011764700000000001	0.2514741001042922
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.011764700000000001	0.2514741001042922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.011764700000000001	0.2514741001042922
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.011764700000000001	0.2514741001042922
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.011764700000000001	0.2514741001042922
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.011721780000000001	0.2505566718335776
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.01171274	0.25036343903844105
MYOCLONIC EPILEPSY OF LAFORA	0.01171274	0.25036343903844105
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.011704280000000001	0.2501826039226386
SENGERS SYNDROME	0.01170428	0.2501826039226385
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.0116279	0.2485499578062084
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.0116279	0.2485499578062084
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0116279	0.2485499578062084
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.0116279	0.2485499578062084
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0116279	0.2485499578062084
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.0116279	0.2485499578062084
AMYOTROPHIC LATERAL SCLEROSIS 3	0.0116279	0.2485499578062084
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.0116279	0.2485499578062084
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0116279	0.2485499578062084
MICROFORM HOLOPROSENCEPHALY	0.0116279	0.2485499578062084
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.0116279	0.2485499578062084
SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0116279	0.2485499578062084
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0116279	0.2485499578062084
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.0116279	0.2485499578062084
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0116279	0.2485499578062084
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.0116279	0.2485499578062084
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0116279	0.2485499578062084
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.0116279	0.2485499578062084
NEUROFIBROMATOSIS, TYPE II	0.01154918	0.24686729346625833
AMERICAN TRYPANOSOMIASIS	0.01154918	0.24686729346625833
PINEOCYTOMA	0.01151131	0.2460578105069862
PAROXYSMAL COLD HEMOGLOBINURIA	0.01151131	0.2460578105069862
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.01151131	0.2460578105069862
PAPILLARY TUMOR OF THE PINEAL REGION	0.01151131	0.2460578105069862
SCRUB TYPHUS	0.01151131	0.2460578105069862
MALARIA	0.01151131	0.2460578105069862
RHABDOID TUMOR	0.01151131	0.2460578105069862
CENTRAL DIABETES INSIPIDUS	0.01151131	0.2460578105069862
YELLOW FEVER	0.01151131	0.2460578105069862
LHERMITTE-DUCLOS DISEASE	0.01151131	0.2460578105069862
MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT	0.01149764	0.24576561003026975
HENNEKAM-BEEMER SYNDROME	0.01143813	0.24449356537998485
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.01142902	0.2442988363132046
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.01142902	0.2442988363132046
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.01142902	0.2442988363132046
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.01142902	0.2442988363132046
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.011395760000000001	0.24358789352932836
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.01138117	0.2432760277681511
CARCINOID SYNDROME	0.0113433	0.24246654480887894
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.0113433	0.24246654480887894
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01131049	0.2417652209141411
TRISOMY 18P	0.01130846	0.24172182903647219
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.01130846	0.24172182903647219
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01130846	0.24172182903647219
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01126244	0.24073813730724836
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.011236	0.2401729741320924
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.011236	0.2401729741320924
SPINOCEREBELLAR ATAXIA TYPE 7	0.01121431	0.23970934367561988
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.01121431	0.23970934367561988
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.01121431	0.23970934367561988
SNEDDON SYNDROME	0.01119029	0.2391959087487195
MIDDLE EAR NEUROENDOCRINE TUMOR	0.01119029	0.2391959087487195
LYSINURIC PROTEIN INTOLERANCE; LPI	0.01111529	0.23759276055898051
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	0.2375031980134471
SCALP-EAR-NIPPLE SYNDROME	0.0111111	0.2375031980134471
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	0.2375031980134471
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	0.2375031980134471
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.0111111	0.2375031980134471
PILONIDAL SINUS	0.0111111	0.2375031980134471
TRIOPIA	0.0111111	0.2375031980134471
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	0.2375031980134471
DERMATOSIS PAPULOSA NIGRA	0.0111111	0.2375031980134471
CAMOS SYNDROME	0.0111111	0.2375031980134471
LICHEN PLANUS, FAMILIAL	0.0111111	0.2375031980134471
GLOMUVENOUS MALFORMATIONS	0.0111111	0.2375031980134471
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.0111111	0.2375031980134471
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.0111111	0.2375031980134471
TYROSINE TRANSAMINASE DEFICIENCY	0.0111111	0.2375031980134471
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	0.2375031980134471
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.0111111	0.2375031980134471
DERMAL RIDGES, PATTERNLESS	0.0111111	0.2375031980134471
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	0.2375031980134471
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	0.2375031980134471
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0111111	0.2375031980134471
SHORT SYNDROME	0.0111111	0.2375031980134471
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	0.2375031980134471
PIGMENTED PURPURIC ERUPTION	0.0111111	0.2375031980134471
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	0.2375031980134471
CAROTENEMIA, FAMILIAL	0.0111111	0.2375031980134471
PRENATAL BOWING	0.0111111	0.2375031980134471
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	0.2375031980134471
PATELLA APLASIA-HYPOPLASIA	0.0111111	0.2375031980134471
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.0111111	0.2375031980134471
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	0.2375031980134471
POLYVALVULAR HEART DISEASE SYNDROME	0.0111111	0.2375031980134471
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	0.2375031980134471
AICARDI SYNDROME; AIC	0.0111111	0.2375031980134471
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0111111	0.2375031980134471
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0111111	0.2375031980134471
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	0.2375031980134471
131600 EPIDERMOID CYSTS	0.0111111	0.2375031980134471
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	0.2375031980134471
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.0111111	0.2375031980134471
CURRY-JONES SYNDROME	0.0111111	0.2375031980134471
TRICHILEMMAL CYST 1	0.0111111	0.2375031980134471
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	0.2375031980134471
MUCOPOLYSACCHARIDOSIS TYPE IX	0.0111111	0.2375031980134471
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	0.2375031980134471
KERATOSIS, FAMILIAL ACTINIC	0.0111111	0.2375031980134471
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	0.2375031980134471
FUTCHER LINE	0.0111111	0.2375031980134471
SYRINGOMAS, MULTIPLE	0.0111111	0.2375031980134471
ACROMIAL DIMPLES	0.0111111	0.2375031980134471
PARANA HARD-SKIN SYNDROME	0.0111111	0.2375031980134471
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	0.2375031980134471
SAY SYNDROME	0.0111111	0.2375031980134471
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0111111	0.2375031980134471
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	0.2375031980134471
PSEUDOATROPHODERMA COLLI	0.0111111	0.2375031980134471
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	0.2375031980134471
KYRLE DISEASE	0.0111111	0.2375031980134471
LENTIGINES	0.0111111	0.2375031980134471
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.01109253	0.23710625852166772
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01109253	0.23710625852166772
KLEEFSTRA SYNDROME	0.01109253	0.23710625852166772
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.011022279999999999	0.2356046430506122
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.011022279999999999	0.2356046430506122
CAREY-FINEMAN-ZITER SYNDROME	0.011022279999999999	0.2356046430506122
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.011022279999999999	0.2356046430506122
15Q OVERGROWTH SYNDROME	0.010870850000000001	0.23236777997898334
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.01079248	0.23069259699725211
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01079248	0.23069259699725211
ADIPOSIS DOLOROSA	0.01079248	0.23069259699725211
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01079248	0.23069259699725211
PERIPHERAL HYPOTHYROIDISM	0.01079248	0.23069259699725211
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.01079248	0.23069259699725211
OSTEOGENESIS IMPERFECTA	0.01076222	0.2300457801409654
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.01070284	0.22877651428087611
NIEMANN-PICK DISEASE TYPE C	0.01069466	0.22860166425164855
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.01069466	0.22860166425164855
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.01064533	0.22754722024898424
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.01064533	0.22754722024898424
ACTH-DEPENDENT CUSHING SYNDROME	0.01064533	0.22754722024898424
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.01045899	0.22356414513330483
ROUSSY-LÉVY SYNDROME	0.01041067	0.222531290192929
SPINOCEREBELLAR ATAXIA TYPE 10	0.0103328	0.22086679486579605
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.0103328	0.22086679486579605
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 1	0.01032222	0.22064064409449685
FLYNN-AIRD SYNDROME	0.01032222	0.22064064409449685
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.01032222	0.22064064409449685
ROTHMUND-THOMSON SYNDROME	0.010284350000000001	0.21983116113522472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0102741	0.21961206421596036
BETA-THALASSEMIA MAJOR	0.01026379	0.21939168477814425
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.01019623	0.21794756888882738
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.0101889	0.2177908878724169
PORPHYRIA VARIEGATA	0.0101889	0.2177908878724169
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.01016528	0.2172860030691951
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.01016528	0.2172860030691951
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.01016528	0.2172860030691951
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.01016528	0.2172860030691951
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01004881	0.21479642080707648
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01004881	0.21479642080707648
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.01004881	0.21479642080707648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.01004881	0.21479642080707648
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.01004881	0.21479642080707648
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.01001899	0.21415900908683627
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00998112	0.21334952612756408
ADENOCARCINOMA OF THE ESOPHAGUS	0.00998112	0.21334952612756408
MONOSOMY 22Q13.3	0.00998112	0.21334952612756408
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00998112	0.21334952612756408
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00994423	0.2125609909713045
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00991224	0.2118771948301078
WALKER-WARBURG SYNDROME	0.00991224	0.2118771948301078
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00991224	0.2118771948301078
RHABDOMYOLYSIS, ACUTE RECURRENT	0.00991224	0.2118771948301078
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.20956182133794082
DISTAL 16P11.2 MICRODELETION SYNDROME	0.00980392	0.20956182133794082
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00980392	0.20956182133794082
SPINOCEREBELLAR ATAXIA TYPE 36	0.00980392	0.20956182133794082
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.20956182133794082
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.20956182133794082
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00980392	0.20956182133794082
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.20956182133794082
MALAN OVERGROWTH SYNDROME	0.00980392	0.20956182133794082
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.20956182133794082
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.20956182133794082
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00980392	0.20956182133794082
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.20956182133794082
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.00980392	0.20956182133794082
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.20956182133794082
KERION CELSI	0.00980392	0.20956182133794082
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00973759	0.20814399707893574
GAMMA-HEAVY CHAIN DISEASE	0.009718939999999999	0.20774534756242058
COCKAYNE SYNDROME	0.009718939999999999	0.20774534756242058
SCHNITZLER SYNDROME	0.009718939999999999	0.20774534756242058
FRANK-TER HAAR SYNDROME	0.00970874	0.2075273194086161
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00970874	0.2075273194086161
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00970874	0.2075273194086161
TEMPLE-BARAITSER SYNDROME	0.00970874	0.2075273194086161
STURGE-WEBER SYNDROME	0.00970874	0.2075273194086161
RAINE SYNDROME	0.00970874	0.2075273194086161
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00970874	0.2075273194086161
INFANTILE SIALIC ACID STORAGE DISEASE	0.00970874	0.2075273194086161
KEPPEN-LUBINSKY SYNDROME	0.00970874	0.2075273194086161
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00970874	0.2075273194086161
ENAMEL-RENAL SYNDROME	0.00970874	0.2075273194086161
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.2075273194086161
HENNEKAM SYNDROME	0.00970874	0.2075273194086161
LATHOSTEROLOSIS	0.00970874	0.2075273194086161
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00970874	0.2075273194086161
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00970874	0.2075273194086161
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00970874	0.2075273194086161
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00970874	0.2075273194086161
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.2075273194086161
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00970874	0.2075273194086161
FGFR2-RELATED BENT BONE DYSPLASIA	0.00970874	0.2075273194086161
HURLER SYNDROME	0.00970874	0.2075273194086161
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00970874	0.2075273194086161
20Q11.2 MICRODUPLICATION SYNDROME	0.00970874	0.2075273194086161
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00970874	0.2075273194086161
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00970874	0.2075273194086161
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00970874	0.2075273194086161
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.2075273194086161
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00970874	0.2075273194086161
COHEN SYNDROME	0.00970874	0.2075273194086161
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00970874	0.2075273194086161
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00970874	0.2075273194086161
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.2075273194086161
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.2075273194086161
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00970874	0.2075273194086161
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00970874	0.2075273194086161
DYSTONIA-APHONIA SYNDROME	0.00970874	0.2075273194086161
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00968992	0.20712503608953764
CASTLEMAN DISEASE	0.00968107	0.20693586460314842
GASTROINTESTINAL STROMAL TUMOR	0.00968107	0.20693586460314842
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00968107	0.20693586460314842
BRANCHIOOCULOFACIAL SYNDROME	0.0096601	0.2064876243692974
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00964389	0.20614113060722183
NEU-LAXOVA SYNDROME	0.00964389	0.20614113060722183
46,XY PARTIAL GONADAL DYSGENESIS	0.00964389	0.20614113060722183
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00962112	0.2056544148168171
OCULODENTODIGITAL DYSPLASIA	0.00956269	0.20440545550046446
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.00952381	0.20357438347890378
CHAND SYNDROME	0.00952381	0.20357438347890378
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00952381	0.20357438347890378
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00952381	0.20357438347890378
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.00952381	0.20357438347890378
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00952381	0.20357438347890378
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.00952381	0.20357438347890378
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00952381	0.20357438347890378
275450 TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY	0.00952381	0.20357438347890378
%107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6;;ANONYCHIA/HYPONYCHIA AND ONYCHODYSTROPHY;;ANONYCHIA, PARTIAL	0.00952381	0.20357438347890378
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.00952381	0.20357438347890378
257960 OCULOTRICHODYSPLASIA; OTD	0.00952381	0.20357438347890378
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00952381	0.20357438347890378
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00952381	0.20357438347890378
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.00952381	0.20357438347890378
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00952381	0.20357438347890378
%613689 MAMMARY-DIGITAL-NAIL SYNDROME; MDNS	0.00952381	0.20357438347890378
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.00952381	0.20357438347890378
NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	0.00952381	0.20357438347890378
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00952381	0.20357438347890378
CHANDS	0.00952381	0.20357438347890378
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00952381	0.20357438347890378
19Q13.11 MICRODELETION SYNDROME	0.00952381	0.20357438347890378
PSORIASIS 14, PUSTULAR	0.00952381	0.20357438347890378
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00952381	0.20357438347890378
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.00952381	0.20357438347890378
DERMOODONTODYSPLASIA	0.00952381	0.20357438347890378
BRACHYDACTYLY TYPE A5	0.00952381	0.20357438347890378
148360 KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORYNEUROPATHY;;AXONAL NEUROPATHY WITH PALMOPLANTAR KERATODERMA;;CHARCOT-MARIE-TOOTH DISEASE WITH PALMOPLANTAR KERATODERMA AND NAILDYSTROPHY	0.00952381	0.20357438347890378
PACHYONYCHIA CONGENITA 2	0.00952381	0.20357438347890378
GAPO SYNDROME; GAPOS	0.00952381	0.20357438347890378
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00952381	0.20357438347890378
MONILETHRIX; MNLIX	0.00952381	0.20357438347890378
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00952381	0.20357438347890378
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE	0.00952381	0.20357438347890378
FOCAL DERMAL HYPOPLASIA; FDH	0.00952381	0.20357438347890378
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.00952381	0.20357438347890378
INCONTINENTIA PIGMENTI; IP	0.00952381	0.20357438347890378
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00952381	0.20357438347890378
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00952381	0.20357438347890378
WEYERS ACROFACIAL DYSOSTOSIS	0.00952381	0.20357438347890378
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00952381	0.20357438347890378
GLASS SYNDROME	0.00952381	0.20357438347890378
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00952381	0.20357438347890378
PALLISTER-HALL SYNDROME	0.00952381	0.20357438347890378
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.00952381	0.20357438347890378
ELLIS-VAN CREVELD SYNDROME	0.00952381	0.20357438347890378
LIMB-MAMMARY SYNDROME	0.00952381	0.20357438347890378
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00952381	0.20357438347890378
PALLISTER-HALL SYNDROME	0.00952381	0.20357438347890378
PHOCOMELIA, SCHINZEL TYPE	0.00952381	0.20357438347890378
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00952381	0.20357438347890378
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.00952381	0.20357438347890378
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.00952381	0.20357438347890378
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00952381	0.20357438347890378
ANAUXETIC DYSPLASIA 2; ANXD2	0.00952381	0.20357438347890378
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00948455	0.20273518883984842
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00948455	0.20273518883984842
JABERI-ELAHI SYNDROME; JABELS	0.00945387	0.2020793943536992
PAPILLOMA OF CHOROID PLEXUS	0.0093924	0.20076545409738916
HYPER-IGD SYNDROME	0.0093924	0.20076545409738916
BENIGN OCCIPITAL EPILEPSY	0.0093924	0.20076545409738916
TURCOT SYNDROME WITH POLYPOSIS	0.0093924	0.20076545409738916
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.0093924	0.20076545409738916
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00937573	0.2004091276930832
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.00937573	0.2004091276930832
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00937573	0.2004091276930832
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.00937573	0.2004091276930832
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00936005	0.20007396284488174
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.00935771	0.20002394462136192
49,XXXXY SYNDROME	0.00934066	0.19965949559956125
X-LINKED EHLERS-DANLOS SYNDROME	0.00934066	0.19965949559956125
BOHRING-OPITZ SYNDROME	0.00934066	0.19965949559956125
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00934066	0.19965949559956125
48,XXXY SYNDROME	0.00934066	0.19965949559956125
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0093374	0.19958981209158058
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.00925926	0.19791954543096454
JOUBERT SYNDROME 21	0.00925926	0.19791954543096454
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.00925926	0.19791954543096454
RAVINE SYNDROME	0.00925926	0.19791954543096454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.00925926	0.19791954543096454
JOUBERT SYNDROME 33; JBTS33	0.00925926	0.19791954543096454
TARP SYNDROME	0.00925926	0.19791954543096454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.00925926	0.19791954543096454
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00925926	0.19791954543096454
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00925926	0.19791954543096454
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00925926	0.19791954543096454
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00925926	0.19791954543096454
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00925926	0.19791954543096454
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00925926	0.19791954543096454
PRIMARY PULMONARY HYPOPLASIA	0.00925926	0.19791954543096454
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00925926	0.19791954543096454
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00925926	0.19791954543096454
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.00925926	0.19791954543096454
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.00925926	0.19791954543096454
HYPEREKPLEXIA 1; HKPX1	0.00925926	0.19791954543096454
GAUCHER DISEASE, TYPE II	0.00925926	0.19791954543096454
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.00925926	0.19791954543096454
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.00925926	0.19791954543096454
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00925926	0.19791954543096454
JOUBERT SYNDROME 30; JBTS30	0.00925926	0.19791954543096454
GLUTAMINE DEFICIENCY, CONGENITAL	0.00925926	0.19791954543096454
JOUBERT SYNDROME 23; JBTS23	0.00925926	0.19791954543096454
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00925926	0.19791954543096454
GAUCHER DISEASE, PERINATAL LETHAL	0.00925926	0.19791954543096454
TRICHOTHIODYSTROPHY	0.00925926	0.19791954543096454
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00925926	0.19791954543096454
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00925926	0.19791954543096454
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.00925926	0.19791954543096454
AORTIC ARCH DEFECTS	0.00925926	0.19791954543096454
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.00925926	0.19791954543096454
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00925926	0.19791954543096454
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00925926	0.19791954543096454
OROFACIODIGITAL SYNDROME TYPE 2	0.00925926	0.19791954543096454
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.00925926	0.19791954543096454
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.00925926	0.19791954543096454
CONGENITAL LEFT VENTRICULAR ANEURYSM	0.00925926	0.19791954543096454
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00920083	0.19667058611461194
STIFF SKIN SYNDROME	0.00912269	0.19500031945399587
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00908482	0.1941908364947237
PORPHYRIA VARIEGATA	0.00908482	0.1941908364947237
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0090843	0.1941797213339415
BROOKE-SPIEGLER SYNDROME	0.00897851	0.19191842737404174
CRANIOMETAPHYSEAL DYSPLASIA	0.00897851	0.19191842737404174
MOEBIUS SYNDROME	0.00897851	0.19191842737404174
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00897851	0.19191842737404174
DOWN SYNDROME	0.00894279	0.19115490132954208
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00892244	0.1907199137873929
TYPHOID	0.00892244	0.1907199137873929
PONTIAC FEVER	0.00892244	0.1907199137873929
PRIMARY FAMILIAL POLYCYTHEMIA	0.00892244	0.1907199137873929
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00890037	0.19024816071342568
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00890037	0.19024816071342568
RIDDLE SYNDROME	0.00882462	0.18862898104178935
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00882462	0.18862898104178935
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.18750271600022475
ARGININEMIA	0.00877193	0.18750271600022475
CAFFEY DISEASE	0.00877193	0.18750271600022475
LOCKED-IN SYNDROME	0.00877193	0.18750271600022475
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.18750271600022475
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.00877193	0.18750271600022475
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.18750271600022475
BREATH-HOLDING SPELLS	0.00877193	0.18750271600022475
HISTIDINEMIA	0.00877193	0.18750271600022475
HISTIDINEMIA	0.00877193	0.18750271600022475
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.18750271600022475
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.18750271600022475
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.00877193	0.18750271600022475
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.18750271600022475
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.18750271600022475
20Q11.2 MICRODELETION SYNDROME	0.00877193	0.18750271600022475
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.18750271600022475
RAYNAUD-CLAES SYNDROME; MRXSRC	0.00877193	0.18750271600022475
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.18750271600022475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00877193	0.18750271600022475
WEAVER SYNDROME	0.00877193	0.18750271600022475
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.18750271600022475
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.18750271600022475
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.18750271600022475
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.18750271600022475
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.18750271600022475
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.18750271600022475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.18750271600022475
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.18750271600022475
1Q41Q42 MICRODELETION SYNDROME	0.00877193	0.18750271600022475
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.18750271600022475
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.18750271600022475
MENTAL RETARDATION, X-LINKED 90	0.00877193	0.18750271600022475
LANDAU-KLEFFNER SYNDROME	0.00877193	0.18750271600022475
2Q33.1 DELETION SYNDROME	0.00877193	0.18750271600022475
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.18750271600022475
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00877193	0.18750271600022475
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.18750271600022475
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.18750271600022475
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.18750271600022475
SOTOS SYNDROME	0.00877193	0.18750271600022475
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	0.18750271600022475
ANGELMAN SYNDROME	0.00877193	0.18750271600022475
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.18750271600022475
FETAL ALCOHOL SYNDROME	0.00877193	0.18750271600022475
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00875443	0.18712864808928564
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00865907	0.18509029860430556
MICROPHTHALMIA, LENZ TYPE	0.00865907	0.18509029860430556
APERT SYNDROME	0.00865907	0.18509029860430556
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00865661	0.18503771534368213
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.00865661	0.18503771534368213
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.00865661	0.18503771534368213
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00844436	0.18050080596672088
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00837289	0.1789731126184456
CAMURATI-ENGELMANN DISEASE	0.00832619	0.1779748856789682
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00832619	0.1779748856789682
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00832619	0.1779748856789682
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00832619	0.1779748856789682
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00832619	0.1779748856789682
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00832619	0.1779748856789682
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00832619	0.1779748856789682
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00829475	0.1773028459578296
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00826446	0.17665538784226703
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.00826446	0.17665538784226703
RETINOSCHISIS OF FOVEA	0.00826446	0.17665538784226703
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00826446	0.17665538784226703
WEILL-MARCHESANI SYNDROME	0.00826446	0.17665538784226703
SENIOR-LOKEN SYNDROME 3	0.00826446	0.17665538784226703
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.17665538784226703
NEUROMYELITIS OPTICA	0.00826446	0.17665538784226703
X-LINKED CORNEAL DERMOID	0.00826446	0.17665538784226703
RETINAL ARTERIES, TORTUOSITY OF	0.00826446	0.17665538784226703
UVEAL MELANOMA	0.00826446	0.17665538784226703
CONGENITAL GLAUCOMA	0.00826446	0.17665538784226703
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00826446	0.17665538784226703
LATE-ONSET RETINAL DEGENERATION; LORD	0.00826446	0.17665538784226703
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00826446	0.17665538784226703
KNOBLOCH SYNDROME 1; KNO1	0.00826446	0.17665538784226703
BIRDSHOT CHORIORETINOPATHY	0.00826446	0.17665538784226703
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00826446	0.17665538784226703
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00826446	0.17665538784226703
OPTICOCOCHLEODENTATE DEGENERATION	0.00826446	0.17665538784226703
USHER SYNDROME TYPE 2	0.00826446	0.17665538784226703
NANCE-HORAN SYNDROME	0.00826446	0.17665538784226703
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00826446	0.17665538784226703
ISOLATED ANIRIDIA	0.00826446	0.17665538784226703
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00826446	0.17665538784226703
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00826446	0.17665538784226703
STICKLER SYNDROME TYPE 1	0.00826446	0.17665538784226703
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.00826446	0.17665538784226703
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00826446	0.17665538784226703
NEOVASCULAR GLAUCOMA	0.00826446	0.17665538784226703
LCAT DEFICIENCY	0.00826446	0.17665538784226703
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00826446	0.17665538784226703
USHER SYNDROME TYPE 3	0.00826446	0.17665538784226703
CATARACT 7; CTRCT7	0.00826446	0.17665538784226703
OPTIC ATROPHY 8	0.00826446	0.17665538784226703
BRITTLE CORNEA SYNDROME	0.00826446	0.17665538784226703
USHER SYNDROME TYPE 1	0.00826446	0.17665538784226703
MOHR-TRANEBJAERG SYNDROME	0.00826446	0.17665538784226703
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00826446	0.17665538784226703
PFEIFFER SYNDROME TYPE 2	0.00826446	0.17665538784226703
CATARACT 44; CTRCT44	0.00826446	0.17665538784226703
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.00826446	0.17665538784226703
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.00826446	0.17665538784226703
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00816544	0.17453880472562766
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00816544	0.17453880472562766
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00816544	0.17453880472562766
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00816544	0.17453880472562766
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.00816544	0.17453880472562766
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00816544	0.17453880472562766
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00816544	0.17453880472562766
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00815818	0.17438361998086094
CHANARIN-DORFMAN SYNDROME	0.00815818	0.17438361998086094
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.00815818	0.17438361998086094
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00815818	0.17438361998086094
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.00815818	0.17438361998086094
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.00815818	0.17438361998086094
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00799553	0.17090692594004706
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00799553	0.17090692594004706
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00789203	0.1686945814382073
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00786221	0.16805716971796708
ESOPHAGEAL ATRESIA	0.00786221	0.16805716971796708
MÉNÉTRIER DISEASE	0.00786221	0.16805716971796708
SSR4-CDG	0.00786221	0.16805716971796708
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00786221	0.16805716971796708
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00786221	0.16805716971796708
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00786221	0.16805716971796708
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00772212	0.16506270265262665
PRIMARY SCLEROSING CHOLANGITIS	0.00769548	0.1644932644156314
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00769548	0.1644932644156314
RARE HEREDITARY HEMOCHROMATOSIS	0.00769548	0.1644932644156314
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.007597660000000001	0.16240233167002788
SPONASTRIME DYSPLASIA	0.007597660000000001	0.16240233167002788
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.007597660000000001	0.16240233167002788
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.00756216	0.16164350819355142
INHALATIONAL ANTHRAX	0.00756216	0.16164350819355142
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.00756216	0.16164350819355142
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00756216	0.16164350819355142
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.00756216	0.16164350819355142
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.00746434	0.15955257544794788
ARTERIAL TORTUOSITY SYNDROME	0.0073922499999999995	0.1580116294079708
REYNOLDS SYNDROME	0.0073922499999999995	0.1580116294079708
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00732425	0.1565581083826075
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00732425	0.1565581083826075
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00731394	0.15633772894479137
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00731394	0.15633772894479137
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00731394	0.15633772894479137
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.00731394	0.15633772894479137
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.00729443	0.1559206966623673
3Q29 MICRODELETION SYNDROME	0.00729443	0.1559206966623673
PANDAS	0.00724638	0.15489361305547453
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00724638	0.15489361305547453
VICI SYNDROME	0.00724638	0.15489361305547453
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.00724638	0.15489361305547453
OPTIC ATROPHY 1; OPA1	0.00724638	0.15489361305547453
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00724638	0.15489361305547453
DESANTO-SHINAWI SYNDROME	0.00724638	0.15489361305547453
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00724638	0.15489361305547453
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00724638	0.15489361305547453
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.00724638	0.15489361305547453
XQ25 MICRODUPLICATION SYNDROME	0.00724638	0.15489361305547453
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.00724638	0.15489361305547453
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00724638	0.15489361305547453
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00724638	0.15489361305547453
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00724638	0.15489361305547453
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00724638	0.15489361305547453
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00724638	0.15489361305547453
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.00724638	0.15489361305547453
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.00724638	0.15489361305547453
AUTISM, SUSCEPTIBILITY TO, 18	0.00724638	0.15489361305547453
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.00724638	0.15489361305547453
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.00724638	0.15489361305547453
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.00724638	0.15489361305547453
CHRONIC HICCUP	0.00724638	0.15489361305547453
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00724638	0.15489361305547453
CARDIOMYOPATHY, DILATED, 1X	0.00724638	0.15489361305547453
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00724638	0.15489361305547453
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00724638	0.15489361305547453
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.00724638	0.15489361305547453
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.00724638	0.15489361305547453
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00724638	0.15489361305547453
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.00724638	0.15489361305547453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00724638	0.15489361305547453
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00724638	0.15489361305547453
COFFIN-SIRIS SYNDROME 8; CSS8	0.00724638	0.15489361305547453
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR WITHOUT MUSCLE WEAKNESS; CPVT5	0.00724638	0.15489361305547453
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00724638	0.15489361305547453
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.00724638	0.15489361305547453
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00724638	0.15489361305547453
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00724638	0.15489361305547453
MYOPATHY, VACUOLAR, WITH CASQ1 AGGREGATES; VMCQA	0.00724638	0.15489361305547453
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.00724638	0.15489361305547453
CHAR SYNDROME	0.00724638	0.15489361305547453
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.00724638	0.15489361305547453
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.00724638	0.15489361305547453
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00724638	0.15489361305547453
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.00724638	0.15489361305547453
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.00724638	0.15489361305547453
PRIMARY CONGENITAL HYPOTHYROIDISM	0.00724638	0.15489361305547453
EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3	0.00724638	0.15489361305547453
2Q32Q33 MICRODELETION SYNDROME	0.00724638	0.15489361305547453
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00724638	0.15489361305547453
SMITH-MAGENIS SYNDROME	0.00724638	0.15489361305547453
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA	0.00724638	0.15489361305547453
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00724638	0.15489361305547453
1Q21.1 MICRODELETION SYNDROME	0.00724638	0.15489361305547453
2Q23.1 MICRODELETION SYNDROME	0.00724638	0.15489361305547453
4Q21 MICRODELETION SYNDROME	0.00724638	0.15489361305547453
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.00724638	0.15489361305547453
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.00724638	0.15489361305547453
XQ25 DUPLICATION SYNDROME	0.00724638	0.15489361305547453
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00724638	0.15489361305547453
MYOSITIS	0.00724638	0.15489361305547453
CK SYNDROME	0.00724638	0.15489361305547453
MILD CANAVAN DISEASE	0.00724638	0.15489361305547453
PERMANENT CONGENITAL HYPOTHYROIDISM	0.00724638	0.15489361305547453
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.00718062	0.15348797272271142
BETA-KETOTHIOLASE DEFICIENCY	0.0071024799999999996	0.15181770606209538
SECONDARY SHORT BOWEL SYNDROME	0.0071024799999999996	0.15181770606209538
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00709923	0.15174823630720669
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00709923	0.15174823630720669
SIALIDOSIS TYPE 2	0.00709923	0.15174823630720669
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00709923	0.15174823630720669
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00709923	0.15174823630720669
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00709923	0.15174823630720669
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00704053	0.150493505657371
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00704053	0.150493505657371
LOWE OCULOCEREBRORENAL SYNDROME	0.00704053	0.150493505657371
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00701071	0.14985609393713079
HEART AND BRAIN MALFORMATION SYNDROME	0.00701071	0.14985609393713079
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00701071	0.14985609393713079
GAUCHER DISEASE TYPE 3	0.00699438	0.14950703513795163
VALINEMIA	0.0069659100000000005	0.14889848008512674
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0069659100000000005	0.14889848008512674
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.00696239	0.14882323899675495
DE SANCTIS-CACCHIONE SYNDROME	0.00696239	0.14882323899675495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.00696239	0.14882323899675495
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00696239	0.14882323899675495
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.00696239	0.14882323899675495
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00696239	0.14882323899675495
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00696239	0.14882323899675495
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	0.00696239	0.14882323899675495
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.00693257	0.14818582727651475
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00693257	0.14818582727651475
PITT-HOPKINS-LIKE SYNDROME	0.00693257	0.14818582727651475
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00682582	0.14590401301978628
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.00682582	0.14590401301978628
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00682582	0.14590401301978628
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00682582	0.14590401301978628
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.00682582	0.14590401301978628
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00682582	0.14590401301978628
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00682582	0.14590401301978628
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00682582	0.14590401301978628
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00682582	0.14590401301978628
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00671066	0.14344243241271512
ATYPICAL JUVENILE PARKINSONISM	0.006632519999999999	0.14177216575209908
INCONTINENTIA PIGMENTI	0.00661284	0.14135149966711158
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00661284	0.14135149966711158
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00661284	0.14135149966711158
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00661284	0.14135149966711158
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00661284	0.14135149966711158
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00661284	0.14135149966711158
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00661284	0.14135149966711158
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00661284	0.14135149966711158
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00661284	0.14135149966711158
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.0065347	0.13968123300649557
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0065347	0.13968123300649557
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0065347	0.13968123300649557
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.00649595	0.13885293977513044
MYXEDEMA	0.00649595	0.13885293977513044
ATHYREOSIS	0.00649595	0.13885293977513044
EISENMENGER SYNDROME	0.00649595	0.13885293977513044
ACTH-INDEPENDENT CUSHING SYNDROME	0.00649595	0.13885293977513044
LIDDLE SYNDROME	0.00649595	0.13885293977513044
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.00649595	0.13885293977513044
EVANS SYNDROME	0.00649595	0.13885293977513044
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.00649595	0.13885293977513044
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.00649595	0.13885293977513044
X-LINKED SIDEROBLASTIC ANEMIA	0.00649595	0.13885293977513044
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.00649595	0.13885293977513044
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00649595	0.13885293977513044
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00649595	0.13885293977513044
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00639813	0.1367620070295269
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00639813	0.1367620070295269
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00639813	0.1367620070295269
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00639813	0.1367620070295269
OLIVER-MCFARLANE SYNDROME	0.00628931	0.13443594588276167
WELANDER DISTAL MYOPATHY; WDM	0.00628931	0.13443594588276167
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00628931	0.13443594588276167
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00628931	0.13443594588276167
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00628931	0.13443594588276167
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00628931	0.13443594588276167
AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES	0.00628931	0.13443594588276167
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.00628931	0.13443594588276167
PEROXISOME BIOGENESIS DISORDER 6B	0.00625098	0.13361663028125909
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.00617284	0.13194636362064302
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00617284	0.13194636362064302
IRIDA SYNDROME	0.00617284	0.13194636362064302
DISORDER OF BILE ACID SYNTHESIS	0.00617284	0.13194636362064302
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00617284	0.13194636362064302
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00617284	0.13194636362064302
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00617284	0.13194636362064302
SPINOCEREBELLAR ATAXIA TYPE 11	0.00617284	0.13194636362064302
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.00617284	0.13194636362064302
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00617284	0.13194636362064302
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00617284	0.13194636362064302
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00617284	0.13194636362064302
PRIMARY HYPEROXALURIA	0.00617284	0.13194636362064302
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.00617284	0.13194636362064302
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00617284	0.13194636362064302
SÉZARY SYNDROME	0.00617284	0.13194636362064302
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00617284	0.13194636362064302
MEDNIK SYNDROME	0.00617284	0.13194636362064302
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00617284	0.13194636362064302
CARPAL TUNNEL SYNDROME	0.00617284	0.13194636362064302
PRIMARY ERYTHROMELALGIA	0.00617284	0.13194636362064302
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00617284	0.13194636362064302
MICRO SYNDROME	0.00617284	0.13194636362064302
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00617284	0.13194636362064302
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.00617284	0.13194636362064302
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.00617284	0.13194636362064302
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.00617284	0.13194636362064302
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00617284	0.13194636362064302
NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE	0.00617284	0.13194636362064302
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.00617284	0.13194636362064302
FAMILIAL MULTIPLE LIPOMATOSIS	0.00617284	0.13194636362064302
PEDIATRIC-ONSET GRAVES DISEASE	0.00613497	0.13113688066137086
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00613497	0.13113688066137086
PPOMA	0.00613497	0.13113688066137086
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00613497	0.13113688066137086
CLASSIC PHENYLKETONURIA	0.00613497	0.13113688066137086
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.00613497	0.13113688066137086
NEPHROGENIC DIABETES INSIPIDUS	0.00613497	0.13113688066137086
NODULAR NON-SUPPURATIVE PANNICULITIS	0.00613497	0.13113688066137086
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00613497	0.13113688066137086
BURKITT LYMPHOMA	0.00613497	0.13113688066137086
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.00613497	0.13113688066137086
DRACUNCULIASIS	0.00613497	0.13113688066137086
GALACTOSE EPIMERASE DEFICIENCY	0.00613497	0.13113688066137086
MICROSCOPIC POLYANGIITIS	0.00613497	0.13113688066137086
GRFOMA	0.00613497	0.13113688066137086
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.00613497	0.13113688066137086
HALL-RIGGS SYNDROME	0.00613497	0.13113688066137086
WOLMAN DISEASE	0.00613497	0.13113688066137086
NEUROENDOCRINE TUMOR OF STOMACH	0.00613497	0.13113688066137086
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00613497	0.13113688066137086
GRISCELLI SYNDROME TYPE 2	0.00613497	0.13113688066137086
CHOLESTERYL ESTER STORAGE DISEASE	0.00613497	0.13113688066137086
RECURRENT ACUTE PANCREATITIS	0.00613497	0.13113688066137086
CARCINOMA OF GALLBLADDER AND EXTRAHEPATIC BILIARY TRACT	0.00613497	0.13113688066137086
HYDATIDIFORM MOLE	0.00613497	0.13113688066137086
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.13113688066137086
HIRSCHSPRUNG DISEASE	0.00613497	0.13113688066137086
PRIMARY PERITONEAL CARCINOMA	0.00613497	0.13113688066137086
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00613497	0.13113688066137086
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.00613497	0.13113688066137086
PSEUDOMYXOMA PERITONEI	0.00613497	0.13113688066137086
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.00613497	0.13113688066137086
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.00613497	0.13113688066137086
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00611441	0.13069740430429042
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00611441	0.13069740430429042
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00611441	0.13069740430429042
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00603627	0.12902713764367438
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.00603627	0.12902713764367438
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.00603627	0.12902713764367438
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00603627	0.12902713764367438
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.00603627	0.12902713764367438
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00603627	0.12902713764367438
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00603627	0.12902713764367438
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.00603627	0.12902713764367438
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.00581395	0.1242749789031042
BRANCHIOOTIC SYNDROME	0.00581395	0.1242749789031042
PONTINE TEGMENTAL CAP DYSPLASIA	0.00581395	0.1242749789031042
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00581395	0.1242749789031042
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.00581395	0.1242749789031042
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00581395	0.1242749789031042
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00581395	0.1242749789031042
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00581395	0.1242749789031042
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00581395	0.1242749789031042
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00581395	0.1242749789031042
BENIGN SCHWANNOMA	0.00581395	0.1242749789031042
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00581395	0.1242749789031042
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00581395	0.1242749789031042
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00581395	0.1242749789031042
BRANCHIOOTORENAL SYNDROME 1	0.00581395	0.1242749789031042
JOHNSON NEUROECTODERMAL SYNDROME	0.00581395	0.1242749789031042
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.00581395	0.1242749789031042
BOR SYNDROME	0.00581395	0.1242749789031042
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00581395	0.1242749789031042
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00581395	0.1242749789031042
FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL	0.00581395	0.1242749789031042
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00581395	0.1242749789031042
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.00581395	0.1242749789031042
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00581395	0.1242749789031042
CHARGE SYNDROME	0.00581395	0.1242749789031042
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00581395	0.1242749789031042
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00581395	0.1242749789031042
WILDERVANCK SYNDROME	0.00581395	0.1242749789031042
SCLEROSTEOSIS	0.00581395	0.1242749789031042
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00581395	0.1242749789031042
CAMURATI-ENGELMANN DISEASE	0.00581395	0.1242749789031042
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00581395	0.1242749789031042
HYPOTONIA-CYSTINURIA SYNDROME	0.00581395	0.1242749789031042
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00581395	0.1242749789031042
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.00581395	0.1242749789031042
HEART-HAND SYNDROME TYPE 2	0.00549451	0.11744685013336802
AXENFELD-RIEGER SYNDROME	0.00549451	0.11744685013336802
TRISOMY 18-LIKE SYNDROME	0.00549451	0.11744685013336802
6Q16 MICRODELETION SYNDROME	0.00549451	0.11744685013336802
TRISOMY 4P	0.00549451	0.11744685013336802
DISTAL TRISOMY 6P	0.00549451	0.11744685013336802
TRISOMY 8Q	0.00549451	0.11744685013336802
AUROCEPHALOSYNDACTYLY	0.00549451	0.11744685013336802
ACROCALLOSAL SYNDROME; ACLS	0.00549451	0.11744685013336802
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00549451	0.11744685013336802
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.00549451	0.11744685013336802
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00549451	0.11744685013336802
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.11744685013336802
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00549451	0.11744685013336802
DISTAL MONOSOMY 10P	0.00549451	0.11744685013336802
DISTAL TRISOMY 18Q	0.00549451	0.11744685013336802
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00549451	0.11744685013336802
FRONTONASAL DYSPLASIA	0.00549451	0.11744685013336802
MESOMELIA-SYNOSTOSES SYNDROME	0.00549451	0.11744685013336802
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00549451	0.11744685013336802
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00549451	0.11744685013336802
MCDONOUGH SYNDROME	0.00549451	0.11744685013336802
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.11744685013336802
MATTHEW-WOOD SYNDROME	0.00549451	0.11744685013336802
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.11744685013336802
RENAL AGENESIS, BILATERAL	0.00549451	0.11744685013336802
NAGER SYNDROME	0.00549451	0.11744685013336802
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00549451	0.11744685013336802
AARSKOG-SCOTT SYNDROME	0.00549451	0.11744685013336802
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00549451	0.11744685013336802
DISTAL TRISOMY 15Q	0.00549451	0.11744685013336802
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.11744685013336802
BARTSOCAS-PAPAS SYNDROME	0.00549451	0.11744685013336802
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00549451	0.11744685013336802
WEAVER SYNDROME	0.00549451	0.11744685013336802
PSEUDODIASTROPHIC DYSPLASIA	0.00549451	0.11744685013336802
DISTAL MONOSOMY 9P	0.00549451	0.11744685013336802
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.11744685013336802
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.00549451	0.11744685013336802
CAMPOMELIA, CUMMING TYPE	0.00549451	0.11744685013336802
OHDO SYNDROME	0.00549451	0.11744685013336802
BOWEN-CONRADI SYNDROME	0.00549451	0.11744685013336802
CAMPOMELIC DYSPLASIA	0.00549451	0.11744685013336802
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.11744685013336802
COFFIN-SIRIS SYNDROME	0.00549451	0.11744685013336802
ANTLEY-BIXLER SYNDROME	0.00549451	0.11744685013336802
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.11744685013336802
MOSAIC TRISOMY 14	0.00549451	0.11744685013336802
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.11744685013336802
LARYNX ATRESIA	0.00549451	0.11744685013336802
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00549451	0.11744685013336802
ACHONDROGENESIS TYPE 2	0.00549451	0.11744685013336802
NON-DISTAL TRISOMY 10Q	0.00549451	0.11744685013336802
TRISOMY 12P	0.00549451	0.11744685013336802
RUBINSTEIN-TAYBI SYNDROME	0.00549451	0.11744685013336802
15Q26 OVERGROWTH SYNDROME	0.00549451	0.11744685013336802
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00549451	0.11744685013336802
ACHONDROGENESIS TYPE 1B	0.00549451	0.11744685013336802
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00549451	0.11744685013336802
ACHONDROGENESIS TYPE 1A	0.00549451	0.11744685013336802
FAMILIAL VISCERAL MYOPATHY	0.00549451	0.11744685013336802
SCHISIS ASSOCIATION	0.00549451	0.11744685013336802
ROBERTS SYNDROME	0.00549451	0.11744685013336802
FEMORAL-FACIAL SYNDROME	0.00549451	0.11744685013336802
DUANE RETRACTION SYNDROME	0.00549451	0.11744685013336802
HOLZGREVE SYNDROME	0.00549451	0.11744685013336802
CONGENITAL DIAPHRAGMATIC HERNIA	0.00549451	0.11744685013336802
ISOLATED HEMIHYPERPLASIA	0.00549451	0.11744685013336802
MOSAIC TRISOMY 8	0.00549451	0.11744685013336802
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.00549451	0.11744685013336802
FRASER SYNDROME	0.00549451	0.11744685013336802
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00549451	0.11744685013336802
TETRASOMY X	0.00549451	0.11744685013336802
FLOATING-HARBOR SYNDROME	0.00549451	0.11744685013336802
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.11744685013336802
ACALVARIA	0.00549451	0.11744685013336802
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.11744685013336802
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.00549451	0.11744685013336802
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00549451	0.11744685013336802
TARP SYNDROME; TARPS	0.00549451	0.11744685013336802
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.11744685013336802
PHENYLKETONURIA	0.00549451	0.11744685013336802
DUBOWITZ SYNDROME	0.00549451	0.11744685013336802
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00549451	0.11744685013336802
LAURENCE-MOON SYNDROME	0.00549451	0.11744685013336802
15Q11Q13 MICRODUPLICATION SYNDROME	0.00549451	0.11744685013336802
CROUZON DISEASE	0.00537634	0.11492092984561532
PRIMARY CILIARY DYSKINESIA	0.00537634	0.11492092984561532
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.11492092984561532
PITUITARY CARCINOMA	0.00537634	0.11492092984561532
INTERNAL CAROTID AGENESIS	0.00537634	0.11492092984561532
SYDENHAM CHOREA	0.00537634	0.11492092984561532
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.11492092984561532
PARIETAL FORAMINA	0.00537634	0.11492092984561532
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.11492092984561532
SOLAR URTICARIA	0.00537634	0.11492092984561532
BRUNNER SYNDROME; BRNRS	0.00537634	0.11492092984561532
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.11492092984561532
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.11492092984561532
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.11492092984561532
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.11492092984561532
TEMPI SYNDROME	0.00537634	0.11492092984561532
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.11492092984561532
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.11492092984561532
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.11492092984561532
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.11492092984561532
CUTANEOUS MASTOCYTOMA	0.00537634	0.11492092984561532
MARSILI SYNDROME; MARSIS	0.00537634	0.11492092984561532
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.11492092984561532
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.11492092984561532
MAJEED SYNDROME	0.00537634	0.11492092984561532
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.11492092984561532
ROSAÏ-DORFMAN DISEASE	0.00537634	0.11492092984561532
IDIOPATHIC PANUVEITIS	0.00537634	0.11492092984561532
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00520833	0.11132966414750807
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00520833	0.11132966414750807
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.00520833	0.11132966414750807
MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS	0.00520833	0.11132966414750807
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00520833	0.11132966414750807
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00520833	0.11132966414750807
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00520833	0.11132966414750807
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.00520833	0.11132966414750807
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.00520833	0.11132966414750807
PRIMARY LIPODYSTROPHY	0.00520833	0.11132966414750807
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00520833	0.11132966414750807
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00520833	0.11132966414750807
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00520833	0.11132966414750807
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00520833	0.11132966414750807
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.00520833	0.11132966414750807
FINGERPRINT BODY MYOPATHY	0.00520833	0.11132966414750807
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00520833	0.11132966414750807
VACUOLAR MYOPATHY WITH SARCOPLASMIC RETICULUM PROTEIN AGGREGATES	0.00520833	0.11132966414750807
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00520833	0.11132966414750807
MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT	0.00520833	0.11132966414750807
ADDUCTED THUMBS SYNDROME	0.00520833	0.11132966414750807
CARNITINE DEFICIENCY, MYOPATHIC	0.00520833	0.11132966414750807
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00520833	0.11132966414750807
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.00520833	0.11132966414750807
HYPOPHOSPHATASIA, CHILDHOOD	0.00520833	0.11132966414750807
STROMME SYNDROME; STROMS	0.00520833	0.11132966414750807
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00520833	0.11132966414750807
OCULOGASTROINTESTINAL MUSCULAR DYSTROPHY	0.00520833	0.11132966414750807
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00520833	0.11132966414750807
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00520833	0.11132966414750807
SANJAD-SAKATI SYNDROME	0.00520833	0.11132966414750807
VICI SYNDROME; VICIS	0.00520833	0.11132966414750807
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00520833	0.11132966414750807
ACQUIRED PARTIAL LIPODYSTROPHY	0.00520833	0.11132966414750807
B4GALT1-CDG	0.00520833	0.11132966414750807
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00520833	0.11132966414750807
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.00520833	0.11132966414750807
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00520833	0.11132966414750807
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00520833	0.11132966414750807
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00520833	0.11132966414750807
XANTHINURIA, TYPE I	0.00520833	0.11132966414750807
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.00520833	0.11132966414750807
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00520833	0.11132966414750807
DISTAL MYOPATHY	0.00520833	0.11132966414750807
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00520833	0.11132966414750807
CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH	0.00520833	0.11132966414750807
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00414938	0.08869428047385382
ESTROGEN RESISTANCE SYNDROME	0.00414938	0.08869428047385382
WERNER SYNDROME; WRN	0.00414938	0.08869428047385382
AROMATASE DEFICIENCY	0.00414938	0.08869428047385382
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 2	0.00414938	0.08869428047385382
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.00414938	0.08869428047385382
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00414938	0.08869428047385382
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00414938	0.08869428047385382
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00414938	0.08869428047385382
DESBUQUOIS DYSPLASIA 1	0.00414938	0.08869428047385382
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00414938	0.08869428047385382
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00414938	0.08869428047385382
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00414938	0.08869428047385382
WARBURG MICRO SYNDROME 1	0.00414938	0.08869428047385382
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00414938	0.08869428047385382
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18	0.00414938	0.08869428047385382
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00414938	0.08869428047385382
PREMATURE OVARIAN FAILURE 2B	0.00414938	0.08869428047385382
FORSYTHE-WAKELING SYNDROME; FWS	0.00414938	0.08869428047385382
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00414938	0.08869428047385382
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00414938	0.08869428047385382
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00414938	0.08869428047385382
ATYPICAL WERNER SYNDROME	0.00414938	0.08869428047385382
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.08869428047385382
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2	0.00414938	0.08869428047385382
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00414938	0.08869428047385382
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1	0.00414938	0.08869428047385382
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00414938	0.08869428047385382
OSTEOPOROSIS, JUVENILE	0.00414938	0.08869428047385382
WERNER SYNDROME	0.00414938	0.08869428047385382
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00414938	0.08869428047385382
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.00414938	0.08869428047385382
GLYCOGEN STORAGE DISEASE IA	0.00414938	0.08869428047385382
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00414938	0.08869428047385382
BRUCK SYNDROME	0.00414938	0.08869428047385382
CLASSIC HOMOCYSTINURIA	0.00414938	0.08869428047385382
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00414938	0.08869428047385382
FAMILIAL HYPERPROLACTINEMIA	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20	0.00414938	0.08869428047385382
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00414938	0.08869428047385382
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00414938	0.08869428047385382
EHLERS-DANLOS SYNDROME, TYPE VI	0.00414938	0.08869428047385382
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00414938	0.08869428047385382
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00414938	0.08869428047385382
BETA-THALASSEMIA INTERMEDIA	0.00414938	0.08869428047385382
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00414938	0.08869428047385382
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00414938	0.08869428047385382
IDIOPATHIC HYPERCALCIURIA	0.00414938	0.08869428047385382
JUVENILE PAGET DISEASE	0.00414938	0.08869428047385382
SHASHI-PENA SYNDROME; SHAPNS	0.00414938	0.08869428047385382
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00414938	0.08869428047385382
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00414938	0.08869428047385382
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00414938	0.08869428047385382
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00414938	0.08869428047385382
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00414938	0.08869428047385382
THROMBOCYTOPENIA 6	0.00414938	0.08869428047385382
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00414938	0.08869428047385382
OVARIAN DYSGENESIS 1	0.00414938	0.08869428047385382
PACHYDERMOPERIOSTOSIS	0.00414938	0.08869428047385382
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00414938	0.08869428047385382
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00414938	0.08869428047385382
AMISH LETHAL MICROCEPHALY	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00414938	0.08869428047385382
ODONTOCHONDRODYSPLASIA; ODCD	0.00414938	0.08869428047385382
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00414938	0.08869428047385382
MU-HEAVY CHAIN DISEASE	0.00414938	0.08869428047385382
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.00414938	0.08869428047385382
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00414938	0.08869428047385382
URBAN-ROGERS-MEYER SYNDROME	0.00414938	0.08869428047385382
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00414938	0.08869428047385382
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00414938	0.08869428047385382
OVARIAN DYSGENESIS 8; ODG8	0.00414938	0.08869428047385382
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00414938	0.08869428047385382
MYCETOMA	0.00414938	0.08869428047385382
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00414938	0.08869428047385382
OSTEOPOROSIS	0.00414938	0.08869428047385382
PANCREATOBLASTOMA	0.00401606	0.08584452425177386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00401606	0.08584452425177386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00401606	0.08584452425177386
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.00401606	0.08584452425177386
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00401606	0.08584452425177386
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00401606	0.08584452425177386
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00401606	0.08584452425177386
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00401606	0.08584452425177386
CITRULLINEMIA TYPE II	0.00401606	0.08584452425177386
CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY	0.00401606	0.08584452425177386
HEREDITARY ANGIOEDEMA TYPE 1	0.00401606	0.08584452425177386
ACID PHOSPHATASE DEFICIENCY	0.00401606	0.08584452425177386
GALACTOSE EPIMERASE DEFICIENCY	0.00401606	0.08584452425177386
COLCHICINE POISONING	0.00401606	0.08584452425177386
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.00401606	0.08584452425177386
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00401606	0.08584452425177386
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.00401606	0.08584452425177386
GALACTOSEMIA	0.00401606	0.08584452425177386
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00401606	0.08584452425177386
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.00401606	0.08584452425177386
ALPHA-METHYLACETOACETIC ACIDURIA	0.00401606	0.08584452425177386
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00401606	0.08584452425177386
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00401606	0.08584452425177386
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00401606	0.08584452425177386
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00401606	0.08584452425177386
INFANTILE LIVER FAILURE SYNDROME 2	0.00401606	0.08584452425177386
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00401606	0.08584452425177386
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00401606	0.08584452425177386
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.08584452425177386
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.00401606	0.08584452425177386
CRYPTOSPORIDIOSIS	0.00401606	0.08584452425177386
HISTIOCYTOID CARDIOMYOPATHY	0.00401606	0.08584452425177386
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00401606	0.08584452425177386
VISCERAL MYOPATHY; VSCM	0.00401606	0.08584452425177386
ARGININOSUCCINIC ACIDURIA	0.00401606	0.08584452425177386
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00401606	0.08584452425177386
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.00401606	0.08584452425177386
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00401606	0.08584452425177386
CITRULLINEMIA, CLASSIC	0.00401606	0.08584452425177386
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00401606	0.08584452425177386
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00401606	0.08584452425177386
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00401606	0.08584452425177386
MEVALONIC ACIDURIA; MEVA	0.00401606	0.08584452425177386
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00401606	0.08584452425177386
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00401606	0.08584452425177386
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.08584452425177386
KRABBE DISEASE	0.00401606	0.08584452425177386
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00401606	0.08584452425177386
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00401606	0.08584452425177386
LIVER FAILURE, INFANTILE, TRANSIENT	0.00401606	0.08584452425177386
EOSINOPHILIC GASTROENTERITIS	0.00401606	0.08584452425177386
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00401606	0.08584452425177386
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00401606	0.08584452425177386
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00401606	0.08584452425177386
CONGENITAL SHORT BOWEL SYNDROME	0.00401606	0.08584452425177386
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00401606	0.08584452425177386
CONGENITAL PANCREATIC CYST	0.00401606	0.08584452425177386
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00401606	0.08584452425177386
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00401606	0.08584452425177386
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00401606	0.08584452425177386
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00401606	0.08584452425177386
MAPLE SYRUP URINE DISEASE; MSUD	0.00401606	0.08584452425177386
ENTERIC ANENDOCRINOSIS	0.00401606	0.08584452425177386
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00401606	0.08584452425177386
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.00401606	0.08584452425177386
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.00401606	0.08584452425177386
LESCH-NYHAN SYNDROME; LNS	0.00401606	0.08584452425177386
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.00401606	0.08584452425177386
METHYLMALONIC ACIDURIA, CBLA TYPE	0.00401606	0.08584452425177386
METHYLMALONIC ACIDURIA, CBLB TYPE	0.00401606	0.08584452425177386
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00401606	0.08584452425177386
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00401606	0.08584452425177386
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00401606	0.08584452425177386
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00401606	0.08584452425177386
HEREDITARY FRUCTOSE INTOLERANCE	0.00401606	0.08584452425177386
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00401606	0.08584452425177386
HYPERLIPOPROTEINEMIA, TYPE I	0.00401606	0.08584452425177386
ANGIOEDEMA, HEREDITARY, TYPE III	0.00401606	0.08584452425177386
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00401606	0.08584452425177386
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00401606	0.08584452425177386
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00401606	0.08584452425177386
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00401606	0.08584452425177386
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00401606	0.08584452425177386
ALAGILLE SYNDROME 1; ALGS1	0.00387597	0.08285005718643343
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.00387597	0.08285005718643343
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00387597	0.08285005718643343
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00387597	0.08285005718643343
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00387597	0.08285005718643343
USHER SYNDROME, TYPE IE; USH1E	0.00387597	0.08285005718643343
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00387597	0.08285005718643343
RICHARDS-RUNDLE SYNDROME; RRNS	0.00387597	0.08285005718643343
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.00387597	0.08285005718643343
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00387597	0.08285005718643343
PIERSON SYNDROME	0.00387597	0.08285005718643343
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00387597	0.08285005718643343
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00387597	0.08285005718643343
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.00387597	0.08285005718643343
ALPERS-HUTTENLOCHER SYNDROME	0.00387597	0.08285005718643343
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.00387597	0.08285005718643343
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00387597	0.08285005718643343
DEAFNESS, X-LINKED 5; DFNX5	0.00387597	0.08285005718643343
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.00387597	0.08285005718643343
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.00387597	0.08285005718643343
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.00387597	0.08285005718643343
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.00387597	0.08285005718643343
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00387597	0.08285005718643343
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00387597	0.08285005718643343
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00387597	0.08285005718643343
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.00387597	0.08285005718643343
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00387597	0.08285005718643343
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00384615	0.08221264546619322
8Q12 MICRODUPLICATION SYNDROME	0.00384615	0.08221264546619322
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00384615	0.08221264546619322
DDOST-CDG	0.00384615	0.08221264546619322
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00384615	0.08221264546619322
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00384615	0.08221264546619322
COSTELLO SYNDROME	0.00384615	0.08221264546619322
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.08221264546619322
CANAVAN DISEASE	0.00384615	0.08221264546619322
1Q21.1 MICRODUPLICATION SYNDROME	0.00384615	0.08221264546619322
GASTROESOPHAGEAL REFLUX	0.00384615	0.08221264546619322
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.08221264546619322
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00384615	0.08221264546619322
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00384615	0.08221264546619322
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00384615	0.08221264546619322
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00384615	0.08221264546619322
FRYNS SYNDROME	0.00384615	0.08221264546619322
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.00384615	0.08221264546619322
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00384615	0.08221264546619322
INFANTILE DYSTONIA-PARKINSONISM	0.00384615	0.08221264546619322
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00384615	0.08221264546619322
WIEDEMANN-STEINER SYNDROME	0.00384615	0.08221264546619322
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00384615	0.08221264546619322
TOWNES-BROCKS SYNDROME 1; TBS1	0.00384615	0.08221264546619322
CODAS SYNDROME	0.00384615	0.08221264546619322
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00384615	0.08221264546619322
EOSINOPHILIC ESOPHAGITIS	0.00384615	0.08221264546619322
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00384615	0.08221264546619322
MEIER-GORLIN SYNDROME 5; MGORS5	0.00384615	0.08221264546619322
MEIER-GORLIN SYNDROME 6; MGORS6	0.00384615	0.08221264546619322
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00384615	0.08221264546619322
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00384615	0.08221264546619322
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00384615	0.08221264546619322
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.08221264546619322
CHOPS SYNDROME; CHOPS	0.00384615	0.08221264546619322
HOLMES-GANG SYNDROME	0.00384615	0.08221264546619322
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00384615	0.08221264546619322
FG SYNDROME TYPE 1	0.00384615	0.08221264546619322
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.00384615	0.08221264546619322
NK-CELL ENTEROPATHY	0.00384615	0.08221264546619322
WEBB-DATTANI SYNDROME; WEDAS	0.00384615	0.08221264546619322
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00384615	0.08221264546619322
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00384615	0.08221264546619322
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.00384615	0.08221264546619322
OKAMOTO SYNDROME	0.00384615	0.08221264546619322
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00384615	0.08221264546619322
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.00384615	0.08221264546619322
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00384615	0.08221264546619322
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.00384615	0.08221264546619322
AICARDI SYNDROME	0.00384615	0.08221264546619322
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00384615	0.08221264546619322
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.00384615	0.08221264546619322
RETT SYNDROME, CONGENITAL VARIANT	0.00384615	0.08221264546619322
8Q24.3 MICRODELETION SYNDROME	0.00384615	0.08221264546619322
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00384615	0.08221264546619322
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00384615	0.08221264546619322
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00384615	0.08221264546619322
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.08221264546619322
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00384615	0.08221264546619322
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00384615	0.08221264546619322
EMANUEL SYNDROME	0.00384615	0.08221264546619322
MEIER-GORLIN SYNDROME 1; MGORS1	0.00384615	0.08221264546619322
POPOV-CHANG SYNDROME; POPCHAS	0.00384615	0.08221264546619322
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00384615	0.08221264546619322
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.00384615	0.08221264546619322
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.00384615	0.08221264546619322
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.00384615	0.08221264546619322
BOHRING-OPITZ SYNDROME	0.00384615	0.08221264546619322
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.00384615	0.08221264546619322
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.00384615	0.08221264546619322
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.00384615	0.08221264546619322
COFFIN-SIRIS SYNDROME 6; CSS6	0.00384615	0.08221264546619322
SWEENEY-COX SYNDROME; SWCOS	0.00384615	0.08221264546619322
EMANUEL SYNDROME	0.00384615	0.08221264546619322
14Q12 MICRODELETION SYNDROME	0.00384615	0.08221264546619322
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.00384615	0.08221264546619322
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00384615	0.08221264546619322
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00384615	0.08221264546619322
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00384615	0.08221264546619322
CHRISTIANSON SYNDROME	0.00384615	0.08221264546619322
CARCINOMA OF ESOPHAGUS	0.00384615	0.08221264546619322
16P13.11 MICRODELETION SYNDROME	0.00384615	0.08221264546619322
3C SYNDROME	0.00384615	0.08221264546619322
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00384615	0.08221264546619322
XQ28 (MECP2) DUPLICATION	0.00384615	0.08221264546619322
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00384615	0.08221264546619322
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00384615	0.08221264546619322
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00384615	0.08221264546619322
MIRAGE SYNDROME; MIRAGE	0.00384615	0.08221264546619322
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00384615	0.08221264546619322
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00384615	0.08221264546619322
MEIER-GORLIN SYNDROME 3; MGORS3	0.00384615	0.08221264546619322
DUBIN-JOHNSON SYNDROME	0.0035461	0.07579898394177757
ANISOCORIA	0.0035461	0.07579898394177757
HERMANSKY-PUDLAK SYNDROME	0.0035461	0.07579898394177757
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0035461	0.07579898394177757
CRONKHITE-CANADA SYNDROME	0.0035461	0.07579898394177757
PRIMARY MYELOFIBROSIS	0.0035461	0.07579898394177757
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.0035461	0.07579898394177757
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.07579898394177757
LYMPHANGIOLEIOMYOMATOSIS	0.0035461	0.07579898394177757
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.07579898394177757
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.07579898394177757
REFRACTORY ANEMIA	0.0035461	0.07579898394177757
TUBERCULOSIS	0.0035461	0.07579898394177757
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0035461	0.07579898394177757
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.07579898394177757
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.07579898394177757
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.07579898394177757
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.07579898394177757
CHOLANGIOCARCINOMA	0.0035461	0.07579898394177757
THYROID HYPOPLASIA	0.0035461	0.07579898394177757
THYROID HEMIAGENESIS	0.0035461	0.07579898394177757
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.07579898394177757
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.07579898394177757
FAMILIAL THYROID DYSHORMONOGENESIS	0.0035461	0.07579898394177757
MAST CELL SARCOMA	0.0035461	0.07579898394177757
X-LINKED AGAMMAGLOBULINEMIA	0.0035461	0.07579898394177757
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0035461	0.07579898394177757
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0035461	0.07579898394177757
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.07579898394177757
PERIPARTUM CARDIOMYOPATHY	0.0035461	0.07579898394177757
CHRONIC MYELOID LEUKEMIA	0.0035461	0.07579898394177757
FOLLICULAR LYMPHOMA	0.0035461	0.07579898394177757
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.07579898394177757
KLATSKIN TUMOR	0.0035461	0.07579898394177757
EOSINOPHILIC FASCIITIS	0.0035461	0.07579898394177757
EBSTEIN MALFORMATION	0.0035461	0.07579898394177757
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.0035461	0.07579898394177757
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.07579898394177757
TETRASOMY 9P	0.0035461	0.07579898394177757
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.07579898394177757
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.07579898394177757
CONGENITAL ISOLATED ACTH DEFICIENCY	0.0035461	0.07579898394177757
SATOYOSHI SYNDROME	0.0035461	0.07579898394177757
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.07579898394177757
CONGENITAL ANALBUMINEMIA	0.0035461	0.07579898394177757
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.07579898394177757
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.07579898394177757
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0035461	0.07579898394177757
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.07579898394177757
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.07579898394177757
INSULIN-RESISTANCE SYNDROME TYPE B	0.0035461	0.07579898394177757
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.07579898394177757
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.07579898394177757
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.00344828	0.07370805119617405
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.07370805119617405
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.07370805119617405
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.07370805119617405
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.07370805119617405
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.07370805119617405
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.07370805119617405
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.07370805119617405
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.07370805119617405
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.07370805119617405
PARTINGTON SYNDROME	0.00344828	0.07370805119617405
HYDROCEPHALUS, NORMAL-PRESSURE	0.00344828	0.07370805119617405
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.00344828	0.07370805119617405
FRIED SYNDROME	0.00344828	0.07370805119617405
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.07370805119617405
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00344828	0.07370805119617405
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.07370805119617405
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.07370805119617405
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00344828	0.07370805119617405
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.07370805119617405
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.07370805119617405
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.07370805119617405
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.07370805119617405
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.07370805119617405
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.07370805119617405
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.07370805119617405
MUCOLIPIDOSIS TYPE IV	0.00344828	0.07370805119617405
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.07370805119617405
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.07370805119617405
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00344828	0.07370805119617405
FOIX-CHAVANY-MARIE SYNDROME	0.00344828	0.07370805119617405
PSEUDOACHONDROPLASIA	0.00344828	0.07370805119617405
ATAXIA-TELANGIECTASIA	0.00344828	0.07370805119617405
JOUBERT SYNDROME 24	0.00344828	0.07370805119617405
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.07370805119617405
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00344828	0.07370805119617405
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.07370805119617405
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00344828	0.07370805119617405
LERI PLEONOSTEOSIS	0.00344828	0.07370805119617405
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.07370805119617405
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.07370805119617405
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.07370805119617405
KUFOR-RAKEB SYNDROME	0.00344828	0.07370805119617405
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.07370805119617405
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.00344828	0.07370805119617405
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.07370805119617405
MASA SYNDROME	0.00344828	0.07370805119617405
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.07370805119617405
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00344828	0.07370805119617405
DYSTONIA 16; DYT16	0.00344828	0.07370805119617405
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00344828	0.07370805119617405
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00344828	0.07370805119617405
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.07370805119617405
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.00344828	0.07370805119617405
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.07370805119617405
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00344828	0.07370805119617405
ALZHEIMER DISEASE 3; AD	0.00344828	0.07370805119617405
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.07370805119617405
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.07370805119617405
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00344828	0.07370805119617405
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.07370805119617405
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.07370805119617405
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.07370805119617405
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00344828	0.07370805119617405
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.07370805119617405
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00344828	0.07370805119617405
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00344828	0.07370805119617405
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.07370805119617405
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.07370805119617405
TETRASOMY 18P	0.00344828	0.07370805119617405
THORACOMELIC DYSPLASIA	0.00344828	0.07370805119617405
DYSTONIA 23; DYT23	0.00344828	0.07370805119617405
NON-DISTAL MONOSOMY 10Q	0.00344828	0.07370805119617405
TRISOMY XQ28	0.00344828	0.07370805119617405
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.07370805119617405
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.07370805119617405
OSTEOCHONDRITIS DISSECANS	0.00344828	0.07370805119617405
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.00344828	0.07370805119617405
BENIGN HEREDITARY CHOREA	0.00344828	0.07370805119617405
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.00344828	0.07370805119617405
COHEN-GIBSON SYNDROME; COGIS	0.00344828	0.07370805119617405
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.00344828	0.07370805119617405
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.07370805119617405
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00344828	0.07370805119617405
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.00344828	0.07370805119617405
MELNICK-NEEDLES SYNDROME	0.00344828	0.07370805119617405
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.07370805119617405
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.07370805119617405
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.07370805119617405
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.06764344847093755
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.06764344847093755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.00316456	0.06764344847093755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00316456	0.06764344847093755
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00316456	0.06764344847093755
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.06764344847093755
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.00316456	0.06764344847093755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.00316456	0.06764344847093755
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.06764344847093755
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.06764344847093755
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.06764344847093755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.00316456	0.06764344847093755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.06764344847093755
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.00316456	0.06764344847093755
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00316456	0.06764344847093755
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.06764344847093755
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00316456	0.06764344847093755
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.06764344847093755
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.00316456	0.06764344847093755
GAPO SYNDROME	0.00316456	0.06764344847093755
NEONATAL ADRENOLEUKODYSTROPHY	0.00316456	0.06764344847093755
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00316456	0.06764344847093755
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00316456	0.06764344847093755
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.06764344847093755
FETAL METHYLMERCURY SYNDROME	0.00316456	0.06764344847093755
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.06764344847093755
INFANTILE NEUROAXONAL DYSTROPHY	0.00316456	0.06764344847093755
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.06764344847093755
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.06764344847093755
ASCHER SYNDROME	0.00316456	0.06764344847093755
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.06764344847093755
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.06764344847093755
AYMÉ-GRIPP SYNDROME	0.00316456	0.06764344847093755
VOGT-KOYANAGI-HARADA DISEASE	0.00316456	0.06764344847093755
MMEP SYNDROME	0.00316456	0.06764344847093755
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.06764344847093755
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.06764344847093755
RENAL COLOBOMA SYNDROME	0.00316456	0.06764344847093755
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.06764344847093755
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.06764344847093755
X-LINKED RETINAL DYSPLASIA	0.00316456	0.06764344847093755
CRANIOTELENCEPHALIC DYSPLASIA	0.00316456	0.06764344847093755
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.06764344847093755
LOWRY-WOOD SYNDROME	0.00316456	0.06764344847093755
BLUE CONE MONOCHROMATISM	0.00316456	0.06764344847093755
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.06764344847093755
COFFIN-SIRIS SYNDROME 1; CSS1	0.00316456	0.06764344847093755
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.06764344847093755
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00316456	0.06764344847093755
CONE ROD DYSTROPHY	0.00316456	0.06764344847093755
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.06764344847093755
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.06764344847093755
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00316456	0.06764344847093755
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00316456	0.06764344847093755
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00316456	0.06764344847093755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00316456	0.06764344847093755
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.06764344847093755
COHEN SYNDROME	0.00316456	0.06764344847093755
JALILI SYNDROME	0.00316456	0.06764344847093755
ACRODERMATITIS ENTEROPATHICA	0.00316456	0.06764344847093755
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.06764344847093755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.00316456	0.06764344847093755
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00316456	0.06764344847093755
GILLESPIE SYNDROME; GLSP	0.00316456	0.06764344847093755
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00316456	0.06764344847093755
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.00316456	0.06764344847093755
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00316456	0.06764344847093755
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00316456	0.06764344847093755
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.06764344847093755
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.06764344847093755
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.06764344847093755
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.06764344847093755
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.06764344847093755
PETERS PLUS SYNDROME	0.00316456	0.06764344847093755
FILIPPI SYNDROME; FLPIS	0.00316456	0.06764344847093755
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.06764344847093755
BRADYOPSIA	0.00316456	0.06764344847093755
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.06764344847093755
WAGR SYNDROME	0.00316456	0.06764344847093755
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.06764344847093755
OCULAR ALBINISM	0.00316456	0.06764344847093755
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.06764344847093755
FUMARASE DEFICIENCY; FMRD	0.00316456	0.06764344847093755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.00316456	0.06764344847093755
HYPERTRYPTOPHANEMIA; HYPTRP	0.00316456	0.06764344847093755
JOUBERT SYNDROME 2	0.00316456	0.06764344847093755
JOUBERT SYNDROME 3; JBTS3	0.00316456	0.06764344847093755
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.06764344847093755
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00316456	0.06764344847093755
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.06764344847093755
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.06764344847093755
CONGENITAL RUBELLA SYNDROME	0.00316456	0.06764344847093755
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.06764344847093755
RFT1-CDG	0.00316456	0.06764344847093755
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.06764344847093755
TRIPLE A SYNDROME	0.00316456	0.06764344847093755
CONE DYSTROPHY 4	0.00316456	0.06764344847093755
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.06764344847093755
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.06764344847093755
ALBINISM, OCULAR, TYPE I	0.00316456	0.06764344847093755
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.06764344847093755
CHROMOSOME XP11.3 DELETION SYNDROME	0.00316456	0.06764344847093755
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.06764344847093755
16Q24.3 MICRODELETION SYNDROME	0.00316456	0.06764344847093755
PAPILLOMA OF CHOROID PLEXUS	0.00316456	0.06764344847093755
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00316456	0.06764344847093755
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00316456	0.06764344847093755
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.06764344847093755
N SYNDROME	0.00316456	0.06764344847093755
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.06764344847093755
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.06764344847093755
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.06764344847093755
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00316456	0.06764344847093755
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.06764344847093755
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.00316456	0.06764344847093755
CONGENITAL TOXOPLASMOSIS	0.00316456	0.06764344847093755
N SYNDROME	0.00316456	0.06764344847093755
FISH-EYE DISEASE	0.00316456	0.06764344847093755
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.00316456	0.06764344847093755
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.06764344847093755
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.06764344847093755
MULTIPLE SULFATASE DEFICIENCY	0.00316456	0.06764344847093755
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.06764344847093755
OCULOCUTANEOUS ALBINISM	0.00316456	0.06764344847093755
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.06764344847093755
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.00316456	0.06764344847093755
MUCOLIPIDOSIS IV; ML4	0.00316456	0.06764344847093755
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00316456	0.06764344847093755
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.06764344847093755
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.06764344847093755
RETINITIS PIGMENTOSA 20	0.00316456	0.06764344847093755
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.06764344847093755
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.06764344847093755
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00316456	0.06764344847093755
ABLEPHARON MACROSTOMIA SYNDROME	0.00316456	0.06764344847093755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00316456	0.06764344847093755
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.06764344847093755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00316456	0.06764344847093755
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.06764344847093755
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.06764344847093755
IMMUNODEFICIENCY 23; IMD23	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA TYPE 1	0.00308642	0.06597318181032151
CHROMOSOME 2Q37 DELETION SYNDROME	0.00308642	0.06597318181032151
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA TYPE 2	0.00308642	0.06597318181032151
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00308642	0.06597318181032151
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.00308642	0.06597318181032151
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00308642	0.06597318181032151
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00308642	0.06597318181032151
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00308642	0.06597318181032151
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA TYPE 31	0.00308642	0.06597318181032151
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00308642	0.06597318181032151
ADIE PUPIL	0.00308642	0.06597318181032151
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00308642	0.06597318181032151
PELIZAEUS-MERZBACHER DISEASE	0.00308642	0.06597318181032151
LOEYS-DIETZ SYNDROME 5	0.00308642	0.06597318181032151
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00308642	0.06597318181032151
PERRAULT SYNDROME 5; PRLTS5	0.00308642	0.06597318181032151
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.00308642	0.06597318181032151
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.00308642	0.06597318181032151
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00308642	0.06597318181032151
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00308642	0.06597318181032151
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00308642	0.06597318181032151
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.00308642	0.06597318181032151
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00308642	0.06597318181032151
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00308642	0.06597318181032151
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00308642	0.06597318181032151
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00308642	0.06597318181032151
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00308642	0.06597318181032151
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.00308642	0.06597318181032151
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00308642	0.06597318181032151
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00308642	0.06597318181032151
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00308642	0.06597318181032151
NON-DISTAL MONOSOMY 20Q	0.00308642	0.06597318181032151
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.00308642	0.06597318181032151
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00308642	0.06597318181032151
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00308642	0.06597318181032151
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00308642	0.06597318181032151
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00308642	0.06597318181032151
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.06597318181032151
VERVERI-BRADY SYNDROME; VERBRAS	0.00308642	0.06597318181032151
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00308642	0.06597318181032151
FACIAL SPASM	0.00308642	0.06597318181032151
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00308642	0.06597318181032151
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00308642	0.06597318181032151
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.00308642	0.06597318181032151
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00308642	0.06597318181032151
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.00308642	0.06597318181032151
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00308642	0.06597318181032151
GLYCINE ENCEPHALOPATHY; GCE	0.00308642	0.06597318181032151
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00308642	0.06597318181032151
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00308642	0.06597318181032151
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.00308642	0.06597318181032151
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00308642	0.06597318181032151
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00308642	0.06597318181032151
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.00294985	0.06305395583335285
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00294985	0.06305395583335285
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00294985	0.06305395583335285
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.00294985	0.06305395583335285
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00294985	0.06305395583335285
NAKAJO-NISHIMURA SYNDROME	0.00294985	0.06305395583335285
STIFF SKIN SYNDROME	0.00294985	0.06305395583335285
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.00294985	0.06305395583335285
SPASTIC PARAPLEGIA TYPE 2	0.00294985	0.06305395583335285
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00294985	0.06305395583335285
%300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX	0.00294985	0.06305395583335285
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.06305395583335285
NIJMEGEN BREAKAGE SYNDROME	0.00294985	0.06305395583335285
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.00294985	0.06305395583335285
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00294985	0.06305395583335285
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.00294985	0.06305395583335285
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.00294985	0.06305395583335285
NOONAN SYNDROME	0.00294985	0.06305395583335285
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00294985	0.06305395583335285
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.00294985	0.06305395583335285
CRYOGLOBULINEMIC VASCULITIS	0.00294985	0.06305395583335285
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION	0.00294985	0.06305395583335285
EPISODIC ATAXIA, TYPE 7; EA7	0.00294985	0.06305395583335285
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.00294985	0.06305395583335285
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.00294985	0.06305395583335285
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00294985	0.06305395583335285
SPONDYLOOCULAR SYNDROME; SOS	0.00294985	0.06305395583335285
GLYCOGEN STORAGE DISEASE IXB	0.00294985	0.06305395583335285
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.00294985	0.06305395583335285
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.00294985	0.06305395583335285
RETT SYNDROME	0.00294985	0.06305395583335285
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00294985	0.06305395583335285
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00294985	0.06305395583335285
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00294985	0.06305395583335285
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00294985	0.06305395583335285
KEARNS-SAYRE SYNDROME; KSS	0.00294985	0.06305395583335285
COWCHOCK SYNDROME; COWCK	0.00294985	0.06305395583335285
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.00294985	0.06305395583335285
HEREDITARY SPHEROCYTOSIS	0.00294985	0.06305395583335285
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00294985	0.06305395583335285
MUSCLE GLYCOGENOSIS, X-LINKED	0.00294985	0.06305395583335285
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00294985	0.06305395583335285
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00294985	0.06305395583335285
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES	0.00294985	0.06305395583335285
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.00294985	0.06305395583335285
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00294985	0.06305395583335285
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00294985	0.06305395583335285
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00294985	0.06305395583335285
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00294985	0.06305395583335285
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00294985	0.06305395583335285
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00294985	0.06305395583335285
SUPRABULBAR PARESIS, CONGENITAL	0.00294985	0.06305395583335285
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00294985	0.06305395583335285
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.00294985	0.06305395583335285
MULTICENTRIC RETICULOHISTIOCYTOSIS	0.00294985	0.06305395583335285
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00294985	0.06305395583335285
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00294985	0.06305395583335285
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.00294985	0.06305395583335285
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE	0.00294985	0.06305395583335285
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00294985	0.06305395583335285
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00294985	0.06305395583335285
THYROID ECTOPIA	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.00294985	0.06305395583335285
ISAAC SYNDROME	0.00294985	0.06305395583335285
GLYCOGEN STORAGE DISEASE VII	0.00294985	0.06305395583335285
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00294985	0.06305395583335285
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00294985	0.06305395583335285
EPISODIC ATAXIA, TYPE 8	0.00294985	0.06305395583335285
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7; MDDGC7	0.00294985	0.06305395583335285
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00294985	0.06305395583335285
FOCAL MYOSITIS	0.00294985	0.06305395583335285
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00294985	0.06305395583335285
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00294985	0.06305395583335285
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00294985	0.06305395583335285
GLYCOGEN STORAGE DISEASE V; GSD5	0.00294985	0.06305395583335285
